activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	129353	CHEMBL769385	Inhibition of Protein tyrosine kinase Lyn	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	129353	CHEMBL769385	Inhibition of Protein tyrosine kinase Lyn	B	O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl		CHEMBL319556	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	182568	CHEMBL769208	Inhibition of Protein tyrosine kinase Lyn	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	IC50	nM	1800.0	CHEMBL3905	Homo sapiens	IC50	uM	1.8
Not Determined	305993	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2ccccc2cc1C(=O)Nc1ccccc1O		CHEMBL79508		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
Not Determined	307295	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2cc(O)ccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL79253		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
Not Determined	310020	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	COc1cccc2cc(C(=O)Nc3cccc(O)c3)c(=N)oc12		CHEMBL81599		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
	311334	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL82085	<	IC50	ug.mL-1	10.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	10.0
	312683	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1cccc(CO)c1		CHEMBL81806	=	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
	313983	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2ccccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL81826	=	IC50	ug.mL-1	10.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	10.0
	318890	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccccc1O		CHEMBL79977	>	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
	318894	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1cccc(CO)c1		CHEMBL81137	=	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
	320122	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2cc(O)cc(O)c2cc1C(=O)Nc1ccccc1O		CHEMBL79506	>>	IC50	ug.mL-1	5.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	5.0
Not Determined	320126	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	COc1ccc2oc(=N)c(C(=O)Nc3ccc(O)cc3)cc2c1		CHEMBL310404		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
Not Determined	321350	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2ccccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL309785		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
Not Determined	322629	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2cc(O)ccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79252		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
Not Determined	325066	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2ccc(O)cc2cc1C(=O)Nc1cccc(O)c1		CHEMBL79888		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
	325070	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79745	>	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
	331643	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccccc1CO		CHEMBL311194	>	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
	332976	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1cccc(O)c1		CHEMBL81043	=	IC50	ug.mL-1	18.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	18.0
	334391	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1O		CHEMBL81403	>	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
	336812	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2cc(O)cc(O)c2cc1C(=O)Nc1cccc(O)c1		CHEMBL309385	=	IC50	ug.mL-1	5.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	5.0
Not Determined	336816	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1CO		CHEMBL81807		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
Not Determined	338105	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2ccc(O)cc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL81561		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
	338109	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)c(O)ccc2cc1C(=O)Nc1ccccc1		CHEMBL80091	>	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
	338113	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2cc(O)cc(O)c2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79920	=	IC50	ug.mL-1	5.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	5.0
Not Determined	339480	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	N=c1oc2cc(O)ccc2cc1C(=O)Nc1ccccc1O		CHEMBL80073		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
	342029	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	CC(=O)c1cccc(NC(=O)c2cc3ccc(O)c(O)c3oc2=N)c1		CHEMBL81700	=	IC50	ug.mL-1	10.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	10.0
	344492	CHEMBL823027	Inhibitory activity against p56 Lyn tyrosine kinase	B	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccc(O)cc1		CHEMBL79581	=	IC50	ug.mL-1	20.0	CHEMBL3905	Homo sapiens	IC50	ug ml-1	20.0
Not Determined	344496	CHEMBL823028	Inhibitory activity against p56 Lyn tyrosine kinase; ND: Not determined	B	COc1ccc2cc(C(=O)Nc3ccc(O)cc3)c(=N)oc2c1		CHEMBL433140		IC50	ug.mL-1		CHEMBL3905	Homo sapiens	IC50	ug ml-1	
	464559	CHEMBL769384	Inhibition of Protein tyrosine kinase Lyn	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	IC50	nM	420.0	CHEMBL3905	Homo sapiens	IC50	uM	0.42
	475736	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	C[C@@H](c1ccc2ccccc2c1)[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O	Outside typical range	CHEMBL413670	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	476897	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	C[C@@H](c1ccc2ccccc2c1)[C@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O	Outside typical range	CHEMBL412218	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	485518	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2ccc(O)c(I)c2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1	Outside typical range	CHEMBL436961	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	487904	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	CC1(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc2cc(I)c(O)c(I)c2)NC(=O)[C@@H]1NC(=O)[C@@H](N)Cc1ccc(O)cc1	Outside typical range	CHEMBL216490	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	503344	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	C[C@H](c1ccc2ccccc2c1)[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O	Outside typical range	CHEMBL414159	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	509376	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	CC(=O)N[C@H]1C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)CSSC1(C)C	Outside typical range	CHEMBL405681	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	509381	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	CC(=O)N[C@H]1C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)CSSC1(C)C	Outside typical range	CHEMBL404595	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	509386	CHEMBL769207	Inhibition of Lyn kinase against 100 uM cdc2 substrate	B	C[C@H](c1ccc2ccccc2c1)[C@H]1NC(=O)[C@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(C)(C)SSC[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CO)NC(=O)CNC1=O	Outside typical range	CHEMBL262212	>	IC50	nM	800000.0	CHEMBL3905	Homo sapiens	IC50	uM	800.0
	616552	CHEMBL769210	Inhibition of Protein tyrosine kinase Lyn at 100 M	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	78.0	CHEMBL3905	Homo sapiens	Control	%	78.0
	616591	CHEMBL769211	Inhibition of Protein tyrosine kinase Lyn at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	18.0	CHEMBL3905	Homo sapiens	Control	%	18.0
	750648	CHEMBL769386	Inhibition of Protein tyrosine kinase Lyn	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	915762	CHEMBL769382	Inhibition of Protein tyrosine kinase Lyn at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	99.0	CHEMBL3905	Homo sapiens	Activity	%	99.0
	931223	CHEMBL769382	Inhibition of Protein tyrosine kinase Lyn at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	92.0	CHEMBL3905	Homo sapiens	Activity	%	92.0
	1173941	CHEMBL769383	Inhibition of Protein tyrosine kinase Lyn	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	=	IC50	nM	2.0	CHEMBL3905	Homo sapiens	IC50	uM	0.002
	1185359	CHEMBL823026	Inhibition of human p56 Lyn tyrosine kinase	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	430.0	CHEMBL3905	Homo sapiens	IC50	uM	0.43
	1192047	CHEMBL841385	Inhibition of Lyn tyrosine kinase	B	O=[N+]([O-])c1ccc(Cl)c(-c2[nH]ccc3c4ccccc4nc2-3)c1	Outside typical range	CHEMBL14217	>	IC50	nM	250000.0	CHEMBL3905	Homo sapiens	IC50	uM	250.0
	1210389	CHEMBL841385	Inhibition of Lyn tyrosine kinase	B	Cc1[nH]cnc1-c1[nH]ccc2c3ccccc3nc1-2	Outside typical range	CHEMBL273547	>	IC50	nM	250000.0	CHEMBL3905	Homo sapiens	IC50	uM	250.0
	1213067	CHEMBL823026	Inhibition of human p56 Lyn tyrosine kinase	B	CN1CCN([C@H]2CC[C@@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL47203	=	IC50	nM	29.0	CHEMBL3905	Homo sapiens	IC50	uM	0.029
	1215610	CHEMBL841385	Inhibition of Lyn tyrosine kinase	B	Cc1nccc2c1[nH]c1cc(F)ccc12	Outside typical range	CHEMBL14445	>	IC50	nM	250000.0	CHEMBL3905	Homo sapiens	IC50	uM	250.0
	1219665	CHEMBL841385	Inhibition of Lyn tyrosine kinase	B	COc1ccc2c(c1)[nH]c1c(C)nccc12	Outside typical range	CHEMBL269538	>	IC50	nM	250000.0	CHEMBL3905	Homo sapiens	IC50	uM	250.0
	1466801	CHEMBL832906	Inhibition of Lyn kinase	B	Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN[C@@H](C)C3)nc2n2cncc12		CHEMBL189338	>	IC50	nM	0.5	CHEMBL3905	Homo sapiens	IC50	nM	0.5
	1607559	CHEMBL884327	Inhibitory concentration against Lyn-transformed rat fibroblast cells	F	COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1Cl		CHEMBL195029	=	IC50	nM	140.0	CHEMBL3905	Homo sapiens	IC50	uM	0.14
Not Active	1650774	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3905	Homo sapiens	Kd		
	1650775	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	960.0	CHEMBL3905	Homo sapiens	Kd	uM	0.96
Not Active	1650776	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3905	Homo sapiens	Kd		
	1650777	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	540.0	CHEMBL3905	Homo sapiens	Kd	uM	0.54
Not Active	1650778	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1650779	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1650780	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1650781	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1650782	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3905	Homo sapiens	Kd		
	1651313	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	210.0	CHEMBL3905	Homo sapiens	Kd	uM	0.21
Not Active	1651314	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1651315	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1651316	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1651317	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1651318	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1651319	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1651320	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3905	Homo sapiens	Kd		
Not Active	1651321	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3905	Homo sapiens	Kd		
	1651322	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	710.0	CHEMBL3905	Homo sapiens	Kd	uM	0.71
	1651323	CHEMBL860805	Average Binding Constant for LYN; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	780.0	CHEMBL3905	Homo sapiens	Kd	uM	0.78
Not Active	1658696	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL3905	Homo sapiens	Activity		
	1663202	CHEMBL863870	Inhibitory activity against lyn	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL197603	=	IC50	nM	1180.0	CHEMBL3905	Homo sapiens	IC50	uM	1.18
	1723316	CHEMBL863159	Inhibition of Lyn	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	1700.0	CHEMBL3905	Homo sapiens	Ki	nM	1700.0
	1723393	CHEMBL863159	Inhibition of Lyn	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	1700.0	CHEMBL3905	Homo sapiens	Ki	nM	1700.0
	1723394	CHEMBL863159	Inhibition of Lyn	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	1700.0	CHEMBL3905	Homo sapiens	Ki	nM	1700.0
	1723395	CHEMBL863159	Inhibition of Lyn	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	1700.0	CHEMBL3905	Homo sapiens	Ki	nM	1700.0
	1723396	CHEMBL863159	Inhibition of Lyn	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	1700.0	CHEMBL3905	Homo sapiens	Ki	nM	1700.0
	1723397	CHEMBL863159	Inhibition of Lyn	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	1700.0	CHEMBL3905	Homo sapiens	Ki	nM	1700.0
	1727575	CHEMBL859764	Inhibition of human Lyn at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	21.0	CHEMBL3905	Homo sapiens	Inhibition	%	21.0
Not Determined	1728720	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1728763	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1728806	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1728849	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1728892	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1728945	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1728988	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729031	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729074	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729117	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729160	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729203	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729246	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729289	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729335	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729378	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729421	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729464	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729507	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729550	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729608	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	1729651	CHEMBL860387	Inhibitory activity against Lyn at 10 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL3905	Homo sapiens	Activity		
	1734175	CHEMBL862490	Residual activity at human Lyn at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	101.0	CHEMBL3905	Homo sapiens	Activity	%	101.0
	1744433	CHEMBL866122	Inhibition of Lyn	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	1600.0	CHEMBL3905	Homo sapiens	Ki	uM	1.6
	1769400	CHEMBL910920	Inhibition of LYN	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3905	Homo sapiens	IC50	uM	1.0
	1778607	CHEMBL912342	Inhibition of Lyn	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	=	IC50	nM	4.0	CHEMBL3905	Homo sapiens	IC50	nM	4.0
	1781999	CHEMBL911848	Inhibition of LYN	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	1790044	CHEMBL854712	Percentage activity of human Lyn in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	89.0	CHEMBL3905	Homo sapiens	Activity	%	89.0
Active	1794869	CHEMBL856503	Inhibition of LYN at 10 uM	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1		CHEMBL374680		Activity			CHEMBL3905	Homo sapiens	Activity		
	1807168	CHEMBL908985	Inhibition of Lyn	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	21.0	CHEMBL3905	Homo sapiens	IC50	uM	0.021
	1815212	CHEMBL908522	Inhibition of Lyn	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	4900.0	CHEMBL3905	Homo sapiens	IC50	nM	4900.0
	1815236	CHEMBL908522	Inhibition of Lyn	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL385956	<	IC50	nM	25.0	CHEMBL3905	Homo sapiens	IC50	nM	25.0
	1815344	CHEMBL910177	Inhibition of Lyn	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	180.0	CHEMBL3905	Homo sapiens	IC50	nM	180.0
	1824627	CHEMBL914405	Inhibition of Lyn	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL3905	Homo sapiens	Ki	uM	10.0
	1824739	CHEMBL914405	Inhibition of Lyn	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL3905	Homo sapiens	Ki	uM	10.0
	1824818	CHEMBL914405	Inhibition of Lyn	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL3905	Homo sapiens	Ki	uM	10.0
	1837923	CHEMBL920476	Inhibition of Lyn at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	91.0	CHEMBL3905	Homo sapiens	Inhibition	%	91.0
	1837962	CHEMBL920476	Inhibition of Lyn at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	99.0	CHEMBL3905	Homo sapiens	Inhibition	%	99.0
	1891425	CHEMBL905849	Inhibition of Lyn	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	25.9	CHEMBL3905	Homo sapiens	Ki	nM	25.9
	1915519	CHEMBL894104	Inhibition of Lyn	B	COc1c(NC(=O)c2cc3cccc(NC(=O)c4ccc(NC5CC5)nc4)c3s2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL243575	=	IC50	nM	230.0	CHEMBL3905	Homo sapiens	IC50	nM	230.0
	1923430	CHEMBL896206	Inhibition of LYN	B	Cn1cnc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)c1		CHEMBL230761	>	IC50	nM	30000.0	CHEMBL3905	Homo sapiens	IC50	uM	30.0
	1954739	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	220.0	CHEMBL3905	Homo sapiens	IC50	nM	220.0
	1954751	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(O)c2ccc(CN3CC(N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1.Cl		CHEMBL536983	=	IC50	nM	29.0	CHEMBL3905	Homo sapiens	IC50	nM	29.0
	1954752	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(O)c2ccc(CN3CC[C@@H](CN(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1.Cl		CHEMBL538337	=	IC50	nM	7.6	CHEMBL3905	Homo sapiens	IC50	nM	7.6
Not Determined	1954753	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](CN(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1.Cl		CHEMBL536753		IC50			CHEMBL3905	Homo sapiens	IC50		
	1954754	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1.Cl		CHEMBL536073	=	IC50	nM	3.4	CHEMBL3905	Homo sapiens	IC50	nM	3.4
	1954755	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	IC50	nM	11.0	CHEMBL3905	Homo sapiens	IC50	nM	11.0
	1954756	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL205723	=	IC50	nM	8.5	CHEMBL3905	Homo sapiens	IC50	nM	8.5
	1954757	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL203343	=	IC50	nM	4.8	CHEMBL3905	Homo sapiens	IC50	nM	4.8
Not Determined	1954758	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(I)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL203071		IC50			CHEMBL3905	Homo sapiens	IC50		
	1954759	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(Br)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL383010	=	IC50	nM	3.1	CHEMBL3905	Homo sapiens	IC50	nM	3.1
Not Determined	1954760	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(Cl)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL382605		IC50			CHEMBL3905	Homo sapiens	IC50		
	1954761	CHEMBL892515	Inhibition of human Lyn kinase expressed in Sf9 cells	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL205409	=	IC50	nM	35.0	CHEMBL3905	Homo sapiens	IC50	nM	35.0
	1964512	CHEMBL897119	Inhibition of Lyn	B	CCN(CC)C/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)c4cc5ccccc5n4C)c(OC)c3)csc12		CHEMBL232542	=	IC50	nM	1180.0	CHEMBL3905	Homo sapiens	IC50	uM	1.18
	1964513	CHEMBL897119	Inhibition of Lyn	B	COc1cc(-c2csc3c(/C=C/CN4CCC(O)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL233958	=	IC50	nM	5300.0	CHEMBL3905	Homo sapiens	IC50	uM	5.3
	1964514	CHEMBL897119	Inhibition of Lyn	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395666	=	IC50	nM	12900.0	CHEMBL3905	Homo sapiens	IC50	uM	12.9
	1964515	CHEMBL897119	Inhibition of Lyn	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395665	=	IC50	nM	18500.0	CHEMBL3905	Homo sapiens	IC50	uM	18.5
	1964516	CHEMBL897119	Inhibition of Lyn	B	COc1cc(-c2csc3c(/C=C/CNC4CCNCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395664	=	IC50	nM	3700.0	CHEMBL3905	Homo sapiens	IC50	uM	3.7
	1968060	CHEMBL895281	Inhibition of LYN	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
Active	1989333	CHEMBL899080	Inhibitory of lyn	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12		CHEMBL237127		Activity			CHEMBL3905	Homo sapiens	Activity		
Active	1989334	CHEMBL899080	Inhibitory of lyn	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(CN4CCOCC4)n3)c(S(C)(=O)=O)cc12		CHEMBL399208		Activity			CHEMBL3905	Homo sapiens	Activity		
Active	1989335	CHEMBL899080	Inhibitory of lyn	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347		Activity			CHEMBL3905	Homo sapiens	Activity		
	2025156	CHEMBL886981	Inhibition of human Lyn at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	76.0	CHEMBL3905	Homo sapiens	Inhibition	%	76.0
	2025354	CHEMBL886981	Inhibition of human Lyn at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	107.0	CHEMBL3905	Homo sapiens	Inhibition	%	107.0
	2025355	CHEMBL886981	Inhibition of human Lyn at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	78.0	CHEMBL3905	Homo sapiens	Inhibition	%	78.0
	2025356	CHEMBL886981	Inhibition of human Lyn at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	87.0	CHEMBL3905	Homo sapiens	Inhibition	%	87.0
	2027330	CHEMBL906398	Inhibition of Lyn by HTRF assay	B	COCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245769	=	IC50	nM	20806.0	CHEMBL3905	Homo sapiens	IC50	uM	20.806
	2027356	CHEMBL906398	Inhibition of Lyn by HTRF assay	B	CN1CCN(CC(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2csc(C#CCOc3ccccc3)c2)CC1		CHEMBL245377	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	2027357	CHEMBL906398	Inhibition of Lyn by HTRF assay	B	CCOC(=O)CC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL395427	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	2027358	CHEMBL906398	Inhibition of Lyn by HTRF assay	B	COC(=O)C(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL246166	=	IC50	nM	30587.0	CHEMBL3905	Homo sapiens	IC50	uM	30.587
	2027359	CHEMBL906398	Inhibition of Lyn by HTRF assay	B	COCCOCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245968	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	2035447	CHEMBL907533	Inhibition of Lyn	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc1		CHEMBL381743	=	IC50	nM	1000.0	CHEMBL3905	Homo sapiens	IC50	uM	1.0
	2038503	CHEMBL923139	Inhibition of Lyn	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	IC50	nM	3.0	CHEMBL3905	Homo sapiens	IC50	nM	3.0
	2038509	CHEMBL923139	Inhibition of Lyn	B	Cc1ccc2[nH]ncc2c1Nc1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL248676	=	IC50	nM	430.0	CHEMBL3905	Homo sapiens	IC50	nM	430.0
	2038510	CHEMBL923139	Inhibition of Lyn	B	Cc1ccc2[nH]ncc2c1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL398422	=	IC50	nM	40.0	CHEMBL3905	Homo sapiens	IC50	nM	40.0
	2038511	CHEMBL923139	Inhibition of Lyn	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL249317	=	IC50	nM	1.0	CHEMBL3905	Homo sapiens	IC50	nM	1.0
	2051641	CHEMBL941778	Inhibition of LYN	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	1667.0	CHEMBL3905	Homo sapiens	Ki	uM	1.667
	2081801	CHEMBL928824	Inhibition of Lyn A at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL3905	Homo sapiens	Inhibition	%	20.0
	2081802	CHEMBL928825	Inhibition of Lyn B at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL3905	Homo sapiens	Inhibition	%	20.0
	2081981	CHEMBL929886	Inhibition of lyn at 1uM	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258015	>	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	Inhibition	%	80.0
	2081986	CHEMBL929886	Inhibition of lyn at 1uM	B	CCO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2C(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL401896	>	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	Inhibition	%	80.0
	2109091	CHEMBL947980	Inhibition of LYN by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c2c(N)noc12		CHEMBL270084	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	nM	50000.0
	2109107	CHEMBL947980	Inhibition of LYN by HTRF assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	nM	50000.0
	2109108	CHEMBL947980	Inhibition of LYN by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)c2c(N)noc12		CHEMBL269884	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	nM	50000.0
	2109109	CHEMBL947980	Inhibition of LYN by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12		CHEMBL430090	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	nM	50000.0
	2110289	CHEMBL950979	Inhibition of LYN	B	COC[C@H]1OC(=O)/C(=C/N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C		CHEMBL410643	>	IC50	nM	30000.0	CHEMBL3905	Homo sapiens	IC50	uM	30.0
	2110301	CHEMBL950979	Inhibition of LYN	B	COC[C@H]1OC(=O)/C(=C/N(CCO)C(C)(C)C)C2=C(O)C(=O)C3=C([C@H](OC(C)=O)C[C@]4(C)[C@@H](O)CC[C@@H]34)[C@]21C		CHEMBL271190	>	IC50	nM	30000.0	CHEMBL3905	Homo sapiens	IC50	uM	30.0
	2112045	CHEMBL934196	Inhibition of Lyn by HTRF assay	B	Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n2c3ccccc3nc12		CHEMBL410295	=	IC50	nM	21.0	CHEMBL3905	Homo sapiens	IC50	uM	0.021
	2120472	CHEMBL951120	Inhibition of Lyn by HTRF assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1		CHEMBL272888	=	IC50	nM	0.9	CHEMBL3905	Homo sapiens	IC50	uM	0.0009
	2120853	CHEMBL950240	Inhibition of Lyn	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198	=	IC50	nM	27.0	CHEMBL3905	Homo sapiens	IC50	nM	27.0
	2120854	CHEMBL950240	Inhibition of Lyn	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271188	=	IC50	nM	275.0	CHEMBL3905	Homo sapiens	IC50	nM	275.0
	2120855	CHEMBL950240	Inhibition of Lyn	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL271984	=	IC50	nM	88.0	CHEMBL3905	Homo sapiens	IC50	nM	88.0
	2137383	CHEMBL936935	Inhibition of Lyn kinase	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	130.0	CHEMBL3905	Homo sapiens	IC50	nM	130.0
	2147298	CHEMBL921983	Activity of human Lyn kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	46.0	CHEMBL3905	Homo sapiens	Activity	%	46.0
	2147538	CHEMBL934544	Inhibition of Lyn by luminescence based kinase assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	25.9	CHEMBL3905	Homo sapiens	Ki	nM	25.9
	2147543	CHEMBL934544	Inhibition of Lyn by luminescence based kinase assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCC[N+]4([O-])CCCC4)cc3)nc12		CHEMBL256101	=	Ki	nM	4.19	CHEMBL3905	Homo sapiens	Ki	nM	4.19
Not Active	2170362	CHEMBL930317	Activity at Lyn at 10 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL3905	Homo sapiens	Activity		
	2198013	CHEMBL1006343	Inhibition of Tel-fused Lyn kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	1308.0	CHEMBL3905	Homo sapiens	IC50	uM	1.308
	2206837	CHEMBL990528	Inhibition of Lyn	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	540.0	CHEMBL3905	Homo sapiens	Kd	nM	540.0
	2248251	CHEMBL1012700	Inhibition of LYN at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	2248252	CHEMBL1012700	Inhibition of LYN at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	2279702	CHEMBL960110	Inhibition of LYN	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Ki	nM	10000.0	CHEMBL3905	Homo sapiens	Ki	uM	10.0
	2298904	CHEMBL1018049	Inhibition of human Lyn	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	195.0	CHEMBL3905	Homo sapiens	IC50	nM	195.0
Not Active	2298919	CHEMBL1018049	Inhibition of human Lyn	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL3905	Homo sapiens	Activity		
	2341437	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	2341478	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	75.0	CHEMBL3905	Homo sapiens	INH	%	75.0
	2341519	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	2341560	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	2341601	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	4.0	CHEMBL3905	Homo sapiens	INH	%	4.0
	2341642	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	2341683	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	2341724	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	4.0	CHEMBL3905	Homo sapiens	INH	%	4.0
	2341765	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	2341806	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	2341847	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	18.0	CHEMBL3905	Homo sapiens	INH	%	18.0
	2341888	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	2341929	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	48.0	CHEMBL3905	Homo sapiens	INH	%	48.0
	2341970	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	2342011	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	2342052	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	47.0	CHEMBL3905	Homo sapiens	INH	%	47.0
	2342093	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	2342134	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	29.0	CHEMBL3905	Homo sapiens	INH	%	29.0
	2342175	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	2342215	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	2342261	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	14.0	CHEMBL3905	Homo sapiens	INH	%	14.0
	2342298	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	29.0	CHEMBL3905	Homo sapiens	INH	%	29.0
	2342339	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	19.0	CHEMBL3905	Homo sapiens	INH	%	19.0
	2342380	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	48.0	CHEMBL3905	Homo sapiens	INH	%	48.0
	2342421	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	2342462	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	2342503	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	2342544	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	12.0	CHEMBL3905	Homo sapiens	INH	%	12.0
	2342695	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	2342696	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	2342697	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	2342698	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	2342699	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	2342700	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	2342701	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	2342702	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	2342703	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	2342704	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	2342705	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	2342706	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	2342707	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	2342708	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	2342709	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	2342710	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	2342711	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	2342712	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	2342713	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	2342714	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	2342715	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	2342716	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	2342717	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	2342718	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	2342719	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	2342720	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	2342721	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	14.0	CHEMBL3905	Homo sapiens	INH	%	14.0
	2342722	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	90.0	CHEMBL3905	Homo sapiens	INH	%	90.0
	2342723	CHEMBL953398	Inhibition of Lyn at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	17.0	CHEMBL3905	Homo sapiens	INH	%	17.0
	2362689	CHEMBL1034893	Inhibition of Lyn	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	2367448	CHEMBL986285	Inhibition of Lyn	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2c(O[C@@H](C)C(F)(F)F)nncc2c1		CHEMBL493671	=	IC50	nM	954.0	CHEMBL3905	Homo sapiens	IC50	nM	954.0
	2401971	CHEMBL1011864	Inhibition of LYN	B	O=C1NC(=O)c2ccc(I)cc2/C1=C/NCc1ccc(-c2ccoc2)c(O)c1		CHEMBL504547	=	IC50	nM	8500.0	CHEMBL3905	Homo sapiens	IC50	uM	8.5
	2419159	CHEMBL1019646	Inhibition of LYN A at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	2449129	CHEMBL985582	Inhibition of Lyn	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	506.0	CHEMBL3905	Homo sapiens	IC50	nM	506.0
	2466410	CHEMBL994993	Inhibition of TEL fused Lyn-mediated proliferation of TEL-Lyn transformed mouse BA/F3 cells after 48 hrs by bright-glo luciferase assay	B	Cc1cccc(Cl)c1Nc1nc2ccccc2n1-c1cc(Nc2ccc(CCN3CCOCC3)cn2)ncn1		CHEMBL473250	=	IC50	nM	215.0	CHEMBL3905	Homo sapiens	IC50	uM	0.215
	2466411	CHEMBL994993	Inhibition of TEL fused Lyn-mediated proliferation of TEL-Lyn transformed mouse BA/F3 cells after 48 hrs by bright-glo luciferase assay	B	Cc1nc(Nc2cc(-n3c(Nc4c(C)cccc4Cl)nc4ccccc43)ncn2)cc(N2CCN(CCO)CC2)n1		CHEMBL447107	=	IC50	nM	30.0	CHEMBL3905	Homo sapiens	IC50	uM	0.03
	2467251	CHEMBL995057	Inhibition of Lyn in presence of 20 uM ATP	B	CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1		CHEMBL489058	=	IC50	nM	58.0	CHEMBL3905	Homo sapiens	IC50	uM	0.058
	2468093	CHEMBL992549	Inhibition of Lyn	B	CN(C(=O)c1ccccc1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL460824	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	2468105	CHEMBL992549	Inhibition of Lyn	B	CCN(C(=O)c1ccccc1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL462301	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	2468106	CHEMBL992549	Inhibition of Lyn	B	CN(C(=O)c1ccccc1)c1ccc2c(c1)nc(NC(=O)c1ccc(Cl)cc1)n2CCC(N)=O		CHEMBL485203	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	2468214	CHEMBL992565	Inhibition of Lyn kinase	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(Cl)cc1)n2CCC(N)=O	Outside typical range	CHEMBL483403	>	IC50	nM	1000000.0	CHEMBL3905	Homo sapiens	IC50	uM	1000.0
	2468222	CHEMBL992565	Inhibition of Lyn kinase	B	CCN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O	Outside typical range	CHEMBL458787	>	IC50	nM	1000000.0	CHEMBL3905	Homo sapiens	IC50	uM	1000.0
	2468223	CHEMBL992565	Inhibition of Lyn kinase	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCCn1ccnc1	Outside typical range	CHEMBL485031	>	IC50	nM	1000000.0	CHEMBL3905	Homo sapiens	IC50	uM	1000.0
Not Active	2468246	CHEMBL992565	Inhibition of Lyn kinase	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCC(N)=O		CHEMBL485564		Activity			CHEMBL3905	Homo sapiens	Activity		
	2470249	CHEMBL987168	Inhibition of LYN at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	2476608	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	26.9	CHEMBL3905	Homo sapiens	Activity	%	26.9
Not Evaluated	2476811	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Evaluated	2478650	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Evaluated	2478853	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Evaluated	2479708	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3905	Homo sapiens	Activity		
	2480707	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.2	CHEMBL3905	Homo sapiens	Activity	%	0.2
	2482698	CHEMBL987149	Inhibition of Lyn	B	Nc1ccc(N)c2c1C(=O)c1ccccc1C2=O		CHEMBL86771	>	IC50	nM	40000.0	CHEMBL3905	Homo sapiens	IC50	uM	40.0
	2489308	CHEMBL990378	Inhibition of Lyn	B	COc1ccc(CN(C)C)c(-c2cc3c(Nc4ccc5[nH]ccc5c4C)c(C#N)cnc3s2)c1		CHEMBL479835	=	IC50	nM	13000.0	CHEMBL3905	Homo sapiens	IC50	nM	13000.0
	2489309	CHEMBL990378	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cncc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL518942	=	IC50	nM	2200.0	CHEMBL3905	Homo sapiens	IC50	nM	2200.0
	2489310	CHEMBL990378	Inhibition of Lyn	B	COc1ccccc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL480839	=	IC50	nM	310.0	CHEMBL3905	Homo sapiens	IC50	nM	310.0
	2489311	CHEMBL990378	Inhibition of Lyn	B	COc1ccc(CN(C)C)cc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL516913	=	IC50	nM	23.0	CHEMBL3905	Homo sapiens	IC50	nM	23.0
	2489312	CHEMBL990378	Inhibition of Lyn	B	CCOc1ccc(CN(C)C)cc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL479470	=	IC50	nM	74.0	CHEMBL3905	Homo sapiens	IC50	nM	74.0
	2489316	CHEMBL990378	Inhibition of Lyn	B	COc1c(CN(C)C)cccc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL480223	=	IC50	nM	1700.0	CHEMBL3905	Homo sapiens	IC50	nM	1700.0
	2489326	CHEMBL990378	Inhibition of Lyn	B	Cc1ccc(CN(C)C)cc1-c1cc2c(Nc3ccc4[nH]ccc4c3C)c(C#N)cnc2s1		CHEMBL480222	=	IC50	nM	230.0	CHEMBL3905	Homo sapiens	IC50	nM	230.0
	2489333	CHEMBL990378	Inhibition of Lyn	B	N#Cc1cnc2sc(-c3ccccc3)cc2c1Nc1ccc2[nH]ccc2c1		CHEMBL409155	=	IC50	nM	3400.0	CHEMBL3905	Homo sapiens	IC50	nM	3400.0
	2489334	CHEMBL990378	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL402818	=	IC50	nM	520.0	CHEMBL3905	Homo sapiens	IC50	nM	520.0
	2489335	CHEMBL990378	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cnc3sc(-c4ccc(CN(C)C)cc4)cc23)ccc2[nH]ccc12		CHEMBL471795	=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	nM	100.0
	2489336	CHEMBL990378	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cnc3sc(-c4ccccc4CN(C)C)cc23)ccc2[nH]ccc12		CHEMBL480641	=	IC50	nM	37000.0	CHEMBL3905	Homo sapiens	IC50	nM	37000.0
	2489337	CHEMBL990378	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cnc3sc(-c4csc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL480838	=	IC50	nM	410.0	CHEMBL3905	Homo sapiens	IC50	nM	410.0
	2511594	CHEMBL973448	Inhibition of LYN	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.49	CHEMBL3905	Homo sapiens	IC50	uM	0.00049
	2527200	CHEMBL984181	Inhibition of Lyn	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523	=	IC50	nM	2400.0	CHEMBL3905	Homo sapiens	IC50	uM	2.4
	2558427	CHEMBL989973	Inhibition of LYN	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	=	IC50	nM	4000.0	CHEMBL3905	Homo sapiens	IC50	uM	4.0
	2559671	CHEMBL982996	Inhibition of LYN	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	=	IC50	nM	28.0	CHEMBL3905	Homo sapiens	IC50	nM	28.0
	2567254	CHEMBL974586	Inhibition of human Lyn kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	60.0	CHEMBL3905	Homo sapiens	Activity	%	60.0
Not Evaluated	2577329	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Evaluated	2577532	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3905	Homo sapiens	Activity		
	2593534	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	6.3	CHEMBL3905	Homo sapiens	Activity	%	6.3
	2593737	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.1	CHEMBL3905	Homo sapiens	Activity	%	0.1
	2594003	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.2	CHEMBL3905	Homo sapiens	Activity	%	0.2
Not Evaluated	2594946	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Evaluated	2595149	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3905	Homo sapiens	Activity		
	2595215	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	2.2	CHEMBL3905	Homo sapiens	Activity	%	2.2
	2596346	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	13.8	CHEMBL3905	Homo sapiens	Activity	%	13.8
Not Evaluated	2597615	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Evaluated	2597818	CHEMBL1035872	Binding affinity to human LYN at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3905	Homo sapiens	Activity		
	2624355	CHEMBL1007482	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL467069	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	2636767	CHEMBL978880	Inhibition of Lyn	B	CN1CCN(CCOc2cccc(-c3cncc(C#N)c3Nc3cccc4[nH]ccc34)c2)CC1		CHEMBL467321	>	IC50	nM	100000.0	CHEMBL3905	Homo sapiens	IC50	uM	100.0
	2652711	CHEMBL1026941	Inhibition of LYN	B	NCc1ccc(-c2cnc3[nH]cc(-c4cccc(NC(=O)Nc5ccc(C(F)(F)F)cc5F)c4)c3c2)cc1		CHEMBL551024	=	IC50	nM	40.0	CHEMBL3905	Homo sapiens	IC50	nM	40.0
	2661418	CHEMBL1058624	Inhibition of LYN	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	2661590	CHEMBL1060454	Inhibition of LYN after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	2676434	CHEMBL1035538	Inhibition of LYN	B	CCOC(=O)c1cnn2c(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)ccnc12		CHEMBL565061	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	2704991	CHEMBL1054878	Inhibition of LYN at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	-1.45	CHEMBL3905	Homo sapiens	INH	%	-1.45
	2719531	CHEMBL1059981	Inhibition of Tel fused Lyn expressed in mouse BA/F3 cells	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140	<	EC50	nM	500.0	CHEMBL3905	Homo sapiens	EC50	nM	500.0
	2721642	CHEMBL1057471	Inhibition of Lyn at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	2897219	CHEMBL1051275	Percent residual Lyn activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	93.0	CHEMBL3905	Homo sapiens	Activity	%	93.0
	2897220	CHEMBL1051275	Percent residual Lyn activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	88.0	CHEMBL3905	Homo sapiens	Activity	%	88.0
	2897221	CHEMBL1051275	Percent residual Lyn activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	90.0	CHEMBL3905	Homo sapiens	Activity	%	90.0
	2898024	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898025	CHEMBL1037544	Binding constant for LYN kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	160.0	CHEMBL3905	Homo sapiens	Kd	nM	160.0
	2898026	CHEMBL1037544	Binding constant for LYN kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	14.0	CHEMBL3905	Homo sapiens	Kd	nM	14.0
	2898027	CHEMBL1037544	Binding constant for LYN kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1600.0	CHEMBL3905	Homo sapiens	Kd	nM	1600.0
	2898028	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	2700.0	CHEMBL3905	Homo sapiens	Kd	nM	2700.0
	2898029	CHEMBL1037544	Binding constant for LYN kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898030	CHEMBL1037544	Binding constant for LYN kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	750.0	CHEMBL3905	Homo sapiens	Kd	nM	750.0
	2898031	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	370.0	CHEMBL3905	Homo sapiens	Kd	nM	370.0
	2898032	CHEMBL1037544	Binding constant for LYN kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	810.0	CHEMBL3905	Homo sapiens	Kd	nM	810.0
	2898033	CHEMBL1037544	Binding constant for LYN kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898034	CHEMBL1037544	Binding constant for LYN kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898035	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.57	CHEMBL3905	Homo sapiens	Kd	nM	0.57
	2898036	CHEMBL1037544	Binding constant for LYN kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	720.0	CHEMBL3905	Homo sapiens	Kd	nM	720.0
	2898037	CHEMBL1037544	Binding constant for LYN kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	530.0	CHEMBL3905	Homo sapiens	Kd	nM	530.0
	2898038	CHEMBL1037544	Binding constant for LYN kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898039	CHEMBL1037544	Binding constant for LYN kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	990.0	CHEMBL3905	Homo sapiens	Kd	nM	990.0
	2898040	CHEMBL1037544	Binding constant for LYN kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898041	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	890.0	CHEMBL3905	Homo sapiens	Kd	nM	890.0
	2898042	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898043	CHEMBL1037544	Binding constant for LYN kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898044	CHEMBL1037544	Binding constant for LYN kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898045	CHEMBL1037544	Binding constant for LYN kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898046	CHEMBL1037544	Binding constant for LYN kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898047	CHEMBL1037544	Binding constant for LYN kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1400.0	CHEMBL3905	Homo sapiens	Kd	nM	1400.0
	2898048	CHEMBL1037544	Binding constant for LYN kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898049	CHEMBL1037544	Binding constant for LYN kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	4200.0	CHEMBL3905	Homo sapiens	Kd	nM	4200.0
	2898050	CHEMBL1037544	Binding constant for LYN kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898051	CHEMBL1037544	Binding constant for LYN kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898052	CHEMBL1037544	Binding constant for LYN kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898053	CHEMBL1037544	Binding constant for LYN kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898054	CHEMBL1037544	Binding constant for LYN kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	2898055	CHEMBL1037544	Binding constant for LYN kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3000.0	CHEMBL3905	Homo sapiens	Kd	nM	3000.0
	2898056	CHEMBL1037544	Binding constant for LYN kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	40.0	CHEMBL3905	Homo sapiens	Kd	nM	40.0
	2898057	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	810.0	CHEMBL3905	Homo sapiens	Kd	nM	810.0
	2898058	CHEMBL1037544	Binding constant for LYN kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	270.0	CHEMBL3905	Homo sapiens	Kd	nM	270.0
	2898059	CHEMBL1037544	Binding constant for LYN kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	650.0	CHEMBL3905	Homo sapiens	Kd	nM	650.0
	2898060	CHEMBL1037544	Binding constant for LYN kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1700.0	CHEMBL3905	Homo sapiens	Kd	nM	1700.0
	2898061	CHEMBL1037544	Binding constant for LYN kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	110.0	CHEMBL3905	Homo sapiens	Kd	nM	110.0
	2921288	CHEMBL1049111	Inhibition of LYN assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	18.0	CHEMBL3905	Homo sapiens	Activity	%	18.0
	2928486	CHEMBL1043878	Binding affinity to LYN assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	0.4	CHEMBL3905	Homo sapiens	Activity	%	0.4
	2938489	CHEMBL1041376	Inhibition of LYN at 2 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
Not Active	2938620	CHEMBL1041490	Inhibition of LYN at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	2950313	CHEMBL1052171	Inhibition of human Lyn	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.3	CHEMBL3905	Homo sapiens	IC50	nM	1.3
	2983208	CHEMBL1046247	Inhibition of Lyn A	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	=	IC50	nM	7.0	CHEMBL3905	Homo sapiens	IC50	uM	0.007
	3001950	CHEMBL1049805	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL571581	=	IC50	nM	730.0	CHEMBL3905	Homo sapiens	IC50	uM	0.73
	3006343	CHEMBL1040178	Inhibition of Lyn	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989	>	IC50	nM	7000.0	CHEMBL3905	Homo sapiens	IC50	uM	7.0
	3006344	CHEMBL1040178	Inhibition of Lyn	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887	>	IC50	nM	7000.0	CHEMBL3905	Homo sapiens	IC50	uM	7.0
	3006345	CHEMBL1040178	Inhibition of Lyn	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922	>	IC50	nM	7000.0	CHEMBL3905	Homo sapiens	IC50	uM	7.0
	3006346	CHEMBL1040178	Inhibition of Lyn	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601	>	IC50	nM	7000.0	CHEMBL3905	Homo sapiens	IC50	uM	7.0
	3011618	CHEMBL1037492	Inhibition of Lyn	B	C#Cc1cccc(-c2ccc(CN3CCN(C)CC3)o2)c1Cc1ccc2c(c1C)C=CC2		CHEMBL570865	>	IC50	nM	5000.0	CHEMBL3905	Homo sapiens	IC50	uM	5.0
	3017860	CHEMBL1039941	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(OCCN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL567124	=	IC50	nM	520.0	CHEMBL3905	Homo sapiens	IC50	nM	520.0
	3052648	CHEMBL1041135	Residual activity of LYN at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL3905	Homo sapiens	Residual activity	%	93.0
	3053957	CHEMBL1050288	Residual activity of LYN at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	36.0	CHEMBL3905	Homo sapiens	Residual activity	%	36.0
	3054209	CHEMBL1040677	Residual activity of LYN at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	112.0	CHEMBL3905	Homo sapiens	Residual activity	%	112.0
	3055496	CHEMBL1041135	Residual activity of LYN at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	104.0	CHEMBL3905	Homo sapiens	Residual activity	%	104.0
	3056801	CHEMBL1050288	Residual activity of LYN at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	112.0	CHEMBL3905	Homo sapiens	Residual activity	%	112.0
	3057053	CHEMBL1040677	Residual activity of LYN at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	108.0	CHEMBL3905	Homo sapiens	Residual activity	%	108.0
	3058373	CHEMBL1041135	Residual activity of LYN at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	119.0	CHEMBL3905	Homo sapiens	Residual activity	%	119.0
	3058625	CHEMBL1050288	Residual activity of LYN at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	142.0	CHEMBL3905	Homo sapiens	Residual activity	%	142.0
	3072971	CHEMBL1040677	Residual activity of LYN at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	102.0	CHEMBL3905	Homo sapiens	Residual activity	%	102.0
	3084444	CHEMBL1073307	Inhibition of LYN	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	3089489	CHEMBL1070552	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCNCC2)ccc2[nH]ccc12		CHEMBL593619	=	IC50	nM	30000.0	CHEMBL3905	Homo sapiens	IC50	nM	30000.0
	3089492	CHEMBL1070552	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(NS(C)(=O)=O)CC2)ccc2[nH]ccc12		CHEMBL595048	=	IC50	nM	20000.0	CHEMBL3905	Homo sapiens	IC50	nM	20000.0
	3089493	CHEMBL1070552	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	19000.0	CHEMBL3905	Homo sapiens	IC50	nM	19000.0
	3089504	CHEMBL1070552	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(N)CC2)ccc2[nH]ccc12		CHEMBL593883	=	IC50	nM	9600.0	CHEMBL3905	Homo sapiens	IC50	nM	9600.0
	3089507	CHEMBL1070552	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCNCC2)ccc2[nH]ccc12		CHEMBL603418	=	IC50	nM	5100.0	CHEMBL3905	Homo sapiens	IC50	nM	5100.0
	3094773	CHEMBL1069041	Inhibition of LYN at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	3094781	CHEMBL1069041	Inhibition of LYN at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	3094813	CHEMBL1069041	Inhibition of LYN at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	3094822	CHEMBL1069041	Inhibition of LYN at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	39.0	CHEMBL3905	Homo sapiens	INH	%	39.0
	3117934	CHEMBL1072210	Inhibition of LYN	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	3117987	CHEMBL1072210	Inhibition of LYN	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	3118040	CHEMBL1072210	Inhibition of LYN	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	3121095	CHEMBL1065595	Inhibition of Lyn	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	IC50	nM	840.0	CHEMBL3905	Homo sapiens	IC50	nM	840.0
	3130768	CHEMBL1065741	Inhibition of LYN	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	3185712	CHEMBL1105160	Inhibition of Lyn	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCN(C)CC3)n2)ccc2[nH]ccc12		CHEMBL1084411	=	IC50	nM	540.0	CHEMBL3905	Homo sapiens	IC50	nM	540.0
	3191061	CHEMBL1101928	Inhibition of LYN at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	=	Inhibition	%	21.0	CHEMBL3905	Homo sapiens	INH	%	21.0
	3210392	CHEMBL1109433	Inhibition of Lyn after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	6000.0	CHEMBL3905	Homo sapiens	IC50	uM	6.0
	3213841	CHEMBL1111257	Inhibition of LYN A at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	102.0	CHEMBL3905	Homo sapiens	INH	%	102.0
	3213842	CHEMBL1111258	Inhibition of LYN B at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	104.0	CHEMBL3905	Homo sapiens	INH	%	104.0
	3219850	CHEMBL1113998	Inhibition of LYN A	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	=	IC50	nM	290.0	CHEMBL3905	Homo sapiens	IC50	nM	290.0
	3219851	CHEMBL1113998	Inhibition of LYN A	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	nM	50000.0
	3220008	CHEMBL1115857	Inhibition of LYN	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	1760.0	CHEMBL3905	Homo sapiens	IC50	uM	1.76
	3224859	CHEMBL1100377	Inhibition of LYN A at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3224860	CHEMBL1100378	Inhibition of LYN B at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3225109	CHEMBL1100377	Inhibition of LYN A at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3225110	CHEMBL1100378	Inhibition of LYN B at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3227061	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079422	=	IC50	nM	133.0	CHEMBL3905	Homo sapiens	IC50	nM	133.0
	3227062	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079945	=	IC50	nM	14.0	CHEMBL3905	Homo sapiens	IC50	nM	14.0
	3227063	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(Cl)cc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079946	=	IC50	nM	3608.0	CHEMBL3905	Homo sapiens	IC50	nM	3608.0
	3227064	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1cccc(C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1080299	=	IC50	nM	82.0	CHEMBL3905	Homo sapiens	IC50	nM	82.0
	3227065	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2ccncc2C(C)(C)C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080475	=	IC50	nM	7.0	CHEMBL3905	Homo sapiens	IC50	nM	7.0
	3227066	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2ccncc2Cl)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086730	=	IC50	nM	595.0	CHEMBL3905	Homo sapiens	IC50	nM	595.0
	3227067	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(OC3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076432	=	IC50	nM	5.0	CHEMBL3905	Homo sapiens	IC50	nM	5.0
	3227068	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)s2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086731	=	IC50	nM	5.0	CHEMBL3905	Homo sapiens	IC50	nM	5.0
	3227069	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(C3CC3)n[nH]2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086860	=	IC50	nM	96.0	CHEMBL3905	Homo sapiens	IC50	nM	96.0
	3227070	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(C(C)(C)C)nn2C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088153	=	IC50	nM	332.0	CHEMBL3905	Homo sapiens	IC50	nM	332.0
	3227071	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc2Cl)CC1		CHEMBL1076433	=	IC50	nM	10.0	CHEMBL3905	Homo sapiens	IC50	nM	10.0
	3227072	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(CN3CCN(C)CC3)n(C(C)(C)C)n2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1075628	=	IC50	nM	88.0	CHEMBL3905	Homo sapiens	IC50	nM	88.0
	3227073	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076436	=	IC50	nM	6.0	CHEMBL3905	Homo sapiens	IC50	nM	6.0
	3227074	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	CCN1CCN(c2cc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL1076437	=	IC50	nM	9.0	CHEMBL3905	Homo sapiens	IC50	nM	9.0
	3227075	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(Cl)ncn1		CHEMBL1088429	=	IC50	nM	3296.0	CHEMBL3905	Homo sapiens	IC50	nM	3296.0
	3227076	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	COc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1087513	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	3227077	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN)ncn1		CHEMBL1087636	=	IC50	nM	1471.0	CHEMBL3905	Homo sapiens	IC50	nM	1471.0
	3227078	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN)ncn1		CHEMBL1076465	=	IC50	nM	1117.0	CHEMBL3905	Homo sapiens	IC50	nM	1117.0
	3227079	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN)ncn1		CHEMBL1076466	=	IC50	nM	457.0	CHEMBL3905	Homo sapiens	IC50	nM	457.0
	3227080	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	CCN(CC)CCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076468	=	IC50	nM	642.0	CHEMBL3905	Homo sapiens	IC50	nM	642.0
	3227081	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076469	=	IC50	nM	399.0	CHEMBL3905	Homo sapiens	IC50	nM	399.0
	3227082	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076470	=	IC50	nM	217.0	CHEMBL3905	Homo sapiens	IC50	nM	217.0
	3227083	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCC2COCCN2)ncn1		CHEMBL1076471	=	IC50	nM	67.0	CHEMBL3905	Homo sapiens	IC50	nM	67.0
	3227084	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC2CCCN2)ncn1		CHEMBL1076472	=	IC50	nM	818.0	CHEMBL3905	Homo sapiens	IC50	nM	818.0
	3227085	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N[C@H]2CC[C@H](N)CC2)ncn1		CHEMBL1076473	=	IC50	nM	547.0	CHEMBL3905	Homo sapiens	IC50	nM	547.0
	3227086	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NC2CCN(C)CC2)ncn1		CHEMBL1076474	=	IC50	nM	1422.0	CHEMBL3905	Homo sapiens	IC50	nM	1422.0
	3227087	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCc2ccccn2)ncn1		CHEMBL1076475	=	IC50	nM	259.0	CHEMBL3905	Homo sapiens	IC50	nM	259.0
	3227088	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N2CCOCC2)ncn1		CHEMBL1076476	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	3227089	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076477	=	IC50	nM	204.0	CHEMBL3905	Homo sapiens	IC50	nM	204.0
	3227090	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076478	=	IC50	nM	149.0	CHEMBL3905	Homo sapiens	IC50	nM	149.0
	3227091	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCO)ncn1		CHEMBL1087638	=	IC50	nM	400.0	CHEMBL3905	Homo sapiens	IC50	nM	400.0
	3227092	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	COCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076480	=	IC50	nM	126.0	CHEMBL3905	Homo sapiens	IC50	nM	126.0
	3227093	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1087002	=	IC50	nM	1079.0	CHEMBL3905	Homo sapiens	IC50	nM	1079.0
	3227094	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087127	=	IC50	nM	15.0	CHEMBL3905	Homo sapiens	IC50	nM	15.0
	3227095	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087128	=	IC50	nM	16.0	CHEMBL3905	Homo sapiens	IC50	nM	16.0
	3227096	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(OC(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088027	=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	nM	100.0
	3227097	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(Br)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088028	=	IC50	nM	272.0	CHEMBL3905	Homo sapiens	IC50	nM	272.0
	3227098	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087524	=	IC50	nM	15.0	CHEMBL3905	Homo sapiens	IC50	nM	15.0
	3227099	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087649	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	3227100	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	COc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1081090	=	IC50	nM	437.0	CHEMBL3905	Homo sapiens	IC50	nM	437.0
	3227101	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2ccccc2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076533	=	IC50	nM	5512.0	CHEMBL3905	Homo sapiens	IC50	nM	5512.0
	3227102	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc3cnccc23)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1081436	=	IC50	nM	7836.0	CHEMBL3905	Homo sapiens	IC50	nM	7836.0
	3227103	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(N)=O)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080930	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	3227104	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)ccn1		CHEMBL1079424	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	3227105	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1076193	=	IC50	nM	28.0	CHEMBL3905	Homo sapiens	IC50	nM	28.0
	3227106	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCCN(C)C)ncn3)c2)c1		CHEMBL1076194	=	IC50	nM	1384.0	CHEMBL3905	Homo sapiens	IC50	nM	1384.0
	3227107	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076195	=	IC50	nM	1315.0	CHEMBL3905	Homo sapiens	IC50	nM	1315.0
	3227108	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076196	=	IC50	nM	1658.0	CHEMBL3905	Homo sapiens	IC50	nM	1658.0
	3227109	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076197	=	IC50	nM	1228.0	CHEMBL3905	Homo sapiens	IC50	nM	1228.0
	3227110	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076198	=	IC50	nM	134.0	CHEMBL3905	Homo sapiens	IC50	nM	134.0
	3227111	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076199	=	IC50	nM	140.0	CHEMBL3905	Homo sapiens	IC50	nM	140.0
	3227112	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076200	=	IC50	nM	113.0	CHEMBL3905	Homo sapiens	IC50	nM	113.0
	3227113	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076201	=	IC50	nM	84.0	CHEMBL3905	Homo sapiens	IC50	nM	84.0
	3227114	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC#N)ncn1		CHEMBL1076202	=	IC50	nM	468.0	CHEMBL3905	Homo sapiens	IC50	nM	468.0
	3227115	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(N)c1C		CHEMBL1080294	=	IC50	nM	8012.0	CHEMBL3905	Homo sapiens	IC50	nM	8012.0
	3227116	CHEMBL1113979	Inhibition of Tel-fused LYN expressed in mouse BAF3 cells	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(NCCCN2CCN(C)CC2)n1		CHEMBL1076203	=	IC50	nM	43.0	CHEMBL3905	Homo sapiens	IC50	nM	43.0
	3240816	CHEMBL1109688	Inhibition of Lyn	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	IC50	nM	26.0	CHEMBL3905	Homo sapiens	IC50	uM	0.026
	3242221	CHEMBL1111607	Inhibition of LynA	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	3246484	CHEMBL1117095	Inhibition of LYN	B	O=C(Nc1cccc(-c2ncnc3sc(-c4ccncc4)cc23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1090143	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	3251250	CHEMBL1107905	Inhibition of LYN A	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	27.7	CHEMBL3905	Homo sapiens	IC50	nM	27.7
	3261206	CHEMBL1113452	Inhibition of LYN at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
Not Determined	3261207	CHEMBL1113452	Inhibition of LYN at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Determined	3261208	CHEMBL1113452	Inhibition of LYN at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	3261209	CHEMBL1113452	Inhibition of LYN at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	3261210	CHEMBL1113452	Inhibition of LYN at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	3261211	CHEMBL1113452	Inhibition of LYN at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	3264374	CHEMBL1104643	Inhibition of LYN A	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	3271024	CHEMBL1104643	Inhibition of LYN A	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
Not Active	3272024	CHEMBL1108304	Inhibition of LYN	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272025	CHEMBL1108304	Inhibition of LYN	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272026	CHEMBL1108304	Inhibition of LYN	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272027	CHEMBL1108304	Inhibition of LYN	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272028	CHEMBL1108304	Inhibition of LYN	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272029	CHEMBL1108304	Inhibition of LYN	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272030	CHEMBL1108304	Inhibition of LYN	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272031	CHEMBL1108304	Inhibition of LYN	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272032	CHEMBL1108304	Inhibition of LYN	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	3272033	CHEMBL1108304	Inhibition of LYN	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	3272034	CHEMBL1108304	Inhibition of LYN	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL3905	Homo sapiens	INH	%	20.0
Not Active	3272035	CHEMBL1108304	Inhibition of LYN	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	3294395	CHEMBL1108262	Inhibition of LYN	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1089116	=	IC50	nM	398.0	CHEMBL3905	Homo sapiens	IC50	nM	398.0
	3308357	CHEMBL1119637	Inhibition of Lyn at 3 uM	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829	>	Inhibition	%	90.0	CHEMBL3905	Homo sapiens	INH	%	90.0
	3308358	CHEMBL1119637	Inhibition of Lyn at 3 uM	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337	>	Inhibition	%	90.0	CHEMBL3905	Homo sapiens	INH	%	90.0
	3326164	CHEMBL1168294	Inhibition of LYN at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3332002	CHEMBL1166052	Inhibition of LYN at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3333417	CHEMBL1166052	Inhibition of LYN at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3334822	CHEMBL1166052	Inhibition of LYN at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3336242	CHEMBL1166052	Inhibition of LYN at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3337571	CHEMBL1166052	Inhibition of LYN at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3338902	CHEMBL1166052	Inhibition of LYN at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3339156	CHEMBL1166052	Inhibition of LYN at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3340459	CHEMBL1166052	Inhibition of LYN at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3341784	CHEMBL1166052	Inhibition of LYN at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3343231	CHEMBL1166052	Inhibition of LYN at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	3354376	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	53.0	CHEMBL3905	Homo sapiens	INH	%	53.0
	3354377	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	57.0	CHEMBL3905	Homo sapiens	INH	%	57.0
	3354378	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	46.0	CHEMBL3905	Homo sapiens	INH	%	46.0
	3354379	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	94.0	CHEMBL3905	Homo sapiens	INH	%	94.0
	3354380	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	24.0	CHEMBL3905	Homo sapiens	INH	%	24.0
	3354381	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	74.0	CHEMBL3905	Homo sapiens	INH	%	74.0
	3354382	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	37.0	CHEMBL3905	Homo sapiens	INH	%	37.0
	3354383	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	59.0	CHEMBL3905	Homo sapiens	INH	%	59.0
	3354384	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	99.0	CHEMBL3905	Homo sapiens	INH	%	99.0
	3354385	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	99.0	CHEMBL3905	Homo sapiens	INH	%	99.0
	3354386	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	98.0	CHEMBL3905	Homo sapiens	INH	%	98.0
	3354930	CHEMBL1173987	Inhibition of LYN at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	28.0	CHEMBL3905	Homo sapiens	INH	%	28.0
	3358643	CHEMBL1174885	Inhibition of LYN at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.05	CHEMBL3905	Homo sapiens	INH	%	0.05
	3359085	CHEMBL1174885	Inhibition of LYN at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.05	CHEMBL3905	Homo sapiens	INH	%	0.05
	3430281	CHEMBL1248539	Binding affinity to Lyn by radioligand displacement assay	B	O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1		CHEMBL1242923	>=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	Ki	nM	1000.0
	3430282	CHEMBL1248539	Binding affinity to Lyn by radioligand displacement assay	B	CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1		CHEMBL1242950	>=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	Ki	nM	1000.0
	3441514	CHEMBL1244097	Inhibition of human Lyn	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	195.0	CHEMBL3905	Homo sapiens	IC50	nmol/L	195.0
	3443431	CHEMBL1244197	Inhibition of LYN A at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	97.0	CHEMBL3905	Homo sapiens	INH	%	97.0
	3443432	CHEMBL1244198	Inhibition of LYN B at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	98.0	CHEMBL3905	Homo sapiens	INH	%	98.0
	3443648	CHEMBL1244197	Inhibition of LYN A at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	97.0	CHEMBL3905	Homo sapiens	INH	%	97.0
	3443649	CHEMBL1244198	Inhibition of LYN B at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	98.0	CHEMBL3905	Homo sapiens	INH	%	98.0
	3444803	CHEMBL1244197	Inhibition of LYN A at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	85.0	CHEMBL3905	Homo sapiens	INH	%	85.0
	3444804	CHEMBL1244198	Inhibition of LYN B at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	86.0	CHEMBL3905	Homo sapiens	INH	%	86.0
	3445174	CHEMBL1244486	Binding affinity to LYN	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	190.0	CHEMBL3905	Homo sapiens	Kd	nM	190.0
	3445427	CHEMBL1244197	Inhibition of LYN A at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	INH	%	80.0
	3445428	CHEMBL1244198	Inhibition of LYN B at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	81.0	CHEMBL3905	Homo sapiens	INH	%	81.0
	3445644	CHEMBL1244197	Inhibition of LYN A at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	43.0	CHEMBL3905	Homo sapiens	INH	%	43.0
	3445645	CHEMBL1244198	Inhibition of LYN B at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	43.0	CHEMBL3905	Homo sapiens	INH	%	43.0
	3445847	CHEMBL1244197	Inhibition of LYN A at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	96.0	CHEMBL3905	Homo sapiens	INH	%	96.0
	3445848	CHEMBL1244198	Inhibition of LYN B at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	95.0	CHEMBL3905	Homo sapiens	INH	%	95.0
	3446037	CHEMBL1244197	Inhibition of LYN A at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	78.0	CHEMBL3905	Homo sapiens	INH	%	78.0
	3446038	CHEMBL1244198	Inhibition of LYN B at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	83.0	CHEMBL3905	Homo sapiens	INH	%	83.0
	3446196	CHEMBL1244336	Inhibition of LYNA	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	8.0	CHEMBL3905	Homo sapiens	IC50	nM	8.0
	3446197	CHEMBL1244337	Inhibition of LYNB	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	8.0	CHEMBL3905	Homo sapiens	IC50	nM	8.0
	3448479	CHEMBL1244486	Binding affinity to LYN	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	3448972	CHEMBL1244486	Binding affinity to LYN	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	4200.0	CHEMBL3905	Homo sapiens	Kd	nM	4200.0
	3449255	CHEMBL1244486	Binding affinity to LYN	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	270.0	CHEMBL3905	Homo sapiens	Kd	nM	270.0
	3449450	CHEMBL1244486	Binding affinity to LYN	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	1700.0	CHEMBL3905	Homo sapiens	Kd	nM	1700.0
	3449451	CHEMBL1244486	Binding affinity to LYN	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3000.0	CHEMBL3905	Homo sapiens	Kd	nM	3000.0
	3449713	CHEMBL1244486	Binding affinity to LYN	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	uM	10.0
	3457246	CHEMBL1246094	Inhibition of GST-tagged recombinant LynB after 20 mins by autoradiography	B	O=C(O)c1ccc(C(=O)/C(=C\c2ccc(F)c([N+](=O)[O-])c2)SCc2ccc(Br)cc2)cc1		CHEMBL1242482	=	IC50	nM	17000.0	CHEMBL3905	Homo sapiens	IC50	uM	17.0
	3463265	CHEMBL1252468	Inhibition of LYN A at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	3463266	CHEMBL1252469	Inhibition of LYN B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	3463809	CHEMBL1252468	Inhibition of LYN A at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	3463810	CHEMBL1252469	Inhibition of LYN B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	3464028	CHEMBL1252468	Inhibition of LYN A at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	3464029	CHEMBL1252469	Inhibition of LYN B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	21.0	CHEMBL3905	Homo sapiens	INH	%	21.0
	3504306	CHEMBL1260188	Inhibition of LYN	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	5120340	CHEMBL1646183	Inhibition of human Lyn at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	102.0	CHEMBL3905	Homo sapiens	INH	%	102.0
	5138585	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	FC		4.0	CHEMBL3905	Homo sapiens	FC		4.0
	5138586	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3c4c(cccc24)C(=O)N(CC)C3=O)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644433	=	FC		2.5	CHEMBL3905	Homo sapiens	FC		2.5
	5138587	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2cc3ccc(O)cc3oc2=O)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644434	=	FC		1.1	CHEMBL3905	Homo sapiens	FC		1.1
	5138588	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(Cc2cc(=O)oc3cc(N)ccc23)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644435	=	FC		1.3	CHEMBL3905	Homo sapiens	FC		1.3
	5138589	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(Cc2cc(=O)oc3cc(NC(C)=O)ccc23)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644436	=	FC		1.3	CHEMBL3905	Homo sapiens	FC		1.3
	5138590	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(CCNS(=O)(=O)c2cccc3c(N(C)C)cccc23)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644437	=	FC		0.0	CHEMBL3905	Homo sapiens	FC		0.0
	5138591	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3c(C)cc(=O)[nH]c3c2)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644438	=	FC		0.0	CHEMBL3905	Homo sapiens	FC		0.0
	5138592	CHEMBL1647477	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2cccc3ccccc23)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644439	=	FC		0.0	CHEMBL3905	Homo sapiens	FC		0.0
	5138593	CHEMBL1647478	Binding affinity to Lyn assessed as increase of fluorescence after 60 mins by HPLC analysis	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	FC		4.0	CHEMBL3905	Homo sapiens	FC		4.0
tde	5138594	CHEMBL1647479	Binding affinity to Lyn in human K562 CML cells assessed as increase of fluorescence	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Active	5138595	CHEMBL1647480	Binding affinity to Lyn in human K562 CML cells assessed as increase of fluorescence after 60 mins in presence of SFK inhibitor SU6656	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Active	5138596	CHEMBL1647481	Binding affinity to Lyn in human K562 CML cells assessed as increase of fluorescence after 60 mins in presence of Bcr-Abl inhibitor Imatinib	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432		Activity			CHEMBL3905	Homo sapiens	Activity		
	5138597	CHEMBL1647482	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 10 mins	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	1.35	CHEMBL3905	Homo sapiens	Activity	%	1.35
	5138598	CHEMBL1647483	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 20 mins	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	1.67	CHEMBL3905	Homo sapiens	Activity	%	1.67
	5138599	CHEMBL1647484	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 40 mins	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	2.01	CHEMBL3905	Homo sapiens	Activity	%	2.01
	5138600	CHEMBL1647485	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 60 mins	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	4.24	CHEMBL3905	Homo sapiens	Activity	%	4.24
	5138601	CHEMBL1647486	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 10 mins in presence of Bcr-Abl inhibitor Imatinib	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	0.18	CHEMBL3905	Homo sapiens	Activity	%	0.18
	5138602	CHEMBL1647487	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 20 mins in presence of Bcr-Abl inhibitor Imatinib	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	0.25	CHEMBL3905	Homo sapiens	Activity	%	0.25
	5138603	CHEMBL1647488	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 40 mins in presence of Bcr-Abl inhibitor Imatinib	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	0.33	CHEMBL3905	Homo sapiens	Activity	%	0.33
	5138604	CHEMBL1647489	Induction of Lyn phosphorylation in human K562 CML cells assessed as peptide substrate consumption at 25 uM after 60 mins in presence of Bcr-Abl inhibitor Imatinib	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1cn(-c2ccc3ccc4cccc5ccc2c3c45)nn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O		CHEMBL1644432	=	Activity	%	0.41	CHEMBL3905	Homo sapiens	Activity	%	0.41
	5243730	CHEMBL1685693	Inhibition of Lyn at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	15.0	CHEMBL3905	Homo sapiens	INH	%	15.0
	5243838	CHEMBL1686050	Inhibition of Lyn at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	5243951	CHEMBL1685693	Inhibition of Lyn at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	5244059	CHEMBL1686050	Inhibition of Lyn at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	5244932	CHEMBL1685693	Inhibition of Lyn at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	59.0	CHEMBL3905	Homo sapiens	INH	%	59.0
	5245040	CHEMBL1686050	Inhibition of Lyn at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	12.0	CHEMBL3905	Homo sapiens	INH	%	12.0
	5245191	CHEMBL1685693	Inhibition of Lyn at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	91.0	CHEMBL3905	Homo sapiens	INH	%	91.0
	5246021	CHEMBL1686050	Inhibition of Lyn at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	5293864	CHEMBL1697121	Inhibition of LYN after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	23800.0	CHEMBL3905	Homo sapiens	IC50	uM	23.8
	6167609	CHEMBL1768469	Binding affinity to human LYN tyrosine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	76.0	CHEMBL3905	Homo sapiens	Activity	%	76.0
	6167631	CHEMBL1768650	Binding affinity to human LYN tyrosine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	3.2	CHEMBL3905	Homo sapiens	Activity	%	3.2
	6167656	CHEMBL1769197	Inhibition of LYNA	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	Ki	uM	1.0
	6198129	CHEMBL1776220	Inhibition of LYN assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	6219905	CHEMBL1785333	Inhibition of human LYN using poly[Glu:Tyr] by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	<	IC50	nM	0.15	CHEMBL3905	Homo sapiens	IC50	nM	0.15
	6262762	CHEMBL1798985	Inhibition of LYN	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	6294874	CHEMBL1811522	Inhibition of Lyn	B	CC(C)c1nc(-c2ccc(F)c(NS(=O)(=O)c3c(F)cccc3F)c2)c(-c2ccnc(Nc3ccc(N4CCOCC4)nc3)n2)s1		CHEMBL1808264	=	IC50	nM	10.0	CHEMBL3905	Homo sapiens	IC50	nM	10.0
	6315431	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	6315432	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	39.0	CHEMBL3905	Homo sapiens	INH	%	39.0
	6315433	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	6315434	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	39.0	CHEMBL3905	Homo sapiens	INH	%	39.0
	6316327	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	6316328	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	56.0	CHEMBL3905	Homo sapiens	INH	%	56.0
	6316329	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	76.0	CHEMBL3905	Homo sapiens	INH	%	76.0
	6316330	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	63.0	CHEMBL3905	Homo sapiens	INH	%	63.0
	6316331	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	40.0	CHEMBL3905	Homo sapiens	INH	%	40.0
	6316332	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	63.0	CHEMBL3905	Homo sapiens	INH	%	63.0
	6316333	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	-1.0	CHEMBL3905	Homo sapiens	INH	%	-1.0
	6316334	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	12.0	CHEMBL3905	Homo sapiens	INH	%	12.0
	6316335	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	45.0	CHEMBL3905	Homo sapiens	INH	%	45.0
	6316336	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	51.0	CHEMBL3905	Homo sapiens	INH	%	51.0
	6316337	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1	Outside typical range	CHEMBL1813620	=	Inhibition	%	-13.0	CHEMBL3905	Homo sapiens	INH	%	-13.0
	6316338	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	22.0	CHEMBL3905	Homo sapiens	INH	%	22.0
	6316339	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	6316340	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	6316341	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	26.0	CHEMBL3905	Homo sapiens	INH	%	26.0
	6316342	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	54.0	CHEMBL3905	Homo sapiens	INH	%	54.0
	6316343	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	6316344	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	19.0	CHEMBL3905	Homo sapiens	INH	%	19.0
	6316345	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	6316346	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	6316347	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	6316348	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	-1.0	CHEMBL3905	Homo sapiens	INH	%	-1.0
	6316349	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	6316350	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	11.0	CHEMBL3905	Homo sapiens	INH	%	11.0
	6316351	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	17.0	CHEMBL3905	Homo sapiens	INH	%	17.0
	6316352	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	6316353	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	6316354	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	4.0	CHEMBL3905	Homo sapiens	INH	%	4.0
	6316355	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	6316356	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	6316357	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	6316358	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	96.0	CHEMBL3905	Homo sapiens	INH	%	96.0
	6316359	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	97.0	CHEMBL3905	Homo sapiens	INH	%	97.0
	6316360	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	86.0	CHEMBL3905	Homo sapiens	INH	%	86.0
	6316361	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	90.0	CHEMBL3905	Homo sapiens	INH	%	90.0
	6316362	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	100.0	CHEMBL3905	Homo sapiens	INH	%	100.0
	6316363	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	40.0	CHEMBL3905	Homo sapiens	INH	%	40.0
	6316364	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	6316365	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	71.0	CHEMBL3905	Homo sapiens	INH	%	71.0
	6316366	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	6316367	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	6316368	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	6316369	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	29.0	CHEMBL3905	Homo sapiens	INH	%	29.0
	6316370	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	6316371	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	6316372	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	6316373	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	23.0	CHEMBL3905	Homo sapiens	INH	%	23.0
	6316374	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	6316375	CHEMBL1815728	Inhibition of LYN at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	6318067	CHEMBL1816258	Inhibition of Lyn kinase at 1 uM	B	CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccccc4)CC3)n2)c1C		CHEMBL1813033	>	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	6318068	CHEMBL1816258	Inhibition of Lyn kinase at 1 uM	B	CC(=O)Nc1cccc(Nc2ncnc(N3CCC(OCc4ccccc4)CC3)n2)c1		CHEMBL1813032	=	Inhibition	%	74.0	CHEMBL3905	Homo sapiens	INH	%	74.0
	6318851	CHEMBL1815747	Inhibition of LYN by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	IC50	nM	14000.0	CHEMBL3905	Homo sapiens	IC50	uM	14.0
	6318852	CHEMBL1815747	Inhibition of LYN by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	IC50	nM	1400.0	CHEMBL3905	Homo sapiens	IC50	uM	1.4
	6341081	CHEMBL1828394	Activity of LYN kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3905	Homo sapiens	Activity	%	100.0
	6382482	CHEMBL1838269	Inhibition of LYN	B	Cc1ccc(Nc2nc(N[C@@H]3CCOC[C@@H]3N)ncc2C(N)=O)cc1		CHEMBL1835071	=	IC50	nM	3981.07	CHEMBL3905	Homo sapiens	pIC50		5.4
	6385818	CHEMBL1838331	Inhibition of human LYN in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	6385819	CHEMBL1838331	Inhibition of human LYN in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	6385820	CHEMBL1838331	Inhibition of human LYN in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	6385821	CHEMBL1838331	Inhibition of human LYN in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	6385822	CHEMBL1838331	Inhibition of human LYN in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	6386446	CHEMBL1837862	Inhibition of LYN-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	3019.0	CHEMBL3905	Homo sapiens	IC50	nM	3019.0
	6386455	CHEMBL1837853	Inhibition of recombinant LYN kinase	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	300.0	CHEMBL3905	Homo sapiens	IC50	uM	0.3
	7567257	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	270.0	CHEMBL3905	Homo sapiens	Kd	nM	270.0
	7567716	CHEMBL1908559	Binding constant for LYN kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7568187	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	890.0	CHEMBL3905	Homo sapiens	Kd	nM	890.0
	7568645	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	810.0	CHEMBL3905	Homo sapiens	Kd	nM	810.0
	7569230	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7569690	CHEMBL1908559	Binding constant for LYN kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	940.0	CHEMBL3905	Homo sapiens	Kd	nM	940.0
	7570183	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7570610	CHEMBL1908559	Binding constant for LYN kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	270.0	CHEMBL3905	Homo sapiens	Kd	nM	270.0
	7571206	CHEMBL1908559	Binding constant for LYN kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7571663	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.57	CHEMBL3905	Homo sapiens	Kd	nM	0.57
	7571697	CHEMBL1908559	Binding constant for LYN kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7572160	CHEMBL1908559	Binding constant for LYN kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7572576	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	280.0	CHEMBL3905	Homo sapiens	Kd	nM	280.0
	7573187	CHEMBL1908559	Binding constant for LYN kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	940.0	CHEMBL3905	Homo sapiens	Kd	nM	940.0
	7573678	CHEMBL1908559	Binding constant for LYN kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1600.0	CHEMBL3905	Homo sapiens	Kd	nM	1600.0
	7574147	CHEMBL1908559	Binding constant for LYN kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	4200.0	CHEMBL3905	Homo sapiens	Kd	nM	4200.0
	7574555	CHEMBL1908559	Binding constant for LYN kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7575184	CHEMBL1908559	Binding constant for LYN kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	530.0	CHEMBL3905	Homo sapiens	Kd	nM	530.0
	7575655	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	710.0	CHEMBL3905	Homo sapiens	Kd	nM	710.0
	7576120	CHEMBL1908559	Binding constant for LYN kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	1100.0	CHEMBL3905	Homo sapiens	Kd	nM	1100.0
	7576528	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	500.0	CHEMBL3905	Homo sapiens	Kd	nM	500.0
	7576697	CHEMBL1908559	Binding constant for LYN kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7577156	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	9.1	CHEMBL3905	Homo sapiens	Kd	nM	9.1
	7577634	CHEMBL1908559	Binding constant for LYN kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	3100.0	CHEMBL3905	Homo sapiens	Kd	nM	3100.0
	7578104	CHEMBL1908559	Binding constant for LYN kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	560.0	CHEMBL3905	Homo sapiens	Kd	nM	560.0
	7578509	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	110.0	CHEMBL3905	Homo sapiens	Kd	nM	110.0
	7578705	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7579079	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	2700.0	CHEMBL3905	Homo sapiens	Kd	nM	2700.0
	7579529	CHEMBL1908559	Binding constant for LYN kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7580003	CHEMBL1908559	Binding constant for LYN kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7580472	CHEMBL1908559	Binding constant for LYN kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7580875	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	650.0	CHEMBL3905	Homo sapiens	Kd	nM	650.0
	7581063	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	61.0	CHEMBL3905	Homo sapiens	Kd	nM	61.0
	7581448	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7581893	CHEMBL1908559	Binding constant for LYN kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7582364	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7583409	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7583806	CHEMBL1908559	Binding constant for LYN kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7584251	CHEMBL1908559	Binding constant for LYN kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7584722	CHEMBL1908559	Binding constant for LYN kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7584742	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	26.0	CHEMBL3905	Homo sapiens	Kd	nM	26.0
	7585146	CHEMBL1908559	Binding constant for LYN kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1700.0	CHEMBL3905	Homo sapiens	Kd	nM	1700.0
	7585739	CHEMBL1908559	Binding constant for LYN kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	5700.0	CHEMBL3905	Homo sapiens	Kd	nM	5700.0
	7586147	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7586593	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	990.0	CHEMBL3905	Homo sapiens	Kd	nM	990.0
	7587076	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7587700	CHEMBL1908559	Binding constant for LYN kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7588119	CHEMBL1908559	Binding constant for LYN kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	190.0	CHEMBL3905	Homo sapiens	Kd	nM	190.0
	7588601	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7589052	CHEMBL1908559	Binding constant for LYN kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7589665	CHEMBL1908559	Binding constant for LYN kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	160.0	CHEMBL3905	Homo sapiens	Kd	nM	160.0
	7590089	CHEMBL1908559	Binding constant for LYN kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	750.0	CHEMBL3905	Homo sapiens	Kd	nM	750.0
	7590114	CHEMBL1908559	Binding constant for LYN kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7590588	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7591039	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7592090	CHEMBL1908559	Binding constant for LYN kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7592563	CHEMBL1908559	Binding constant for LYN kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1400.0	CHEMBL3905	Homo sapiens	Kd	nM	1400.0
	7593016	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	4.2	CHEMBL3905	Homo sapiens	Kd	nM	4.2
	7593163	CHEMBL1908559	Binding constant for LYN kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	14.0	CHEMBL3905	Homo sapiens	Kd	nM	14.0
	7593598	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	370.0	CHEMBL3905	Homo sapiens	Kd	nM	370.0
	7594070	CHEMBL1908559	Binding constant for LYN kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7594543	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	100.0	CHEMBL3905	Homo sapiens	Kd	nM	100.0
	7594995	CHEMBL1908559	Binding constant for LYN kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3000.0	CHEMBL3905	Homo sapiens	Kd	nM	3000.0
	7595131	CHEMBL1908559	Binding constant for LYN kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7595575	CHEMBL1908559	Binding constant for LYN kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	810.0	CHEMBL3905	Homo sapiens	Kd	nM	810.0
	7596049	CHEMBL1908559	Binding constant for LYN kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7596520	CHEMBL1908559	Binding constant for LYN kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	1100.0	CHEMBL3905	Homo sapiens	Kd	nM	1100.0
	7596967	CHEMBL1908559	Binding constant for LYN kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	40.0	CHEMBL3905	Homo sapiens	Kd	nM	40.0
	7597103	CHEMBL1908559	Binding constant for LYN kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1600.0	CHEMBL3905	Homo sapiens	Kd	nM	1600.0
	7597556	CHEMBL1908559	Binding constant for LYN kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3905	Homo sapiens	Kd	nM	10000.0
	7598029	CHEMBL1908559	Binding constant for LYN kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	820.0	CHEMBL3905	Homo sapiens	Kd	nM	820.0
	7598499	CHEMBL1908559	Binding constant for LYN kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	2.2	CHEMBL3905	Homo sapiens	Kd	nM	2.2
	7922694	CHEMBL1918452	Inhibition of human recombinant LYN at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	25.0	CHEMBL3905	Homo sapiens	INH	%	25.0
	7930360	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	200.0	CHEMBL3905	Homo sapiens	IC50	nM	200.0
	7930361	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1NC(=O)C#CCN1CCOCC1		CHEMBL1916712	=	IC50	nM	46.6	CHEMBL3905	Homo sapiens	IC50	nM	46.6
	7930362	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1NC(=O)C#CCN1CCCCC1		CHEMBL1916713	=	IC50	nM	21.3	CHEMBL3905	Homo sapiens	IC50	nM	21.3
	7930363	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	C=C(CN1CCOCC1)C(=O)Nc1cc2c(cc1OC)nc(Nc1ccccc1C)c1cncn12		CHEMBL1916714	=	IC50	nM	297.0	CHEMBL3905	Homo sapiens	IC50	nM	297.0
	7930364	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1NC(=O)/C=C/CN(C)C		CHEMBL1916715	=	IC50	nM	10.9	CHEMBL3905	Homo sapiens	IC50	nM	10.9
	7930365	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	COc1cc2nc(Nc3ccccc3C)c3cncn3c2cc1N(CC1CC1)C(=O)/C=C/CN(C)C		CHEMBL1916716	=	IC50	nM	1980.0	CHEMBL3905	Homo sapiens	IC50	nM	1980.0
	7930366	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CCN(C(=O)/C=C/CN(C)C)c1cc2c(cc1OC)nc(Nc1ccccc1C)c1cncn12		CHEMBL1916717	=	IC50	nM	533.0	CHEMBL3905	Homo sapiens	IC50	nM	533.0
	7930367	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916718	=	IC50	nM	623.0	CHEMBL3905	Homo sapiens	IC50	nM	623.0
	7930368	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CN(C)C/C=C/C(=O)N(C)c1ccc2nc(Cl)c3cncn3c2c1		CHEMBL1916719	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	nM	50000.0
	7930369	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916879	=	IC50	nM	1.55	CHEMBL3905	Homo sapiens	IC50	nM	1.55
	7930370	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(F)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916880	=	IC50	nM	1420.0	CHEMBL3905	Homo sapiens	IC50	nM	1420.0
	7930371	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cc(F)ccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916881	=	IC50	nM	716.0	CHEMBL3905	Homo sapiens	IC50	nM	716.0
	7930372	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1c(F)cccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916882	=	IC50	nM	327.0	CHEMBL3905	Homo sapiens	IC50	nM	327.0
	7930373	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cccc(Cl)c1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916883	=	IC50	nM	44.4	CHEMBL3905	Homo sapiens	IC50	nM	44.4
	7930374	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(Cl)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916884	=	IC50	nM	1670.0	CHEMBL3905	Homo sapiens	IC50	nM	1670.0
	7930375	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cc(Cl)ccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916885	=	IC50	nM	378.0	CHEMBL3905	Homo sapiens	IC50	nM	378.0
	7930376	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1c(Cl)cccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916886	=	IC50	nM	2320.0	CHEMBL3905	Homo sapiens	IC50	nM	2320.0
	7930377	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cccc(O)c1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916887	=	IC50	nM	167.0	CHEMBL3905	Homo sapiens	IC50	nM	167.0
	7930378	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(O)cc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916888	=	IC50	nM	10.9	CHEMBL3905	Homo sapiens	IC50	nM	10.9
	7930379	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cc(O)ccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916889	=	IC50	nM	350.0	CHEMBL3905	Homo sapiens	IC50	nM	350.0
	7930380	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1c(O)cccc1Nc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916890	=	IC50	nM	490.0	CHEMBL3905	Homo sapiens	IC50	nM	490.0
	7930381	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	IC50	nM	624.0	CHEMBL3905	Homo sapiens	IC50	nM	624.0
	7930382	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CN(C)C/C=C/C(=O)N(C)c1cc2c(cc1F)nc(Nc1ccccc1Cl)c1cncn12		CHEMBL1916892	=	IC50	nM	2130.0	CHEMBL3905	Homo sapiens	IC50	nM	2130.0
	7930383	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(F)cc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916893	=	IC50	nM	3080.0	CHEMBL3905	Homo sapiens	IC50	nM	3080.0
	7930384	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cc(F)ccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916894	=	IC50	nM	3450.0	CHEMBL3905	Homo sapiens	IC50	nM	3450.0
	7930385	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccccc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916895	=	IC50	nM	1300.0	CHEMBL3905	Homo sapiens	IC50	nM	1300.0
	7930386	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CN(C)C/C=C/C(=O)N(C)c1cc2c(cc1Cl)nc(Nc1ccccc1Cl)c1cncn12		CHEMBL1916896	=	IC50	nM	2000.0	CHEMBL3905	Homo sapiens	IC50	nM	2000.0
	7930387	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(F)cc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916897	=	IC50	nM	3390.0	CHEMBL3905	Homo sapiens	IC50	nM	3390.0
	7930388	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cc(F)ccc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916898	=	IC50	nM	1590.0	CHEMBL3905	Homo sapiens	IC50	nM	1590.0
	7930389	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccccc1Oc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916899	=	IC50	nM	6020.0	CHEMBL3905	Homo sapiens	IC50	nM	6020.0
	7930390	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccc(F)cc1Oc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916900	=	IC50	nM	7400.0	CHEMBL3905	Homo sapiens	IC50	nM	7400.0
	7930391	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cc(F)ccc1Oc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916901	=	IC50	nM	10400.0	CHEMBL3905	Homo sapiens	IC50	nM	10400.0
	7930392	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1cc(F)ccc1Oc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916902	=	IC50	nM	3730.0	CHEMBL3905	Homo sapiens	IC50	nM	3730.0
	7930393	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	Cc1ccccc1Sc1nc2ccc(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916903	=	IC50	nM	19600.0	CHEMBL3905	Homo sapiens	IC50	nM	19600.0
	7930394	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CNc1ccc2nc(Nc3cc(F)ccc3C)c3cncn3c2c1		CHEMBL1916904	=	IC50	nM	40.0	CHEMBL3905	Homo sapiens	IC50	nM	40.0
	7930395	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CNc1ccc2nc(Oc3ccc(F)cc3C)c3cncn3c2c1		CHEMBL1916905	=	IC50	nM	560.0	CHEMBL3905	Homo sapiens	IC50	nM	560.0
	7930396	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CNc1cc2c(cc1F)nc(Nc1ccccc1C)c1cncn12		CHEMBL1916906	=	IC50	nM	19.0	CHEMBL3905	Homo sapiens	IC50	nM	19.0
	7930397	CHEMBL1918489	Inhibition of LYN-A expressed in Sf9 cells after 60 mins by TR-FRET Assay	B	CNc1cc2c(cc1F)nc(Oc1ccccc1C)c1cncn12		CHEMBL1916907	=	IC50	nM	130.0	CHEMBL3905	Homo sapiens	IC50	nM	130.0
	7930433	CHEMBL1919047	Inhibition of LYN-A expressed in Sf9 cells preincubated for 60 mins measured after 60 mins by TR-FRET Assay	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	IC50	nM	353.0	CHEMBL3905	Homo sapiens	IC50	nM	353.0
	7930434	CHEMBL1919047	Inhibition of LYN-A expressed in Sf9 cells preincubated for 60 mins measured after 60 mins by TR-FRET Assay	B	Cc1ccc(F)cc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916897	=	IC50	nM	3020.0	CHEMBL3905	Homo sapiens	IC50	nM	3020.0
	7931105	CHEMBL1919280	Inhibition of LYN-A relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	23.0	CHEMBL3905	Homo sapiens	INH	%	23.0
	7931106	CHEMBL1919281	Inhibition of LYN-B relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	24.0	CHEMBL3905	Homo sapiens	INH	%	24.0
	7943743	CHEMBL1919763	Inhibition of LYN	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.3	CHEMBL3905	Homo sapiens	IC50	nM	1.3
	7943784	CHEMBL1921552	Inhibition of LYN at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	4.6	CHEMBL3905	Homo sapiens	INH	%	4.6
	7956232	CHEMBL1924895	Inhibition of N-terminus flag-tagged LynA expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	7956233	CHEMBL1924896	Inhibition of N-terminus flag-tagged LynB expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	=	IC50	nM	5200.0	CHEMBL3905	Homo sapiens	IC50	nM	5200.0
	7961047	CHEMBL1932886	Inhibition of LYN	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	43000.0	CHEMBL3905	Homo sapiens	IC50	uM	43.0
	7961048	CHEMBL1932886	Inhibition of LYN	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	960.0	CHEMBL3905	Homo sapiens	IC50	uM	0.96
	7970436	CHEMBL1930181	Inhibition of LYN at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	8004412	CHEMBL1943599	Inhibition of human LYN in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	8004413	CHEMBL1943599	Inhibition of human LYN in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	8004414	CHEMBL1943599	Inhibition of human LYN in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	8004415	CHEMBL1943599	Inhibition of human LYN in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	8004498	CHEMBL1943930	Inhibition of LYN at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	8004542	CHEMBL1943930	Inhibition of LYN at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	8005206	CHEMBL1943930	Inhibition of LYN at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	8005249	CHEMBL1943930	Inhibition of LYN at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	8013112	CHEMBL1948131	Inhibition of LYN using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	8018819	CHEMBL1948945	Inhibition of LYN-A assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	96.0	CHEMBL3905	Homo sapiens	Activity	%	96.0
Not Determined	8018820	CHEMBL1948945	Inhibition of LYN-A assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950		Activity			CHEMBL3905	Homo sapiens	Activity		
Not Determined	8018821	CHEMBL1948945	Inhibition of LYN-A assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262		Activity			CHEMBL3905	Homo sapiens	Activity		
	8039296	CHEMBL1953277	Inhibition of Lyn	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	8039297	CHEMBL1953277	Inhibition of Lyn	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	8047136	CHEMBL1958965	Inhibition of LYN at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	8051009	CHEMBL1961069	Inhibition of recombinant LYN at 10 uM after 90 mins fluorescence assay	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL1957675	=	Inhibition	%	60.0	CHEMBL3905	Homo sapiens	INH	%	60.0
	8059493	CHEMBL1958991	Inhibition of Lyn	B	Nc1nc(Nc2ccc([C@H]3CC[C@H](N4CCOCC4)CC3)cc2)nn1-c1ccccn1		CHEMBL1835870	=	Ki	nM	400.0	CHEMBL3905	Homo sapiens	Ki	uM	0.4
	8061581	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	41.75	CHEMBL3905	Homo sapiens	Inhibition	%	41.75
	8061582	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	35.35	CHEMBL3905	Homo sapiens	Inhibition	%	35.35
	8061688	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.88	CHEMBL3905	Homo sapiens	Inhibition	%	4.88
	8061689	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.82	CHEMBL3905	Homo sapiens	Inhibition	%	2.82
	8061912	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	23.3	CHEMBL3905	Homo sapiens	Inhibition	%	23.3
	8061913	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	13.89	CHEMBL3905	Homo sapiens	Inhibition	%	13.89
	8062103	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.97	CHEMBL3905	Homo sapiens	Inhibition	%	6.97
	8062104	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.53	CHEMBL3905	Homo sapiens	Inhibition	%	5.53
	8062219	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	13.51	CHEMBL3905	Homo sapiens	Inhibition	%	13.51
	8062220	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	10.58	CHEMBL3905	Homo sapiens	Inhibition	%	10.58
	8062443	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.05	CHEMBL3905	Homo sapiens	Inhibition	%	4.05
	8062444	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.97	CHEMBL3905	Homo sapiens	Inhibition	%	2.97
	8062605	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	8.89	CHEMBL3905	Homo sapiens	Inhibition	%	8.89
	8062606	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.26	CHEMBL3905	Homo sapiens	Inhibition	%	6.26
	8062927	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.88	CHEMBL3905	Homo sapiens	Inhibition	%	-1.88
	8062928	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.9	CHEMBL3905	Homo sapiens	Inhibition	%	-0.9
	8063059	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	6.73	CHEMBL3905	Homo sapiens	Inhibition	%	6.73
	8063060	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.81	CHEMBL3905	Homo sapiens	Inhibition	%	4.81
	8063283	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	42.8	CHEMBL3905	Homo sapiens	Inhibition	%	42.8
	8063284	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	37.11	CHEMBL3905	Homo sapiens	Inhibition	%	37.11
	8063450	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.95	CHEMBL3905	Homo sapiens	Inhibition	%	2.95
	8063451	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.39	CHEMBL3905	Homo sapiens	Inhibition	%	2.39
	8063782	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.23	CHEMBL3905	Homo sapiens	Inhibition	%	2.23
	8063783	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.62	CHEMBL3905	Homo sapiens	Inhibition	%	1.62
	8063964	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	41.83	CHEMBL3905	Homo sapiens	Inhibition	%	41.83
	8063965	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	35.95	CHEMBL3905	Homo sapiens	Inhibition	%	35.95
	8064303	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.29	CHEMBL3905	Homo sapiens	Inhibition	%	2.29
	8064304	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.52	CHEMBL3905	Homo sapiens	Inhibition	%	1.52
	8064513	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.77	CHEMBL3905	Homo sapiens	Inhibition	%	0.77
	8064514	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.28	CHEMBL3905	Homo sapiens	Inhibition	%	0.28
	8064875	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	7.52	CHEMBL3905	Homo sapiens	Inhibition	%	7.52
	8064876	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.1	CHEMBL3905	Homo sapiens	Inhibition	%	5.1
	8065041	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	7.79	CHEMBL3905	Homo sapiens	Inhibition	%	7.79
	8065042	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	7.64	CHEMBL3905	Homo sapiens	Inhibition	%	7.64
	8065381	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.11	CHEMBL3905	Homo sapiens	Inhibition	%	2.11
	8065382	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.18	CHEMBL3905	Homo sapiens	Inhibition	%	3.18
	8065556	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	7.06	CHEMBL3905	Homo sapiens	Inhibition	%	7.06
	8065557	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.18	CHEMBL3905	Homo sapiens	Inhibition	%	5.18
	8065895	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.48	CHEMBL3905	Homo sapiens	Inhibition	%	1.48
	8065896	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.82	CHEMBL3905	Homo sapiens	Inhibition	%	0.82
	8066105	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.73	CHEMBL3905	Homo sapiens	Inhibition	%	2.73
	8066106	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.62	CHEMBL3905	Homo sapiens	Inhibition	%	1.62
	8066465	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	37.33	CHEMBL3905	Homo sapiens	Inhibition	%	37.33
	8066466	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	32.92	CHEMBL3905	Homo sapiens	Inhibition	%	32.92
	8066631	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.25	CHEMBL3905	Homo sapiens	Inhibition	%	1.25
	8066632	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.89	CHEMBL3905	Homo sapiens	Inhibition	%	0.89
	8066855	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.43	CHEMBL3905	Homo sapiens	Inhibition	%	5.43
	8066856	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.03	CHEMBL3905	Homo sapiens	Inhibition	%	5.03
	8066979	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	9.62	CHEMBL3905	Homo sapiens	Inhibition	%	9.62
	8066980	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.97	CHEMBL3905	Homo sapiens	Inhibition	%	7.97
	8067154	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	39.5	CHEMBL3905	Homo sapiens	Inhibition	%	39.5
	8067155	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	33.87	CHEMBL3905	Homo sapiens	Inhibition	%	33.87
	8067378	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.86	CHEMBL3905	Homo sapiens	Inhibition	%	3.86
	8067379	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.56	CHEMBL3905	Homo sapiens	Inhibition	%	1.56
	8067499	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.6	CHEMBL3905	Homo sapiens	Inhibition	%	1.6
	8067500	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.31	CHEMBL3905	Homo sapiens	Inhibition	%	1.31
	8067709	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	3.82	CHEMBL3905	Homo sapiens	Inhibition	%	3.82
	8067710	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.19	CHEMBL3905	Homo sapiens	Inhibition	%	1.19
	8067933	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	6.26	CHEMBL3905	Homo sapiens	Inhibition	%	6.26
	8067934	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.71	CHEMBL3905	Homo sapiens	Inhibition	%	2.71
	8068068	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.81	CHEMBL3905	Homo sapiens	Inhibition	%	3.81
	8068069	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.46	CHEMBL3905	Homo sapiens	Inhibition	%	2.46
	8068456	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.97	CHEMBL3905	Homo sapiens	Inhibition	%	3.97
	8068457	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.56	CHEMBL3905	Homo sapiens	Inhibition	%	2.56
	8068581	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	15.24	CHEMBL3905	Homo sapiens	Inhibition	%	15.24
	8068582	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	13.81	CHEMBL3905	Homo sapiens	Inhibition	%	13.81
	8068979	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.43	CHEMBL3905	Homo sapiens	Inhibition	%	3.43
	8068980	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.05	CHEMBL3905	Homo sapiens	Inhibition	%	3.05
	8069104	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.64	CHEMBL3905	Homo sapiens	Inhibition	%	0.64
	8069105	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.28	CHEMBL3905	Homo sapiens	Inhibition	%	0.28
	8069328	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	6.12	CHEMBL3905	Homo sapiens	Inhibition	%	6.12
	8069329	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.71	CHEMBL3905	Homo sapiens	Inhibition	%	4.71
	8069399	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	29.29	CHEMBL3905	Homo sapiens	Inhibition	%	29.29
	8069400	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	23.59	CHEMBL3905	Homo sapiens	Inhibition	%	23.59
	8069784	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	10.47	CHEMBL3905	Homo sapiens	Inhibition	%	10.47
	8069785	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	9.05	CHEMBL3905	Homo sapiens	Inhibition	%	9.05
	8069910	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.87	CHEMBL3905	Homo sapiens	Inhibition	%	0.87
	8069911	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.6	CHEMBL3905	Homo sapiens	Inhibition	%	0.6
	8070134	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.77	CHEMBL3905	Homo sapiens	Inhibition	%	2.77
	8070135	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.84	CHEMBL3905	Homo sapiens	Inhibition	%	2.84
	8070306	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.95	CHEMBL3905	Homo sapiens	Inhibition	%	2.95
	8070307	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.98	CHEMBL3905	Homo sapiens	Inhibition	%	1.98
	8070655	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.49	CHEMBL3905	Homo sapiens	Inhibition	%	1.49
	8070656	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.81	CHEMBL3905	Homo sapiens	Inhibition	%	0.81
	8070729	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.7	CHEMBL3905	Homo sapiens	Inhibition	%	6.7
	8070730	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	5.46	CHEMBL3905	Homo sapiens	Inhibition	%	5.46
	8070953	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	32.65	CHEMBL3905	Homo sapiens	Inhibition	%	32.65
	8070954	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	27.48	CHEMBL3905	Homo sapiens	Inhibition	%	27.48
	8071110	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.74	CHEMBL3905	Homo sapiens	Inhibition	%	3.74
	8071111	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.32	CHEMBL3905	Homo sapiens	Inhibition	%	2.32
	8071460	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.89	CHEMBL3905	Homo sapiens	Inhibition	%	0.89
	8071461	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.34	CHEMBL3905	Homo sapiens	Inhibition	%	0.34
	8071633	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	9.35	CHEMBL3905	Homo sapiens	Inhibition	%	9.35
	8071634	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	6.67	CHEMBL3905	Homo sapiens	Inhibition	%	6.67
	8071982	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.48	CHEMBL3905	Homo sapiens	Inhibition	%	1.48
	8071983	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.31	CHEMBL3905	Homo sapiens	Inhibition	%	1.31
	8072296	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	7.9	CHEMBL3905	Homo sapiens	Inhibition	%	7.9
	8072297	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	5.64	CHEMBL3905	Homo sapiens	Inhibition	%	5.64
	8072453	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.11	CHEMBL3905	Homo sapiens	Inhibition	%	4.11
	8072454	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.84	CHEMBL3905	Homo sapiens	Inhibition	%	4.84
	8072802	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	7.91	CHEMBL3905	Homo sapiens	Inhibition	%	7.91
	8072803	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	7.01	CHEMBL3905	Homo sapiens	Inhibition	%	7.01
	8072969	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.37	CHEMBL3905	Homo sapiens	Inhibition	%	4.37
	8072970	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.54	CHEMBL3905	Homo sapiens	Inhibition	%	2.54
	8073193	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.24	CHEMBL3905	Homo sapiens	Inhibition	%	4.24
	8073194	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.6	CHEMBL3905	Homo sapiens	Inhibition	%	3.6
	8073318	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	28.67	CHEMBL3905	Homo sapiens	Inhibition	%	28.67
	8073319	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	22.65	CHEMBL3905	Homo sapiens	Inhibition	%	22.65
	8073661	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.12	CHEMBL3905	Homo sapiens	Inhibition	%	0.12
	8073662	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.75	CHEMBL3905	Homo sapiens	Inhibition	%	0.75
	8073894	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	45.85	CHEMBL3905	Homo sapiens	Inhibition	%	45.85
	8073895	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	41.58	CHEMBL3905	Homo sapiens	Inhibition	%	41.58
	8074046	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.96	CHEMBL3905	Homo sapiens	Inhibition	%	3.96
	8074047	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.63	CHEMBL3905	Homo sapiens	Inhibition	%	2.63
	8074270	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	8.66	CHEMBL3905	Homo sapiens	Inhibition	%	8.66
	8074271	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	6.73	CHEMBL3905	Homo sapiens	Inhibition	%	6.73
	8074400	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.76	CHEMBL3905	Homo sapiens	Inhibition	%	0.76
	8074401	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.93	CHEMBL3905	Homo sapiens	Inhibition	%	0.93
	8074781	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.61	CHEMBL3905	Homo sapiens	Inhibition	%	2.61
	8074782	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.91	CHEMBL3905	Homo sapiens	Inhibition	%	1.91
	8074908	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	70.47	CHEMBL3905	Homo sapiens	Inhibition	%	70.47
	8074909	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	66.45	CHEMBL3905	Homo sapiens	Inhibition	%	66.45
	8075243	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.93	CHEMBL3905	Homo sapiens	Inhibition	%	4.93
	8075244	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.77	CHEMBL3905	Homo sapiens	Inhibition	%	4.77
	8075480	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.54	CHEMBL3905	Homo sapiens	Inhibition	%	-1.54
	8075481	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.39	CHEMBL3905	Homo sapiens	Inhibition	%	-1.39
	8075845	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.89	CHEMBL3905	Homo sapiens	Inhibition	%	3.89
	8075846	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.44	CHEMBL3905	Homo sapiens	Inhibition	%	2.44
	8075987	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	10.95	CHEMBL3905	Homo sapiens	Inhibition	%	10.95
	8075988	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	8.58	CHEMBL3905	Homo sapiens	Inhibition	%	8.58
	8076359	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.78	CHEMBL3905	Homo sapiens	Inhibition	%	3.78
	8076360	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.88	CHEMBL3905	Homo sapiens	Inhibition	%	1.88
	8076493	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.41	CHEMBL3905	Homo sapiens	Inhibition	%	0.41
	8076494	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.31	CHEMBL3905	Homo sapiens	Inhibition	%	0.31
	8076717	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.82	CHEMBL3905	Homo sapiens	Inhibition	%	2.82
	8076718	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.18	CHEMBL3905	Homo sapiens	Inhibition	%	2.18
	8076819	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.59	CHEMBL3905	Homo sapiens	Inhibition	%	-0.59
	8076820	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.0	CHEMBL3905	Homo sapiens	Inhibition	%	-1.0
	8077066	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.2	CHEMBL3905	Homo sapiens	Inhibition	%	0.2
	8077067	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.5	CHEMBL3905	Homo sapiens	Inhibition	%	0.5
	8077418	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.02	CHEMBL3905	Homo sapiens	Inhibition	%	4.02
	8077419	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.42	CHEMBL3905	Homo sapiens	Inhibition	%	3.42
	8077569	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.92	CHEMBL3905	Homo sapiens	Inhibition	%	0.92
	8077570	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.04	CHEMBL3905	Homo sapiens	Inhibition	%	-0.04
	8077793	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.75	CHEMBL3905	Homo sapiens	Inhibition	%	1.75
	8077794	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.72	CHEMBL3905	Homo sapiens	Inhibition	%	1.72
	8077936	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.83	CHEMBL3905	Homo sapiens	Inhibition	%	1.83
	8077937	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.79	CHEMBL3905	Homo sapiens	Inhibition	%	0.79
	8078299	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.66	CHEMBL3905	Homo sapiens	Inhibition	%	2.66
	8078300	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.57	CHEMBL3905	Homo sapiens	Inhibition	%	0.57
	8078401	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.14	CHEMBL3905	Homo sapiens	Inhibition	%	-0.14
	8078402	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.37	CHEMBL3905	Homo sapiens	Inhibition	%	-0.37
	8078625	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.17	CHEMBL3905	Homo sapiens	Inhibition	%	0.17
	8078626	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.33	CHEMBL3905	Homo sapiens	Inhibition	%	-0.33
	8078651	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	2.08	CHEMBL3905	Homo sapiens	Inhibition	%	2.08
	8078652	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.81	CHEMBL3905	Homo sapiens	Inhibition	%	0.81
	8078875	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	22.11	CHEMBL3905	Homo sapiens	Inhibition	%	22.11
	8078876	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	16.75	CHEMBL3905	Homo sapiens	Inhibition	%	16.75
	8078991	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.98	CHEMBL3905	Homo sapiens	Inhibition	%	3.98
	8078992	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.18	CHEMBL3905	Homo sapiens	Inhibition	%	2.18
	8079373	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.6	CHEMBL3905	Homo sapiens	Inhibition	%	-0.6
	8079374	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.83	CHEMBL3905	Homo sapiens	Inhibition	%	-0.83
	8079515	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	9.45	CHEMBL3905	Homo sapiens	Inhibition	%	9.45
	8079516	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	7.19	CHEMBL3905	Homo sapiens	Inhibition	%	7.19
	8079878	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	20.01	CHEMBL3905	Homo sapiens	Inhibition	%	20.01
	8079879	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	17.4	CHEMBL3905	Homo sapiens	Inhibition	%	17.4
	8080207	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.43	CHEMBL3905	Homo sapiens	Inhibition	%	2.43
	8080208	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.99	CHEMBL3905	Homo sapiens	Inhibition	%	0.99
	8080459	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	2.35	CHEMBL3905	Homo sapiens	Inhibition	%	2.35
	8080460	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.51	CHEMBL3905	Homo sapiens	Inhibition	%	0.51
	8080574	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.36	CHEMBL3905	Homo sapiens	Inhibition	%	6.36
	8080575	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.78	CHEMBL3905	Homo sapiens	Inhibition	%	5.78
	8080798	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.3	CHEMBL3905	Homo sapiens	Inhibition	%	2.3
	8080799	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.2	CHEMBL3905	Homo sapiens	Inhibition	%	1.2
	8080962	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.84	CHEMBL3905	Homo sapiens	Inhibition	%	3.84
	8080963	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.72	CHEMBL3905	Homo sapiens	Inhibition	%	2.72
	8081097	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.19	CHEMBL3905	Homo sapiens	Inhibition	%	2.19
	8081098	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.2	CHEMBL3905	Homo sapiens	Inhibition	%	1.2
	8081321	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.34	CHEMBL3905	Homo sapiens	Inhibition	%	5.34
	8081322	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.42	CHEMBL3905	Homo sapiens	Inhibition	%	1.42
	8081465	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.55	CHEMBL3905	Homo sapiens	Inhibition	%	6.55
	8081466	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	4.92	CHEMBL3905	Homo sapiens	Inhibition	%	4.92
	8081792	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.27	CHEMBL3905	Homo sapiens	Inhibition	%	1.27
	8081793	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.38	CHEMBL3905	Homo sapiens	Inhibition	%	0.38
	8082044	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	24.31	CHEMBL3905	Homo sapiens	Inhibition	%	24.31
	8082045	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	20.45	CHEMBL3905	Homo sapiens	Inhibition	%	20.45
	8082381	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	6.36	CHEMBL3905	Homo sapiens	Inhibition	%	6.36
	8082382	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.75	CHEMBL3905	Homo sapiens	Inhibition	%	4.75
	8082554	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.63	CHEMBL3905	Homo sapiens	Inhibition	%	-0.63
	8082555	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.82	CHEMBL3905	Homo sapiens	Inhibition	%	-1.82
	8082901	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.48	CHEMBL3905	Homo sapiens	Inhibition	%	3.48
	8082902	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.55	CHEMBL3905	Homo sapiens	Inhibition	%	2.55
	8083057	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	11.2	CHEMBL3905	Homo sapiens	Inhibition	%	11.2
	8083058	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.3	CHEMBL3905	Homo sapiens	Inhibition	%	7.3
	8083380	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.18	CHEMBL3905	Homo sapiens	Inhibition	%	3.18
	8083381	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.63	CHEMBL3905	Homo sapiens	Inhibition	%	3.63
	8083634	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.05	CHEMBL3905	Homo sapiens	Inhibition	%	-2.05
	8083635	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.46	CHEMBL3905	Homo sapiens	Inhibition	%	-1.46
	8083968	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.99	CHEMBL3905	Homo sapiens	Inhibition	%	1.99
	8083969	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.43	CHEMBL3905	Homo sapiens	Inhibition	%	1.43
	8084153	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	9.44	CHEMBL3905	Homo sapiens	Inhibition	%	9.44
	8084154	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	7.55	CHEMBL3905	Homo sapiens	Inhibition	%	7.55
	8084495	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.47	CHEMBL3905	Homo sapiens	Inhibition	%	2.47
	8084496	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.61	CHEMBL3905	Homo sapiens	Inhibition	%	1.61
	8084656	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	6.54	CHEMBL3905	Homo sapiens	Inhibition	%	6.54
	8084657	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.32	CHEMBL3905	Homo sapiens	Inhibition	%	4.32
	8084880	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	16.12	CHEMBL3905	Homo sapiens	Inhibition	%	16.12
	8084881	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	12.45	CHEMBL3905	Homo sapiens	Inhibition	%	12.45
	8084978	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.17	CHEMBL3905	Homo sapiens	Inhibition	%	1.17
	8084979	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.4	CHEMBL3905	Homo sapiens	Inhibition	%	0.4
	8085234	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.3	CHEMBL3905	Homo sapiens	Inhibition	%	1.3
	8085235	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.59	CHEMBL3905	Homo sapiens	Inhibition	%	-0.59
	8085458	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	7.35	CHEMBL3905	Homo sapiens	Inhibition	%	7.35
	8085459	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.91	CHEMBL3905	Homo sapiens	Inhibition	%	3.91
	8085566	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	10.1	CHEMBL3905	Homo sapiens	Inhibition	%	10.1
	8085567	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	6.85	CHEMBL3905	Homo sapiens	Inhibition	%	6.85
	8085755	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.74	CHEMBL3905	Homo sapiens	Inhibition	%	8.74
	8085756	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	6.92	CHEMBL3905	Homo sapiens	Inhibition	%	6.92
	8085979	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	44.3	CHEMBL3905	Homo sapiens	Inhibition	%	44.3
	8085980	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	39.97	CHEMBL3905	Homo sapiens	Inhibition	%	39.97
	8086094	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.67	CHEMBL3905	Homo sapiens	Inhibition	%	2.67
	8086095	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.82	CHEMBL3905	Homo sapiens	Inhibition	%	2.82
	8086480	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.2	CHEMBL3905	Homo sapiens	Inhibition	%	4.2
	8086481	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.55	CHEMBL3905	Homo sapiens	Inhibition	%	2.55
	8086579	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.49	CHEMBL3905	Homo sapiens	Inhibition	%	1.49
	8086580	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.21	CHEMBL3905	Homo sapiens	Inhibition	%	-0.21
	8086803	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.64	CHEMBL3905	Homo sapiens	Inhibition	%	2.64
	8086804	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.5	CHEMBL3905	Homo sapiens	Inhibition	%	1.5
	8087014	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	11.12	CHEMBL3905	Homo sapiens	Inhibition	%	11.12
	8087015	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	7.62	CHEMBL3905	Homo sapiens	Inhibition	%	7.62
	8087172	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.62	CHEMBL3905	Homo sapiens	Inhibition	%	9.62
	8087173	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.76	CHEMBL3905	Homo sapiens	Inhibition	%	7.76
	8087396	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.52	CHEMBL3905	Homo sapiens	Inhibition	%	4.52
	8087397	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.69	CHEMBL3905	Homo sapiens	Inhibition	%	1.69
	8087510	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	85.0	CHEMBL3905	Homo sapiens	Inhibition	%	85.0
	8087511	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	82.85	CHEMBL3905	Homo sapiens	Inhibition	%	82.85
	8087872	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.39	CHEMBL3905	Homo sapiens	Inhibition	%	9.39
	8087873	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.51	CHEMBL3905	Homo sapiens	Inhibition	%	6.51
	8088014	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.29	CHEMBL3905	Homo sapiens	Inhibition	%	5.29
	8088015	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.79	CHEMBL3905	Homo sapiens	Inhibition	%	1.79
	8088386	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.46	CHEMBL3905	Homo sapiens	Inhibition	%	0.46
	8088387	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-1.81	CHEMBL3905	Homo sapiens	Inhibition	%	-1.81
	8088514	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.4	CHEMBL3905	Homo sapiens	Inhibition	%	6.4
	8088515	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.46	CHEMBL3905	Homo sapiens	Inhibition	%	4.46
	8088738	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.39	CHEMBL3905	Homo sapiens	Inhibition	%	6.39
	8088739	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.74	CHEMBL3905	Homo sapiens	Inhibition	%	4.74
	8088831	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.33	CHEMBL3905	Homo sapiens	Inhibition	%	3.33
	8088832	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.02	CHEMBL3905	Homo sapiens	Inhibition	%	2.02
	8089183	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	Inhibition	%	0.0
	8089184	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.77	CHEMBL3905	Homo sapiens	Inhibition	%	-0.77
	8089331	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	5.89	CHEMBL3905	Homo sapiens	Inhibition	%	5.89
	8089332	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.83	CHEMBL3905	Homo sapiens	Inhibition	%	2.83
	8089555	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	6.78	CHEMBL3905	Homo sapiens	Inhibition	%	6.78
	8089556	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.19	CHEMBL3905	Homo sapiens	Inhibition	%	5.19
	8089675	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.84	CHEMBL3905	Homo sapiens	Inhibition	%	5.84
	8089676	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	4.11	CHEMBL3905	Homo sapiens	Inhibition	%	4.11
	8090079	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.06	CHEMBL3905	Homo sapiens	Inhibition	%	2.06
	8090080	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.59	CHEMBL3905	Homo sapiens	Inhibition	%	2.59
	8090244	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.63	CHEMBL3905	Homo sapiens	Inhibition	%	0.63
	8090245	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.56	CHEMBL3905	Homo sapiens	Inhibition	%	-1.56
	8090411	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.84	CHEMBL3905	Homo sapiens	Inhibition	%	2.84
	8090412	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.39	CHEMBL3905	Homo sapiens	Inhibition	%	3.39
	8090635	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.4	CHEMBL3905	Homo sapiens	Inhibition	%	2.4
	8090636	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.14	CHEMBL3905	Homo sapiens	Inhibition	%	2.14
	8090774	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.33	CHEMBL3905	Homo sapiens	Inhibition	%	4.33
	8090775	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.17	CHEMBL3905	Homo sapiens	Inhibition	%	3.17
	8090979	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	12.65	CHEMBL3905	Homo sapiens	Inhibition	%	12.65
	8090980	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	10.29	CHEMBL3905	Homo sapiens	Inhibition	%	10.29
	8091203	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.79	CHEMBL3905	Homo sapiens	Inhibition	%	4.79
	8091204	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.55	CHEMBL3905	Homo sapiens	Inhibition	%	4.55
	8091340	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	48.7	CHEMBL3905	Homo sapiens	Inhibition	%	48.7
	8091341	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	43.49	CHEMBL3905	Homo sapiens	Inhibition	%	43.49
	8091719	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	5.05	CHEMBL3905	Homo sapiens	Inhibition	%	5.05
	8091720	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.75	CHEMBL3905	Homo sapiens	Inhibition	%	2.75
	8091835	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.91	CHEMBL3905	Homo sapiens	Inhibition	%	5.91
	8091836	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.58	CHEMBL3905	Homo sapiens	Inhibition	%	3.58
	8092196	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.38	CHEMBL3905	Homo sapiens	Inhibition	%	2.38
	8092197	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.89	CHEMBL3905	Homo sapiens	Inhibition	%	0.89
	8092347	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.94	CHEMBL3905	Homo sapiens	Inhibition	%	5.94
	8092348	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.29	CHEMBL3905	Homo sapiens	Inhibition	%	4.29
	8092571	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.45	CHEMBL3905	Homo sapiens	Inhibition	%	5.45
	8092572	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.93	CHEMBL3905	Homo sapiens	Inhibition	%	2.93
	8092719	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.24	CHEMBL3905	Homo sapiens	Inhibition	%	3.24
	8092720	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.8	CHEMBL3905	Homo sapiens	Inhibition	%	0.8
	8093072	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	28.65	CHEMBL3905	Homo sapiens	Inhibition	%	28.65
	8093073	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	21.98	CHEMBL3905	Homo sapiens	Inhibition	%	21.98
	8093160	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.16	CHEMBL3905	Homo sapiens	Inhibition	%	2.16
	8093161	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.98	CHEMBL3905	Homo sapiens	Inhibition	%	0.98
	8093384	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.88	CHEMBL3905	Homo sapiens	Inhibition	%	3.88
	8093385	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	Inhibition	%	3.0
	8093524	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.61	CHEMBL3905	Homo sapiens	Inhibition	%	2.61
	8093525	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.89	CHEMBL3905	Homo sapiens	Inhibition	%	1.89
	8093887	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	35.77	CHEMBL3905	Homo sapiens	Inhibition	%	35.77
	8093888	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	29.95	CHEMBL3905	Homo sapiens	Inhibition	%	29.95
	8094007	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.85	CHEMBL3905	Homo sapiens	Inhibition	%	3.85
	8094008	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.61	CHEMBL3905	Homo sapiens	Inhibition	%	3.61
	8094231	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	18.55	CHEMBL3905	Homo sapiens	Inhibition	%	18.55
	8094232	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	14.8	CHEMBL3905	Homo sapiens	Inhibition	%	14.8
	8094411	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.98	CHEMBL3905	Homo sapiens	Inhibition	%	1.98
	8094412	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.99	CHEMBL3905	Homo sapiens	Inhibition	%	2.99
	8094586	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.57	CHEMBL3905	Homo sapiens	Inhibition	%	-0.57
	8094587	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.54	CHEMBL3905	Homo sapiens	Inhibition	%	-0.54
	8094966	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.59	CHEMBL3905	Homo sapiens	Inhibition	%	2.59
	8094967	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.72	CHEMBL3905	Homo sapiens	Inhibition	%	2.72
	8095106	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	39.92	CHEMBL3905	Homo sapiens	Inhibition	%	39.92
	8095107	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	37.1	CHEMBL3905	Homo sapiens	Inhibition	%	37.1
	8095330	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	83.2	CHEMBL3905	Homo sapiens	Inhibition	%	83.2
	8095331	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	83.57	CHEMBL3905	Homo sapiens	Inhibition	%	83.57
	8095533	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	9.83	CHEMBL3905	Homo sapiens	Inhibition	%	9.83
	8095534	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	8.36	CHEMBL3905	Homo sapiens	Inhibition	%	8.36
	8095674	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.75	CHEMBL3905	Homo sapiens	Inhibition	%	2.75
	8095675	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-0.18	CHEMBL3905	Homo sapiens	Inhibition	%	-0.18
	8096046	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	10.39	CHEMBL3905	Homo sapiens	Inhibition	%	10.39
	8096047	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.01	CHEMBL3905	Homo sapiens	Inhibition	%	7.01
	8096163	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	8.44	CHEMBL3905	Homo sapiens	Inhibition	%	8.44
	8096164	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.77	CHEMBL3905	Homo sapiens	Inhibition	%	5.77
	8096387	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.95	CHEMBL3905	Homo sapiens	Inhibition	%	5.95
	8096388	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.14	CHEMBL3905	Homo sapiens	Inhibition	%	4.14
	8096526	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.64	CHEMBL3905	Homo sapiens	Inhibition	%	2.64
	8096527	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.56	CHEMBL3905	Homo sapiens	Inhibition	%	1.56
	8096906	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.19	CHEMBL3905	Homo sapiens	Inhibition	%	6.19
	8096907	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.07	CHEMBL3905	Homo sapiens	Inhibition	%	6.07
	8097053	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.57	CHEMBL3905	Homo sapiens	Inhibition	%	0.57
	8097054	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.13	CHEMBL3905	Homo sapiens	Inhibition	%	0.13
	8097364	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.65	CHEMBL3905	Homo sapiens	Inhibition	%	5.65
	8097365	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.91	CHEMBL3905	Homo sapiens	Inhibition	%	2.91
	8097584	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.02	CHEMBL3905	Homo sapiens	Inhibition	%	7.02
	8097585	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.51	CHEMBL3905	Homo sapiens	Inhibition	%	4.51
	8097734	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.29	CHEMBL3905	Homo sapiens	Inhibition	%	-0.29
	8097735	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.22	CHEMBL3905	Homo sapiens	Inhibition	%	-1.22
	8098091	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.39	CHEMBL3905	Homo sapiens	Inhibition	%	0.39
	8098092	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.48	CHEMBL3905	Homo sapiens	Inhibition	%	0.48
	8098435	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.93	CHEMBL3905	Homo sapiens	Inhibition	%	-0.93
	8098436	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.21	CHEMBL3905	Homo sapiens	Inhibition	%	-1.21
	8098615	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	5.29	CHEMBL3905	Homo sapiens	Inhibition	%	5.29
	8098616	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.6	CHEMBL3905	Homo sapiens	Inhibition	%	3.6
	8098800	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.75	CHEMBL3905	Homo sapiens	Inhibition	%	2.75
	8098801	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.54	CHEMBL3905	Homo sapiens	Inhibition	%	1.54
	8099024	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.96	CHEMBL3905	Homo sapiens	Inhibition	%	2.96
	8099025	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.29	CHEMBL3905	Homo sapiens	Inhibition	%	1.29
	8099168	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.61	CHEMBL3905	Homo sapiens	Inhibition	%	3.61
	8099169	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.96	CHEMBL3905	Homo sapiens	Inhibition	%	3.96
	8099534	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.36	CHEMBL3905	Homo sapiens	Inhibition	%	3.36
	8099535	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.22	CHEMBL3905	Homo sapiens	Inhibition	%	4.22
	8099728	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.29	CHEMBL3905	Homo sapiens	Inhibition	%	-0.29
	8099729	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.74	CHEMBL3905	Homo sapiens	Inhibition	%	-0.74
	8099875	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.69	CHEMBL3905	Homo sapiens	Inhibition	%	6.69
	8099876	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.97	CHEMBL3905	Homo sapiens	Inhibition	%	2.97
	8100099	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.2	CHEMBL3905	Homo sapiens	Inhibition	%	9.2
	8100100	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.91	CHEMBL3905	Homo sapiens	Inhibition	%	5.91
	8100245	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	46.08	CHEMBL3905	Homo sapiens	Inhibition	%	46.08
	8100246	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	40.71	CHEMBL3905	Homo sapiens	Inhibition	%	40.71
	8100585	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.82	CHEMBL3905	Homo sapiens	Inhibition	%	6.82
	8100586	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.77	CHEMBL3905	Homo sapiens	Inhibition	%	4.77
	8100725	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.18	CHEMBL3905	Homo sapiens	Inhibition	%	1.18
	8100726	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-1.3	CHEMBL3905	Homo sapiens	Inhibition	%	-1.3
	8100949	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	6.07	CHEMBL3905	Homo sapiens	Inhibition	%	6.07
	8100950	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.42	CHEMBL3905	Homo sapiens	Inhibition	%	3.42
	8101109	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.67	CHEMBL3905	Homo sapiens	Inhibition	%	4.67
	8101110	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.01	CHEMBL3905	Homo sapiens	Inhibition	%	2.01
	8101251	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.59	CHEMBL3905	Homo sapiens	Inhibition	%	1.59
	8101252	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.6	CHEMBL3905	Homo sapiens	Inhibition	%	2.6
	8101475	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	7.48	CHEMBL3905	Homo sapiens	Inhibition	%	7.48
	8101476	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	5.8	CHEMBL3905	Homo sapiens	Inhibition	%	5.8
	8101660	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.82	CHEMBL3905	Homo sapiens	Inhibition	%	3.82
	8101661	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.15	CHEMBL3905	Homo sapiens	Inhibition	%	2.15
	8101913	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	40.1	CHEMBL3905	Homo sapiens	Inhibition	%	40.1
	8101914	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	33.84	CHEMBL3905	Homo sapiens	Inhibition	%	33.84
	8102068	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.01	CHEMBL3905	Homo sapiens	Inhibition	%	1.01
	8102069	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.53	CHEMBL3905	Homo sapiens	Inhibition	%	0.53
	8102292	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	58.54	CHEMBL3905	Homo sapiens	Inhibition	%	58.54
	8102293	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	52.29	CHEMBL3905	Homo sapiens	Inhibition	%	52.29
	8102423	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	5.81	CHEMBL3905	Homo sapiens	Inhibition	%	5.81
	8102424	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.9	CHEMBL3905	Homo sapiens	Inhibition	%	2.9
	8102767	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.31	CHEMBL3905	Homo sapiens	Inhibition	%	-1.31
	8102768	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.14	CHEMBL3905	Homo sapiens	Inhibition	%	-1.14
	8102945	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.51	CHEMBL3905	Homo sapiens	Inhibition	%	1.51
	8102946	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.39	CHEMBL3905	Homo sapiens	Inhibition	%	1.39
	8103365	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.19	CHEMBL3905	Homo sapiens	Inhibition	%	4.19
	8103366	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.36	CHEMBL3905	Homo sapiens	Inhibition	%	2.36
	8103503	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.56	CHEMBL3905	Homo sapiens	Inhibition	%	8.56
	8103504	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	6.66	CHEMBL3905	Homo sapiens	Inhibition	%	6.66
	8103877	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	6.9	CHEMBL3905	Homo sapiens	Inhibition	%	6.9
	8103878	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	6.9	CHEMBL3905	Homo sapiens	Inhibition	%	6.9
	8104062	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.87	CHEMBL3905	Homo sapiens	Inhibition	%	1.87
	8104063	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.81	CHEMBL3905	Homo sapiens	Inhibition	%	1.81
	8104434	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	23.24	CHEMBL3905	Homo sapiens	Inhibition	%	23.24
	8104435	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	18.55	CHEMBL3905	Homo sapiens	Inhibition	%	18.55
	8104580	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.33	CHEMBL3905	Homo sapiens	Inhibition	%	3.33
	8104581	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.68	CHEMBL3905	Homo sapiens	Inhibition	%	1.68
	8104918	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.36	CHEMBL3905	Homo sapiens	Inhibition	%	5.36
	8104919	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.37	CHEMBL3905	Homo sapiens	Inhibition	%	3.37
	8105282	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.7	CHEMBL3905	Homo sapiens	Inhibition	%	0.7
	8105283	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.36	CHEMBL3905	Homo sapiens	Inhibition	%	0.36
	8105448	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.69	CHEMBL3905	Homo sapiens	Inhibition	%	4.69
	8105449	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.65	CHEMBL3905	Homo sapiens	Inhibition	%	4.65
	8105810	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	47.83	CHEMBL3905	Homo sapiens	Inhibition	%	47.83
	8105811	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	46.54	CHEMBL3905	Homo sapiens	Inhibition	%	46.54
	8106090	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.26	CHEMBL3905	Homo sapiens	Inhibition	%	1.26
	8106091	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.1	CHEMBL3905	Homo sapiens	Inhibition	%	1.1
	8106255	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	83.27	CHEMBL3905	Homo sapiens	Inhibition	%	83.27
	8106256	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	81.8	CHEMBL3905	Homo sapiens	Inhibition	%	81.8
	8106635	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	91.31	CHEMBL3905	Homo sapiens	Inhibition	%	91.31
	8106636	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	88.94	CHEMBL3905	Homo sapiens	Inhibition	%	88.94
	8106764	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.63	CHEMBL3905	Homo sapiens	Inhibition	%	4.63
	8106765	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.28	CHEMBL3905	Homo sapiens	Inhibition	%	4.28
	8106988	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	34.76	CHEMBL3905	Homo sapiens	Inhibition	%	34.76
	8106989	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	28.91	CHEMBL3905	Homo sapiens	Inhibition	%	28.91
	8107109	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	5.25	CHEMBL3905	Homo sapiens	Inhibition	%	5.25
	8107110	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.62	CHEMBL3905	Homo sapiens	Inhibition	%	2.62
	8107281	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.5	CHEMBL3905	Homo sapiens	Inhibition	%	2.5
	8107282	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.94	CHEMBL3905	Homo sapiens	Inhibition	%	1.94
	8107505	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.08	CHEMBL3905	Homo sapiens	Inhibition	%	3.08
	8107506	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.14	CHEMBL3905	Homo sapiens	Inhibition	%	2.14
	8107706	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.52	CHEMBL3905	Homo sapiens	Inhibition	%	4.52
	8107707	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.2	CHEMBL3905	Homo sapiens	Inhibition	%	4.2
	8107841	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	3.6	CHEMBL3905	Homo sapiens	Inhibition	%	3.6
	8107842	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.42	CHEMBL3905	Homo sapiens	Inhibition	%	2.42
	8108065	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	36.08	CHEMBL3905	Homo sapiens	Inhibition	%	36.08
	8108066	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	30.63	CHEMBL3905	Homo sapiens	Inhibition	%	30.63
	8108223	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.05	CHEMBL3905	Homo sapiens	Inhibition	%	3.05
	8108224	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.12	CHEMBL3905	Homo sapiens	Inhibition	%	4.12
	8108398	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	5.13	CHEMBL3905	Homo sapiens	Inhibition	%	5.13
	8108399	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.25	CHEMBL3905	Homo sapiens	Inhibition	%	4.25
	8108622	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	13.51	CHEMBL3905	Homo sapiens	Inhibition	%	13.51
	8108623	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	11.06	CHEMBL3905	Homo sapiens	Inhibition	%	11.06
	8108769	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.95	CHEMBL3905	Homo sapiens	Inhibition	%	5.95
	8108770	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.21	CHEMBL3905	Homo sapiens	Inhibition	%	4.21
	8108911	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	11.05	CHEMBL3905	Homo sapiens	Inhibition	%	11.05
	8108912	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	8.81	CHEMBL3905	Homo sapiens	Inhibition	%	8.81
	8109135	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.13	CHEMBL3905	Homo sapiens	Inhibition	%	1.13
	8109136	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-1.61	CHEMBL3905	Homo sapiens	Inhibition	%	-1.61
	8109249	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	7.26	CHEMBL3905	Homo sapiens	Inhibition	%	7.26
	8109250	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.34	CHEMBL3905	Homo sapiens	Inhibition	%	4.34
	8109603	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.01	CHEMBL3905	Homo sapiens	Inhibition	%	1.01
	8109604	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.75	CHEMBL3905	Homo sapiens	Inhibition	%	0.75
	8109774	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.54	CHEMBL3905	Homo sapiens	Inhibition	%	3.54
	8109775	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.68	CHEMBL3905	Homo sapiens	Inhibition	%	1.68
	8110130	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.05	CHEMBL3905	Homo sapiens	Inhibition	%	8.05
	8110131	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.81	CHEMBL3905	Homo sapiens	Inhibition	%	5.81
	8110409	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.6	CHEMBL3905	Homo sapiens	Inhibition	%	1.6
	8110410	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.14	CHEMBL3905	Homo sapiens	Inhibition	%	0.14
	8110575	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.87	CHEMBL3905	Homo sapiens	Inhibition	%	1.87
	8110576	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.99	CHEMBL3905	Homo sapiens	Inhibition	%	0.99
	8110799	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.57	CHEMBL3905	Homo sapiens	Inhibition	%	6.57
	8110800	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	5.88	CHEMBL3905	Homo sapiens	Inhibition	%	5.88
	8110957	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.47	CHEMBL3905	Homo sapiens	Inhibition	%	0.47
	8110958	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.28	CHEMBL3905	Homo sapiens	Inhibition	%	1.28
	8111304	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	10.04	CHEMBL3905	Homo sapiens	Inhibition	%	10.04
	8111305	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	7.66	CHEMBL3905	Homo sapiens	Inhibition	%	7.66
	8111431	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	19.38	CHEMBL3905	Homo sapiens	Inhibition	%	19.38
	8111432	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	13.62	CHEMBL3905	Homo sapiens	Inhibition	%	13.62
	8111821	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.62	CHEMBL3905	Homo sapiens	Inhibition	%	4.62
	8111822	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.91	CHEMBL3905	Homo sapiens	Inhibition	%	3.91
	8112026	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.9	CHEMBL3905	Homo sapiens	Inhibition	%	3.9
	8112027	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.22	CHEMBL3905	Homo sapiens	Inhibition	%	2.22
	8112387	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.67	CHEMBL3905	Homo sapiens	Inhibition	%	1.67
	8112388	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.02	CHEMBL3905	Homo sapiens	Inhibition	%	2.02
	8112555	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	8.91	CHEMBL3905	Homo sapiens	Inhibition	%	8.91
	8112556	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.2	CHEMBL3905	Homo sapiens	Inhibition	%	7.2
	8112951	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.38	CHEMBL3905	Homo sapiens	Inhibition	%	2.38
	8112952	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.69	CHEMBL3905	Homo sapiens	Inhibition	%	1.69
	8113103	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	17.67	CHEMBL3905	Homo sapiens	Inhibition	%	17.67
	8113104	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	13.8	CHEMBL3905	Homo sapiens	Inhibition	%	13.8
	8113463	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.54	CHEMBL3905	Homo sapiens	Inhibition	%	2.54
	8113464	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.4	CHEMBL3905	Homo sapiens	Inhibition	%	-0.4
	8113587	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.92	CHEMBL3905	Homo sapiens	Inhibition	%	3.92
	8113588	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.25	CHEMBL3905	Homo sapiens	Inhibition	%	2.25
	8113811	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.54	CHEMBL3905	Homo sapiens	Inhibition	%	5.54
	8113812	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.21	CHEMBL3905	Homo sapiens	Inhibition	%	2.21
	8113927	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.19	CHEMBL3905	Homo sapiens	Inhibition	%	0.19
	8113928	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.13	CHEMBL3905	Homo sapiens	Inhibition	%	-0.13
	8114103	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	6.86	CHEMBL3905	Homo sapiens	Inhibition	%	6.86
	8114104	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.6	CHEMBL3905	Homo sapiens	Inhibition	%	5.6
	8114327	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.67	CHEMBL3905	Homo sapiens	Inhibition	%	4.67
	8114328	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	-0.37	CHEMBL3905	Homo sapiens	Inhibition	%	-0.37
	8114459	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	27.44	CHEMBL3905	Homo sapiens	Inhibition	%	27.44
	8114460	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	22.06	CHEMBL3905	Homo sapiens	Inhibition	%	22.06
	8114735	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.9	CHEMBL3905	Homo sapiens	Inhibition	%	2.9
	8114736	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.53	CHEMBL3905	Homo sapiens	Inhibition	%	1.53
	8115125	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	20.38	CHEMBL3905	Homo sapiens	Inhibition	%	20.38
	8115126	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	17.22	CHEMBL3905	Homo sapiens	Inhibition	%	17.22
	8115290	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.24	CHEMBL3905	Homo sapiens	Inhibition	%	2.24
	8115291	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.49	CHEMBL3905	Homo sapiens	Inhibition	%	0.49
	8115634	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	20.83	CHEMBL3905	Homo sapiens	Inhibition	%	20.83
	8115635	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	15.23	CHEMBL3905	Homo sapiens	Inhibition	%	15.23
	8115767	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.35	CHEMBL3905	Homo sapiens	Inhibition	%	2.35
	8115768	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.2	CHEMBL3905	Homo sapiens	Inhibition	%	1.2
	8115991	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.33	CHEMBL3905	Homo sapiens	Inhibition	%	1.33
	8115992	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.89	CHEMBL3905	Homo sapiens	Inhibition	%	1.89
	8116150	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.12	CHEMBL3905	Homo sapiens	Inhibition	%	-1.12
	8116151	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.58	CHEMBL3905	Homo sapiens	Inhibition	%	-1.58
	8116353	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.28	CHEMBL3905	Homo sapiens	Inhibition	%	8.28
	8116354	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.24	CHEMBL3905	Homo sapiens	Inhibition	%	7.24
	8116711	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.24	CHEMBL3905	Homo sapiens	Inhibition	%	2.24
	8116712	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.38	CHEMBL3905	Homo sapiens	Inhibition	%	1.38
	8116883	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	14.0	CHEMBL3905	Homo sapiens	Inhibition	%	14.0
	8116884	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	10.47	CHEMBL3905	Homo sapiens	Inhibition	%	10.47
	8117107	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	56.69	CHEMBL3905	Homo sapiens	Inhibition	%	56.69
	8117108	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	50.04	CHEMBL3905	Homo sapiens	Inhibition	%	50.04
	8117278	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.27	CHEMBL3905	Homo sapiens	Inhibition	%	4.27
	8117279	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.32	CHEMBL3905	Homo sapiens	Inhibition	%	4.32
	8117436	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.06	CHEMBL3905	Homo sapiens	Inhibition	%	5.06
	8117437	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.97	CHEMBL3905	Homo sapiens	Inhibition	%	2.97
	8117660	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.53	CHEMBL3905	Homo sapiens	Inhibition	%	5.53
	8117661	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.02	CHEMBL3905	Homo sapiens	Inhibition	%	3.02
	8117790	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.21	CHEMBL3905	Homo sapiens	Inhibition	%	1.21
	8117791	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.19	CHEMBL3905	Homo sapiens	Inhibition	%	1.19
	8118152	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.84	CHEMBL3905	Homo sapiens	Inhibition	%	3.84
	8118153	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.34	CHEMBL3905	Homo sapiens	Inhibition	%	2.34
	8118268	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.01	CHEMBL3905	Homo sapiens	Inhibition	%	-0.01
	8118269	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.03	CHEMBL3905	Homo sapiens	Inhibition	%	1.03
	8118664	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.36	CHEMBL3905	Homo sapiens	Inhibition	%	5.36
	8118665	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.74	CHEMBL3905	Homo sapiens	Inhibition	%	2.74
	8118800	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.59	CHEMBL3905	Homo sapiens	Inhibition	%	3.59
	8118801	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.97	CHEMBL3905	Homo sapiens	Inhibition	%	2.97
	8119024	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.38	CHEMBL3905	Homo sapiens	Inhibition	%	4.38
	8119025	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.48	CHEMBL3905	Homo sapiens	Inhibition	%	2.48
	8119071	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.6	CHEMBL3905	Homo sapiens	Inhibition	%	2.6
	8119072	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.34	CHEMBL3905	Homo sapiens	Inhibition	%	0.34
	8119295	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.5	CHEMBL3905	Homo sapiens	Inhibition	%	3.5
	8119296	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.46	CHEMBL3905	Homo sapiens	Inhibition	%	2.46
	8119454	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	73.73	CHEMBL3905	Homo sapiens	Inhibition	%	73.73
	8119455	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	70.48	CHEMBL3905	Homo sapiens	Inhibition	%	70.48
	8119621	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.69	CHEMBL3905	Homo sapiens	Inhibition	%	0.69
	8119622	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.67	CHEMBL3905	Homo sapiens	Inhibition	%	0.67
	8119845	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	4.88	CHEMBL3905	Homo sapiens	Inhibition	%	4.88
	8119846	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.79	CHEMBL3905	Homo sapiens	Inhibition	%	3.79
	8119964	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.29	CHEMBL3905	Homo sapiens	Inhibition	%	4.29
	8119965	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.57	CHEMBL3905	Homo sapiens	Inhibition	%	3.57
	8120327	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.2	CHEMBL3905	Homo sapiens	Inhibition	%	2.2
	8120328	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.57	CHEMBL3905	Homo sapiens	Inhibition	%	1.57
	8120487	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.87	CHEMBL3905	Homo sapiens	Inhibition	%	9.87
	8120488	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	8.71	CHEMBL3905	Homo sapiens	Inhibition	%	8.71
	8120688	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.34	CHEMBL3905	Homo sapiens	Inhibition	%	4.34
	8120689	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.01	CHEMBL3905	Homo sapiens	Inhibition	%	2.01
	8120912	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.35	CHEMBL3905	Homo sapiens	Inhibition	%	4.35
	8120913	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.89	CHEMBL3905	Homo sapiens	Inhibition	%	2.89
	8121040	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.02	CHEMBL3905	Homo sapiens	Inhibition	%	3.02
	8121041	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.61	CHEMBL3905	Homo sapiens	Inhibition	%	2.61
	8121436	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.85	CHEMBL3905	Homo sapiens	Inhibition	%	0.85
	8121437	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.33	CHEMBL3905	Homo sapiens	Inhibition	%	0.33
	8121603	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.64	CHEMBL3905	Homo sapiens	Inhibition	%	2.64
	8121604	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.69	CHEMBL3905	Homo sapiens	Inhibition	%	2.69
	8121990	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.01	CHEMBL3905	Homo sapiens	Inhibition	%	4.01
	8121991	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.96	CHEMBL3905	Homo sapiens	Inhibition	%	1.96
	8122111	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	6.25	CHEMBL3905	Homo sapiens	Inhibition	%	6.25
	8122112	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	5.08	CHEMBL3905	Homo sapiens	Inhibition	%	5.08
	8122473	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.75	CHEMBL3905	Homo sapiens	Inhibition	%	3.75
	8122474	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.48	CHEMBL3905	Homo sapiens	Inhibition	%	2.48
	8122593	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.65	CHEMBL3905	Homo sapiens	Inhibition	%	5.65
	8122594	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.05	CHEMBL3905	Homo sapiens	Inhibition	%	3.05
	8122817	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	6.7	CHEMBL3905	Homo sapiens	Inhibition	%	6.7
	8122818	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.95	CHEMBL3905	Homo sapiens	Inhibition	%	3.95
	8122984	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.08	CHEMBL3905	Homo sapiens	Inhibition	%	6.08
	8122985	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.39	CHEMBL3905	Homo sapiens	Inhibition	%	3.39
	8123350	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	6.12	CHEMBL3905	Homo sapiens	Inhibition	%	6.12
	8123351	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.89	CHEMBL3905	Homo sapiens	Inhibition	%	3.89
	8123628	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.33	CHEMBL3905	Homo sapiens	Inhibition	%	1.33
	8123629	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.14	CHEMBL3905	Homo sapiens	Inhibition	%	-0.14
	8123778	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	17.12	CHEMBL3905	Homo sapiens	Inhibition	%	17.12
	8123779	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	13.3	CHEMBL3905	Homo sapiens	Inhibition	%	13.3
	8124169	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	7.17	CHEMBL3905	Homo sapiens	Inhibition	%	7.17
	8124170	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	6.07	CHEMBL3905	Homo sapiens	Inhibition	%	6.07
	8124288	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	27.34	CHEMBL3905	Homo sapiens	Inhibition	%	27.34
	8124289	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	19.36	CHEMBL3905	Homo sapiens	Inhibition	%	19.36
	8124651	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	6.17	CHEMBL3905	Homo sapiens	Inhibition	%	6.17
	8124652	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	4.82	CHEMBL3905	Homo sapiens	Inhibition	%	4.82
	8124816	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.1	CHEMBL3905	Homo sapiens	Inhibition	%	1.1
	8124817	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.54	CHEMBL3905	Homo sapiens	Inhibition	%	1.54
	8125040	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.11	CHEMBL3905	Homo sapiens	Inhibition	%	1.11
	8125041	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.75	CHEMBL3905	Homo sapiens	Inhibition	%	0.75
	8125241	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.24	CHEMBL3905	Homo sapiens	Inhibition	%	5.24
	8125242	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.59	CHEMBL3905	Homo sapiens	Inhibition	%	1.59
	8125371	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	12.23	CHEMBL3905	Homo sapiens	Inhibition	%	12.23
	8125372	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	10.54	CHEMBL3905	Homo sapiens	Inhibition	%	10.54
	8125595	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.94	CHEMBL3905	Homo sapiens	Inhibition	%	0.94
	8125596	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.05	CHEMBL3905	Homo sapiens	Inhibition	%	1.05
	8125763	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.14	CHEMBL3905	Homo sapiens	Inhibition	%	4.14
	8125764	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.75	CHEMBL3905	Homo sapiens	Inhibition	%	3.75
	8125927	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	6.56	CHEMBL3905	Homo sapiens	Inhibition	%	6.56
	8125928	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.45	CHEMBL3905	Homo sapiens	Inhibition	%	5.45
	8126315	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.01	CHEMBL3905	Homo sapiens	Inhibition	%	6.01
	8126316	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.34	CHEMBL3905	Homo sapiens	Inhibition	%	3.34
	8126430	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	9.18	CHEMBL3905	Homo sapiens	Inhibition	%	9.18
	8126431	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	6.3	CHEMBL3905	Homo sapiens	Inhibition	%	6.3
	8126654	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	57.19	CHEMBL3905	Homo sapiens	Inhibition	%	57.19
	8126655	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	53.62	CHEMBL3905	Homo sapiens	Inhibition	%	53.62
	8126790	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.6	CHEMBL3905	Homo sapiens	Inhibition	%	6.6
	8126791	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.87	CHEMBL3905	Homo sapiens	Inhibition	%	2.87
	8127136	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.46	CHEMBL3905	Homo sapiens	Inhibition	%	3.46
	8127137	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.56	CHEMBL3905	Homo sapiens	Inhibition	%	1.56
	8127303	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.98	CHEMBL3905	Homo sapiens	Inhibition	%	6.98
	8127304	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.79	CHEMBL3905	Homo sapiens	Inhibition	%	4.79
	8127669	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	21.47	CHEMBL3905	Homo sapiens	Inhibition	%	21.47
	8127670	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	17.42	CHEMBL3905	Homo sapiens	Inhibition	%	17.42
	8127957	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.39	CHEMBL3905	Homo sapiens	Inhibition	%	3.39
	8127958	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.89	CHEMBL3905	Homo sapiens	Inhibition	%	1.89
	8128109	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	65.94	CHEMBL3905	Homo sapiens	Inhibition	%	65.94
	8128110	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	62.81	CHEMBL3905	Homo sapiens	Inhibition	%	62.81
	8128333	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.08	CHEMBL3905	Homo sapiens	Inhibition	%	4.08
	8128334	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.61	CHEMBL3905	Homo sapiens	Inhibition	%	3.61
	8128500	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	47.25	CHEMBL3905	Homo sapiens	Inhibition	%	47.25
	8128501	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	41.63	CHEMBL3905	Homo sapiens	Inhibition	%	41.63
	8128619	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	5.3	CHEMBL3905	Homo sapiens	Inhibition	%	5.3
	8128620	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	3.27	CHEMBL3905	Homo sapiens	Inhibition	%	3.27
	8128843	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	16.92	CHEMBL3905	Homo sapiens	Inhibition	%	16.92
	8128844	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	11.29	CHEMBL3905	Homo sapiens	Inhibition	%	11.29
	8128980	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.51	CHEMBL3905	Homo sapiens	Inhibition	%	2.51
	8128981	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.46	CHEMBL3905	Homo sapiens	Inhibition	%	1.46
	8129375	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.86	CHEMBL3905	Homo sapiens	Inhibition	%	0.86
	8129376	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.71	CHEMBL3905	Homo sapiens	Inhibition	%	0.71
	8129564	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	6.76	CHEMBL3905	Homo sapiens	Inhibition	%	6.76
	8129565	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.26	CHEMBL3905	Homo sapiens	Inhibition	%	3.26
	8129927	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.49	CHEMBL3905	Homo sapiens	Inhibition	%	1.49
	8129928	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.61	CHEMBL3905	Homo sapiens	Inhibition	%	1.61
	8130088	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.13	CHEMBL3905	Homo sapiens	Inhibition	%	3.13
	8130089	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.86	CHEMBL3905	Homo sapiens	Inhibition	%	2.86
	8130260	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.08	CHEMBL3905	Homo sapiens	Inhibition	%	0.08
	8130261	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.1	CHEMBL3905	Homo sapiens	Inhibition	%	1.1
	8130484	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.05	CHEMBL3905	Homo sapiens	Inhibition	%	-1.05
	8130485	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.66	CHEMBL3905	Homo sapiens	Inhibition	%	0.66
	8130644	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.53	CHEMBL3905	Homo sapiens	Inhibition	%	3.53
	8130645	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.02	CHEMBL3905	Homo sapiens	Inhibition	%	2.02
	8130984	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.75	CHEMBL3905	Homo sapiens	Inhibition	%	5.75
	8130985	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.63	CHEMBL3905	Homo sapiens	Inhibition	%	3.63
	8131123	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	28.26	CHEMBL3905	Homo sapiens	Inhibition	%	28.26
	8131124	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	22.15	CHEMBL3905	Homo sapiens	Inhibition	%	22.15
	8131467	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.25	CHEMBL3905	Homo sapiens	Inhibition	%	5.25
	8131468	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.92	CHEMBL3905	Homo sapiens	Inhibition	%	2.92
	8131634	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	32.48	CHEMBL3905	Homo sapiens	Inhibition	%	32.48
	8131635	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	26.26	CHEMBL3905	Homo sapiens	Inhibition	%	26.26
	8131858	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	78.71	CHEMBL3905	Homo sapiens	Inhibition	%	78.71
	8131859	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	75.39	CHEMBL3905	Homo sapiens	Inhibition	%	75.39
	8131999	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	19.41	CHEMBL3905	Homo sapiens	Inhibition	%	19.41
	8132000	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	13.32	CHEMBL3905	Homo sapiens	Inhibition	%	13.32
	8132285	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.7	CHEMBL3905	Homo sapiens	Inhibition	%	4.7
	8132286	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.75	CHEMBL3905	Homo sapiens	Inhibition	%	3.75
	8132656	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	7.54	CHEMBL3905	Homo sapiens	Inhibition	%	7.54
	8132657	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.35	CHEMBL3905	Homo sapiens	Inhibition	%	6.35
	8132824	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.6	CHEMBL3905	Homo sapiens	Inhibition	%	1.6
	8132825	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.83	CHEMBL3905	Homo sapiens	Inhibition	%	1.83
	8133169	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.2	CHEMBL3905	Homo sapiens	Inhibition	%	3.2
	8133170	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.68	CHEMBL3905	Homo sapiens	Inhibition	%	1.68
	8133307	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.9	CHEMBL3905	Homo sapiens	Inhibition	%	0.9
	8133308	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.23	CHEMBL3905	Homo sapiens	Inhibition	%	2.23
	8133531	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.32	CHEMBL3905	Homo sapiens	Inhibition	%	3.32
	8133532	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.16	CHEMBL3905	Homo sapiens	Inhibition	%	2.16
	8133703	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	4.14	CHEMBL3905	Homo sapiens	Inhibition	%	4.14
	8133704	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	3.2	CHEMBL3905	Homo sapiens	Inhibition	%	3.2
	8133883	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.45	CHEMBL3905	Homo sapiens	Inhibition	%	2.45
	8133884	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.67	CHEMBL3905	Homo sapiens	Inhibition	%	1.67
	8134255	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.81	CHEMBL3905	Homo sapiens	Inhibition	%	-0.81
	8134256	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.13	CHEMBL3905	Homo sapiens	Inhibition	%	1.13
	8134415	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.07	CHEMBL3905	Homo sapiens	Inhibition	%	3.07
	8134416	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.59	CHEMBL3905	Homo sapiens	Inhibition	%	1.59
	8134823	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.65	CHEMBL3905	Homo sapiens	Inhibition	%	0.65
	8134824	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.91	CHEMBL3905	Homo sapiens	Inhibition	%	-0.91
	8134983	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	11.79	CHEMBL3905	Homo sapiens	Inhibition	%	11.79
	8134984	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	9.31	CHEMBL3905	Homo sapiens	Inhibition	%	9.31
	8135322	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	7.35	CHEMBL3905	Homo sapiens	Inhibition	%	7.35
	8135323	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.45	CHEMBL3905	Homo sapiens	Inhibition	%	3.45
	8135463	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.36	CHEMBL3905	Homo sapiens	Inhibition	%	6.36
	8135464	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.05	CHEMBL3905	Homo sapiens	Inhibition	%	3.05
	8135687	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.75	CHEMBL3905	Homo sapiens	Inhibition	%	5.75
	8135688	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.76	CHEMBL3905	Homo sapiens	Inhibition	%	3.76
	8135808	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.83	CHEMBL3905	Homo sapiens	Inhibition	%	3.83
	8135809	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.4	CHEMBL3905	Homo sapiens	Inhibition	%	1.4
	8136200	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.08	CHEMBL3905	Homo sapiens	Inhibition	%	5.08
	8136201	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.29	CHEMBL3905	Homo sapiens	Inhibition	%	3.29
	8136344	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	72.21	CHEMBL3905	Homo sapiens	Inhibition	%	72.21
	8136345	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	67.82	CHEMBL3905	Homo sapiens	Inhibition	%	67.82
	8136634	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.96	CHEMBL3905	Homo sapiens	Inhibition	%	0.96
	8136635	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.16	CHEMBL3905	Homo sapiens	Inhibition	%	-0.16
	8136993	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.35	CHEMBL3905	Homo sapiens	Inhibition	%	3.35
	8136994	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.18	CHEMBL3905	Homo sapiens	Inhibition	%	2.18
	8137156	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	11.34	CHEMBL3905	Homo sapiens	Inhibition	%	11.34
	8137157	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	8.12	CHEMBL3905	Homo sapiens	Inhibition	%	8.12
	8137500	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.62	CHEMBL3905	Homo sapiens	Inhibition	%	5.62
	8137501	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.11	CHEMBL3905	Homo sapiens	Inhibition	%	3.11
	8137872	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.55	CHEMBL3905	Homo sapiens	Inhibition	%	3.55
	8137873	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.2	CHEMBL3905	Homo sapiens	Inhibition	%	2.2
	8138038	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.87	CHEMBL3905	Homo sapiens	Inhibition	%	-0.87
	8138039	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.31	CHEMBL3905	Homo sapiens	Inhibition	%	-0.31
	8138217	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	19.7	CHEMBL3905	Homo sapiens	Inhibition	%	19.7
	8138218	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	18.06	CHEMBL3905	Homo sapiens	Inhibition	%	18.06
	8138441	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.63	CHEMBL3905	Homo sapiens	Inhibition	%	2.63
	8138442	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.44	CHEMBL3905	Homo sapiens	Inhibition	%	2.44
	8138589	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	3.66	CHEMBL3905	Homo sapiens	Inhibition	%	3.66
	8138590	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	3.28	CHEMBL3905	Homo sapiens	Inhibition	%	3.28
	8138747	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.73	CHEMBL3905	Homo sapiens	Inhibition	%	3.73
	8138748	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.72	CHEMBL3905	Homo sapiens	Inhibition	%	3.72
	8138971	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.68	CHEMBL3905	Homo sapiens	Inhibition	%	3.68
	8138972	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.12	CHEMBL3905	Homo sapiens	Inhibition	%	4.12
	8139156	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	12.13	CHEMBL3905	Homo sapiens	Inhibition	%	12.13
	8139157	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	11.32	CHEMBL3905	Homo sapiens	Inhibition	%	11.32
	8139315	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.33	CHEMBL3905	Homo sapiens	Inhibition	%	3.33
	8139316	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.35	CHEMBL3905	Homo sapiens	Inhibition	%	0.35
	8139539	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	14.0	CHEMBL3905	Homo sapiens	Inhibition	%	14.0
	8139540	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	9.56	CHEMBL3905	Homo sapiens	Inhibition	%	9.56
	8139653	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.35	CHEMBL3905	Homo sapiens	Inhibition	%	4.35
	8139654	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.65	CHEMBL3905	Homo sapiens	Inhibition	%	2.65
	8140018	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.15	CHEMBL3905	Homo sapiens	Inhibition	%	6.15
	8140019	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.42	CHEMBL3905	Homo sapiens	Inhibition	%	5.42
	8140141	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.17	CHEMBL3905	Homo sapiens	Inhibition	%	3.17
	8140142	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.26	CHEMBL3905	Homo sapiens	Inhibition	%	2.26
	8140365	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.91	CHEMBL3905	Homo sapiens	Inhibition	%	3.91
	8140366	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-0.74	CHEMBL3905	Homo sapiens	Inhibition	%	-0.74
	8140524	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	15.33	CHEMBL3905	Homo sapiens	Inhibition	%	15.33
	8140525	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	10.92	CHEMBL3905	Homo sapiens	Inhibition	%	10.92
	8140667	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.3	CHEMBL3905	Homo sapiens	Inhibition	%	5.3
	8140668	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.33	CHEMBL3905	Homo sapiens	Inhibition	%	3.33
	8140891	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.55	CHEMBL3905	Homo sapiens	Inhibition	%	7.55
	8140892	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.4	CHEMBL3905	Homo sapiens	Inhibition	%	5.4
	8140969	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.25	CHEMBL3905	Homo sapiens	Inhibition	%	2.25
	8140970	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.99	CHEMBL3905	Homo sapiens	Inhibition	%	0.99
	8141193	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.75	CHEMBL3905	Homo sapiens	Inhibition	%	1.75
	8141194	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.29	CHEMBL3905	Homo sapiens	Inhibition	%	0.29
	8141323	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	9.96	CHEMBL3905	Homo sapiens	Inhibition	%	9.96
	8141324	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.24	CHEMBL3905	Homo sapiens	Inhibition	%	7.24
	8141483	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	18.01	CHEMBL3905	Homo sapiens	Inhibition	%	18.01
	8141484	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	15.45	CHEMBL3905	Homo sapiens	Inhibition	%	15.45
	8141707	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	69.61	CHEMBL3905	Homo sapiens	Inhibition	%	69.61
	8141708	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	64.79	CHEMBL3905	Homo sapiens	Inhibition	%	64.79
	8141826	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	22.08	CHEMBL3905	Homo sapiens	Inhibition	%	22.08
	8141827	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	17.56	CHEMBL3905	Homo sapiens	Inhibition	%	17.56
	8142211	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	13.85	CHEMBL3905	Homo sapiens	Inhibition	%	13.85
	8142212	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	9.96	CHEMBL3905	Homo sapiens	Inhibition	%	9.96
	8142379	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.22	CHEMBL3905	Homo sapiens	Inhibition	%	0.22
	8142380	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.82	CHEMBL3905	Homo sapiens	Inhibition	%	0.82
	8142779	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.07	CHEMBL3905	Homo sapiens	Inhibition	%	2.07
	8142780	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.23	CHEMBL3905	Homo sapiens	Inhibition	%	1.23
	8142928	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.52	CHEMBL3905	Homo sapiens	Inhibition	%	-2.52
	8142929	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.84	CHEMBL3905	Homo sapiens	Inhibition	%	-1.84
	8143307	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.52	CHEMBL3905	Homo sapiens	Inhibition	%	3.52
	8143308	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.04	CHEMBL3905	Homo sapiens	Inhibition	%	3.04
	8143494	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.2	CHEMBL3905	Homo sapiens	Inhibition	%	4.2
	8143495	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.6	CHEMBL3905	Homo sapiens	Inhibition	%	2.6
	8143877	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	12.63	CHEMBL3905	Homo sapiens	Inhibition	%	12.63
	8143878	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	8.81	CHEMBL3905	Homo sapiens	Inhibition	%	8.81
	8143991	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	10.36	CHEMBL3905	Homo sapiens	Inhibition	%	10.36
	8143992	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.28	CHEMBL3905	Homo sapiens	Inhibition	%	2.28
	8144215	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.6	CHEMBL3905	Homo sapiens	Inhibition	%	4.6
	8144216	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.75	CHEMBL3905	Homo sapiens	Inhibition	%	2.75
	8144354	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.63	CHEMBL3905	Homo sapiens	Inhibition	%	8.63
	8144355	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.66	CHEMBL3905	Homo sapiens	Inhibition	%	7.66
	8144708	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.1	CHEMBL3905	Homo sapiens	Inhibition	%	4.1
	8144709	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.28	CHEMBL3905	Homo sapiens	Inhibition	%	1.28
	8144861	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.72	CHEMBL3905	Homo sapiens	Inhibition	%	2.72
	8144862	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.59	CHEMBL3905	Homo sapiens	Inhibition	%	1.59
	8145222	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.84	CHEMBL3905	Homo sapiens	Inhibition	%	6.84
	8145223	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.9	CHEMBL3905	Homo sapiens	Inhibition	%	3.9
	8145535	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.39	CHEMBL3905	Homo sapiens	Inhibition	%	1.39
	8145536	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.23	CHEMBL3905	Homo sapiens	Inhibition	%	1.23
	8145659	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.83	CHEMBL3905	Homo sapiens	Inhibition	%	2.83
	8145660	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.47	CHEMBL3905	Homo sapiens	Inhibition	%	1.47
	8146044	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	29.68	CHEMBL3905	Homo sapiens	Inhibition	%	29.68
	8146045	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	27.05	CHEMBL3905	Homo sapiens	Inhibition	%	27.05
	8146164	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	72.38	CHEMBL3905	Homo sapiens	Inhibition	%	72.38
	8146165	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	67.82	CHEMBL3905	Homo sapiens	Inhibition	%	67.82
	8146388	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	5.69	CHEMBL3905	Homo sapiens	Inhibition	%	5.69
	8146389	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	4.04	CHEMBL3905	Homo sapiens	Inhibition	%	4.04
	8146548	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	60.42	CHEMBL3905	Homo sapiens	Inhibition	%	60.42
	8146549	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	55.4	CHEMBL3905	Homo sapiens	Inhibition	%	55.4
	8146715	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.14	CHEMBL3905	Homo sapiens	Inhibition	%	1.14
	8146716	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.52	CHEMBL3905	Homo sapiens	Inhibition	%	1.52
	8146939	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	18.95	CHEMBL3905	Homo sapiens	Inhibition	%	18.95
	8146940	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	16.49	CHEMBL3905	Homo sapiens	Inhibition	%	16.49
	8147108	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.89	CHEMBL3905	Homo sapiens	Inhibition	%	2.89
	8147109	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.95	CHEMBL3905	Homo sapiens	Inhibition	%	3.95
	8147250	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.28	CHEMBL3905	Homo sapiens	Inhibition	%	-1.28
	8147251	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.78	CHEMBL3905	Homo sapiens	Inhibition	%	-0.78
	8147474	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.75	CHEMBL3905	Homo sapiens	Inhibition	%	0.75
	8147475	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.52	CHEMBL3905	Homo sapiens	Inhibition	%	0.52
	8147627	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.42	CHEMBL3905	Homo sapiens	Inhibition	%	4.42
	8147628	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.28	CHEMBL3905	Homo sapiens	Inhibition	%	3.28
	8147814	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.49	CHEMBL3905	Homo sapiens	Inhibition	%	7.49
	8147815	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.55	CHEMBL3905	Homo sapiens	Inhibition	%	4.55
	8148038	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.81	CHEMBL3905	Homo sapiens	Inhibition	%	3.81
	8148039	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.84	CHEMBL3905	Homo sapiens	Inhibition	%	2.84
	8148196	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	52.95	CHEMBL3905	Homo sapiens	Inhibition	%	52.95
	8148197	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	47.81	CHEMBL3905	Homo sapiens	Inhibition	%	47.81
	8148534	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	7.84	CHEMBL3905	Homo sapiens	Inhibition	%	7.84
	8148535	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.83	CHEMBL3905	Homo sapiens	Inhibition	%	5.83
	8148673	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.8	CHEMBL3905	Homo sapiens	Inhibition	%	4.8
	8148674	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.74	CHEMBL3905	Homo sapiens	Inhibition	%	2.74
	8149035	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.17	CHEMBL3905	Homo sapiens	Inhibition	%	4.17
	8149036	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.86	CHEMBL3905	Homo sapiens	Inhibition	%	1.86
	8149194	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.56	CHEMBL3905	Homo sapiens	Inhibition	%	2.56
	8149195	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.39	CHEMBL3905	Homo sapiens	Inhibition	%	1.39
	8149418	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.44	CHEMBL3905	Homo sapiens	Inhibition	%	2.44
	8149419	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.32	CHEMBL3905	Homo sapiens	Inhibition	%	1.32
	8149552	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.64	CHEMBL3905	Homo sapiens	Inhibition	%	7.64
	8149553	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.05	CHEMBL3905	Homo sapiens	Inhibition	%	4.05
	8149874	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	13.65	CHEMBL3905	Homo sapiens	Inhibition	%	13.65
	8149875	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	9.47	CHEMBL3905	Homo sapiens	Inhibition	%	9.47
	8149999	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.01	CHEMBL3905	Homo sapiens	Inhibition	%	4.01
	8150000	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.2	CHEMBL3905	Homo sapiens	Inhibition	%	3.2
	8150223	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	13.99	CHEMBL3905	Homo sapiens	Inhibition	%	13.99
	8150224	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	9.31	CHEMBL3905	Homo sapiens	Inhibition	%	9.31
	8150383	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	64.85	CHEMBL3905	Homo sapiens	Inhibition	%	64.85
	8150384	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	60.91	CHEMBL3905	Homo sapiens	Inhibition	%	60.91
	8150727	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	56.1	CHEMBL3905	Homo sapiens	Inhibition	%	56.1
	8150728	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	49.81	CHEMBL3905	Homo sapiens	Inhibition	%	49.81
	8150892	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.9	CHEMBL3905	Homo sapiens	Inhibition	%	3.9
	8150893	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.54	CHEMBL3905	Homo sapiens	Inhibition	%	2.54
	8151279	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.45	CHEMBL3905	Homo sapiens	Inhibition	%	-2.45
	8151280	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.22	CHEMBL3905	Homo sapiens	Inhibition	%	-2.22
	8151456	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.99	CHEMBL3905	Homo sapiens	Inhibition	%	2.99
	8151457	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.78	CHEMBL3905	Homo sapiens	Inhibition	%	2.78
	8151818	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.22	CHEMBL3905	Homo sapiens	Inhibition	%	3.22
	8151819	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.95	CHEMBL3905	Homo sapiens	Inhibition	%	2.95
	8151972	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.45	CHEMBL3905	Homo sapiens	Inhibition	%	4.45
	8151973	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.78	CHEMBL3905	Homo sapiens	Inhibition	%	3.78
	8152384	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	17.13	CHEMBL3905	Homo sapiens	Inhibition	%	17.13
	8152385	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	12.93	CHEMBL3905	Homo sapiens	Inhibition	%	12.93
	8152542	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.9	CHEMBL3905	Homo sapiens	Inhibition	%	5.9
	8152543	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.91	CHEMBL3905	Homo sapiens	Inhibition	%	4.91
	8152880	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	45.7	CHEMBL3905	Homo sapiens	Inhibition	%	45.7
	8152881	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	37.72	CHEMBL3905	Homo sapiens	Inhibition	%	37.72
	8153019	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	7.06	CHEMBL3905	Homo sapiens	Inhibition	%	7.06
	8153020	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.08	CHEMBL3905	Homo sapiens	Inhibition	%	4.08
	8153243	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.27	CHEMBL3905	Homo sapiens	Inhibition	%	3.27
	8153244	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.07	CHEMBL3905	Homo sapiens	Inhibition	%	2.07
	8153380	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.34	CHEMBL3905	Homo sapiens	Inhibition	%	5.34
	8153381	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.92	CHEMBL3905	Homo sapiens	Inhibition	%	4.92
	8153761	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.17	CHEMBL3905	Homo sapiens	Inhibition	%	3.17
	8153762	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.72	CHEMBL3905	Homo sapiens	Inhibition	%	1.72
	8153894	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.55	CHEMBL3905	Homo sapiens	Inhibition	%	5.55
	8153895	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.01	CHEMBL3905	Homo sapiens	Inhibition	%	3.01
	8154215	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	57.13	CHEMBL3905	Homo sapiens	Inhibition	%	57.13
	8154216	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	52.26	CHEMBL3905	Homo sapiens	Inhibition	%	52.26
	8154565	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	65.67	CHEMBL3905	Homo sapiens	Inhibition	%	65.67
	8154566	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	60.51	CHEMBL3905	Homo sapiens	Inhibition	%	60.51
	8154724	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.69	CHEMBL3905	Homo sapiens	Inhibition	%	3.69
	8154725	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.02	CHEMBL3905	Homo sapiens	Inhibition	%	2.02
	8155068	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.88	CHEMBL3905	Homo sapiens	Inhibition	%	0.88
	8155069	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.08	CHEMBL3905	Homo sapiens	Inhibition	%	0.08
	8155244	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	5.94	CHEMBL3905	Homo sapiens	Inhibition	%	5.94
	8155245	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.25	CHEMBL3905	Homo sapiens	Inhibition	%	2.25
	8155468	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.67	CHEMBL3905	Homo sapiens	Inhibition	%	1.67
	8155469	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.33	CHEMBL3905	Homo sapiens	Inhibition	%	1.33
	8155629	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.16	CHEMBL3905	Homo sapiens	Inhibition	%	-0.16
	8155630	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.48	CHEMBL3905	Homo sapiens	Inhibition	%	-0.48
	8155807	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.13	CHEMBL3905	Homo sapiens	Inhibition	%	2.13
	8155808	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.22	CHEMBL3905	Homo sapiens	Inhibition	%	2.22
	8156169	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.33	CHEMBL3905	Homo sapiens	Inhibition	%	4.33
	8156170	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.97	CHEMBL3905	Homo sapiens	Inhibition	%	3.97
	8156381	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.49	CHEMBL3905	Homo sapiens	Inhibition	%	3.49
	8156382	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.57	CHEMBL3905	Homo sapiens	Inhibition	%	1.57
	8156755	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	45.51	CHEMBL3905	Homo sapiens	Inhibition	%	45.51
	8156756	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	40.82	CHEMBL3905	Homo sapiens	Inhibition	%	40.82
	8156898	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.4	CHEMBL3905	Homo sapiens	Inhibition	%	5.4
	8156899	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.72	CHEMBL3905	Homo sapiens	Inhibition	%	2.72
	8157122	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	12.42	CHEMBL3905	Homo sapiens	Inhibition	%	12.42
	8157123	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	9.48	CHEMBL3905	Homo sapiens	Inhibition	%	9.48
	8157242	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.49	CHEMBL3905	Homo sapiens	Inhibition	%	4.49
	8157243	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.98	CHEMBL3905	Homo sapiens	Inhibition	%	1.98
	8157607	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	8.46	CHEMBL3905	Homo sapiens	Inhibition	%	8.46
	8157608	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.92	CHEMBL3905	Homo sapiens	Inhibition	%	5.92
	8157737	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	27.54	CHEMBL3905	Homo sapiens	Inhibition	%	27.54
	8157738	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	23.37	CHEMBL3905	Homo sapiens	Inhibition	%	23.37
	8158122	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.33	CHEMBL3905	Homo sapiens	Inhibition	%	0.33
	8158123	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.08	CHEMBL3905	Homo sapiens	Inhibition	%	2.08
	8158372	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	22.29	CHEMBL3905	Homo sapiens	Inhibition	%	22.29
	8158373	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	16.7	CHEMBL3905	Homo sapiens	Inhibition	%	16.7
	8158530	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.64	CHEMBL3905	Homo sapiens	Inhibition	%	3.64
	8158531	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.83	CHEMBL3905	Homo sapiens	Inhibition	%	1.83
	8158754	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	8.64	CHEMBL3905	Homo sapiens	Inhibition	%	8.64
	8158755	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.14	CHEMBL3905	Homo sapiens	Inhibition	%	5.14
	8158923	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	5.22	CHEMBL3905	Homo sapiens	Inhibition	%	5.22
	8158924	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.27	CHEMBL3905	Homo sapiens	Inhibition	%	3.27
	8159058	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.36	CHEMBL3905	Homo sapiens	Inhibition	%	8.36
	8159059	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.68	CHEMBL3905	Homo sapiens	Inhibition	%	5.68
	8159282	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.44	CHEMBL3905	Homo sapiens	Inhibition	%	5.44
	8159283	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.24	CHEMBL3905	Homo sapiens	Inhibition	%	2.24
	8159402	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	10.95	CHEMBL3905	Homo sapiens	Inhibition	%	10.95
	8159403	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.12	CHEMBL3905	Homo sapiens	Inhibition	%	9.12
	8159757	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	8.1	CHEMBL3905	Homo sapiens	Inhibition	%	8.1
	8159758	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.96	CHEMBL3905	Homo sapiens	Inhibition	%	3.96
	8159898	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.78	CHEMBL3905	Homo sapiens	Inhibition	%	1.78
	8159899	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.94	CHEMBL3905	Homo sapiens	Inhibition	%	0.94
	8160122	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.26	CHEMBL3905	Homo sapiens	Inhibition	%	2.26
	8160123	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.92	CHEMBL3905	Homo sapiens	Inhibition	%	0.92
	8160259	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.72	CHEMBL3905	Homo sapiens	Inhibition	%	4.72
	8160260	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.92	CHEMBL3905	Homo sapiens	Inhibition	%	2.92
	8160409	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	9.35	CHEMBL3905	Homo sapiens	Inhibition	%	9.35
	8160410	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	6.33	CHEMBL3905	Homo sapiens	Inhibition	%	6.33
	8160633	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.13	CHEMBL3905	Homo sapiens	Inhibition	%	3.13
	8160634	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.4	CHEMBL3905	Homo sapiens	Inhibition	%	1.4
	8160703	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.46	CHEMBL3905	Homo sapiens	Inhibition	%	5.46
	8160704	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.61	CHEMBL3905	Homo sapiens	Inhibition	%	2.61
	8160927	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.63	CHEMBL3905	Homo sapiens	Inhibition	%	6.63
	8160928	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.69	CHEMBL3905	Homo sapiens	Inhibition	%	5.69
	8161077	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.34	CHEMBL3905	Homo sapiens	Inhibition	%	4.34
	8161078	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.19	CHEMBL3905	Homo sapiens	Inhibition	%	2.19
	8161444	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.12	CHEMBL3905	Homo sapiens	Inhibition	%	7.12
	8161445	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.02	CHEMBL3905	Homo sapiens	Inhibition	%	4.02
	8161569	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.25	CHEMBL3905	Homo sapiens	Inhibition	%	6.25
	8161570	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.89	CHEMBL3905	Homo sapiens	Inhibition	%	3.89
	8161931	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	27.61	CHEMBL3905	Homo sapiens	Inhibition	%	27.61
	8161932	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	21.86	CHEMBL3905	Homo sapiens	Inhibition	%	21.86
	8162061	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.41	CHEMBL3905	Homo sapiens	Inhibition	%	5.41
	8162062	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.14	CHEMBL3905	Homo sapiens	Inhibition	%	3.14
	8162285	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	20.87	CHEMBL3905	Homo sapiens	Inhibition	%	20.87
	8162286	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	17.19	CHEMBL3905	Homo sapiens	Inhibition	%	17.19
	8162445	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.76	CHEMBL3905	Homo sapiens	Inhibition	%	1.76
	8162446	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.61	CHEMBL3905	Homo sapiens	Inhibition	%	0.61
	8162698	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	8.57	CHEMBL3905	Homo sapiens	Inhibition	%	8.57
	8162699	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.42	CHEMBL3905	Homo sapiens	Inhibition	%	6.42
	8163070	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	11.52	CHEMBL3905	Homo sapiens	Inhibition	%	11.52
	8163071	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	7.96	CHEMBL3905	Homo sapiens	Inhibition	%	7.96
	8163239	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	5.51	CHEMBL3905	Homo sapiens	Inhibition	%	5.51
	8163240	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.53	CHEMBL3905	Homo sapiens	Inhibition	%	2.53
	8163597	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.48	CHEMBL3905	Homo sapiens	Inhibition	%	6.48
	8163598	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.85	CHEMBL3905	Homo sapiens	Inhibition	%	4.85
	8163720	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.47	CHEMBL3905	Homo sapiens	Inhibition	%	2.47
	8163721	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.33	CHEMBL3905	Homo sapiens	Inhibition	%	1.33
	8163944	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.12	CHEMBL3905	Homo sapiens	Inhibition	%	6.12
	8163945	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.93	CHEMBL3905	Homo sapiens	Inhibition	%	3.93
	8164078	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.48	CHEMBL3905	Homo sapiens	Inhibition	%	7.48
	8164079	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.89	CHEMBL3905	Homo sapiens	Inhibition	%	3.89
	8164442	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.33	CHEMBL3905	Homo sapiens	Inhibition	%	0.33
	8164443	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.62	CHEMBL3905	Homo sapiens	Inhibition	%	-0.62
	8164597	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.89	CHEMBL3905	Homo sapiens	Inhibition	%	7.89
	8164598	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.26	CHEMBL3905	Homo sapiens	Inhibition	%	5.26
	8164965	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	23.55	CHEMBL3905	Homo sapiens	Inhibition	%	23.55
	8164966	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	18.02	CHEMBL3905	Homo sapiens	Inhibition	%	18.02
	8165259	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.52	CHEMBL3905	Homo sapiens	Inhibition	%	3.52
	8165260	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.33	CHEMBL3905	Homo sapiens	Inhibition	%	2.33
	8165400	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	14.9	CHEMBL3905	Homo sapiens	Inhibition	%	14.9
	8165401	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	13.61	CHEMBL3905	Homo sapiens	Inhibition	%	13.61
	8165767	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	12.66	CHEMBL3905	Homo sapiens	Inhibition	%	12.66
	8165768	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	11.0	CHEMBL3905	Homo sapiens	Inhibition	%	11.0
	8165893	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.68	CHEMBL3905	Homo sapiens	Inhibition	%	5.68
	8165894	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.34	CHEMBL3905	Homo sapiens	Inhibition	%	1.34
	8166117	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.94	CHEMBL3905	Homo sapiens	Inhibition	%	3.94
	8166118	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.65	CHEMBL3905	Homo sapiens	Inhibition	%	2.65
	8166255	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.86	CHEMBL3905	Homo sapiens	Inhibition	%	5.86
	8166256	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.31	CHEMBL3905	Homo sapiens	Inhibition	%	3.31
	8166609	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.9	CHEMBL3905	Homo sapiens	Inhibition	%	9.9
	8166610	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.99	CHEMBL3905	Homo sapiens	Inhibition	%	6.99
	8166710	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	49.57	CHEMBL3905	Homo sapiens	Inhibition	%	49.57
	8166711	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	44.5	CHEMBL3905	Homo sapiens	Inhibition	%	44.5
	8166934	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	87.36	CHEMBL3905	Homo sapiens	Inhibition	%	87.36
	8166935	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	85.58	CHEMBL3905	Homo sapiens	Inhibition	%	85.58
	8167022	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	7.74	CHEMBL3905	Homo sapiens	Inhibition	%	7.74
	8167023	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.67	CHEMBL3905	Homo sapiens	Inhibition	%	5.67
	8167387	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	47.13	CHEMBL3905	Homo sapiens	Inhibition	%	47.13
	8167388	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	40.87	CHEMBL3905	Homo sapiens	Inhibition	%	40.87
	8167551	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.91	CHEMBL3905	Homo sapiens	Inhibition	%	4.91
	8167552	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.96	CHEMBL3905	Homo sapiens	Inhibition	%	2.96
	8167775	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.68	CHEMBL3905	Homo sapiens	Inhibition	%	5.68
	8167776	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.7	CHEMBL3905	Homo sapiens	Inhibition	%	3.7
	8167908	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.21	CHEMBL3905	Homo sapiens	Inhibition	%	7.21
	8167909	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.75	CHEMBL3905	Homo sapiens	Inhibition	%	3.75
	8168256	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.06	CHEMBL3905	Homo sapiens	Inhibition	%	2.06
	8168257	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.99	CHEMBL3905	Homo sapiens	Inhibition	%	0.99
	8168397	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.83	CHEMBL3905	Homo sapiens	Inhibition	%	7.83
	8168398	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.64	CHEMBL3905	Homo sapiens	Inhibition	%	4.64
	8168757	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.44	CHEMBL3905	Homo sapiens	Inhibition	%	2.44
	8168758	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.86	CHEMBL3905	Homo sapiens	Inhibition	%	0.86
	8168921	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	6.49	CHEMBL3905	Homo sapiens	Inhibition	%	6.49
	8168922	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.82	CHEMBL3905	Homo sapiens	Inhibition	%	4.82
	8169145	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	31.51	CHEMBL3905	Homo sapiens	Inhibition	%	31.51
	8169146	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	22.18	CHEMBL3905	Homo sapiens	Inhibition	%	22.18
	8169287	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.8	CHEMBL3905	Homo sapiens	Inhibition	%	3.8
	8169288	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.46	CHEMBL3905	Homo sapiens	Inhibition	%	2.46
	8169591	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.53	CHEMBL3905	Homo sapiens	Inhibition	%	4.53
	8169592	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.27	CHEMBL3905	Homo sapiens	Inhibition	%	3.27
	8169725	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.92	CHEMBL3905	Homo sapiens	Inhibition	%	4.92
	8169726	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.29	CHEMBL3905	Homo sapiens	Inhibition	%	3.29
	8169949	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.35	CHEMBL3905	Homo sapiens	Inhibition	%	5.35
	8169950	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.88	CHEMBL3905	Homo sapiens	Inhibition	%	4.88
	8170094	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	4.96	CHEMBL3905	Homo sapiens	Inhibition	%	4.96
	8170095	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.86	CHEMBL3905	Homo sapiens	Inhibition	%	3.86
	8170443	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.38	CHEMBL3905	Homo sapiens	Inhibition	%	3.38
	8170444	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.15	CHEMBL3905	Homo sapiens	Inhibition	%	1.15
	8170583	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	10.67	CHEMBL3905	Homo sapiens	Inhibition	%	10.67
	8170584	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.61	CHEMBL3905	Homo sapiens	Inhibition	%	8.61
	8170942	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	31.27	CHEMBL3905	Homo sapiens	Inhibition	%	31.27
	8170943	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	25.42	CHEMBL3905	Homo sapiens	Inhibition	%	25.42
	8171139	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	13.15	CHEMBL3905	Homo sapiens	Inhibition	%	13.15
	8171140	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	9.37	CHEMBL3905	Homo sapiens	Inhibition	%	9.37
	8171356	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.8	CHEMBL3905	Homo sapiens	Inhibition	%	5.8
	8171357	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.05	CHEMBL3905	Homo sapiens	Inhibition	%	3.05
	8171580	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.87	CHEMBL3905	Homo sapiens	Inhibition	%	4.87
	8171581	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.62	CHEMBL3905	Homo sapiens	Inhibition	%	2.62
	8171721	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.53	CHEMBL3905	Homo sapiens	Inhibition	%	4.53
	8171722	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.04	CHEMBL3905	Homo sapiens	Inhibition	%	2.04
	8172098	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	13.87	CHEMBL3905	Homo sapiens	Inhibition	%	13.87
	8172099	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	10.23	CHEMBL3905	Homo sapiens	Inhibition	%	10.23
	8172230	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.59	CHEMBL3905	Homo sapiens	Inhibition	%	9.59
	8172231	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.9	CHEMBL3905	Homo sapiens	Inhibition	%	5.9
	8172582	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.69	CHEMBL3905	Homo sapiens	Inhibition	%	2.69
	8172583	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.73	CHEMBL3905	Homo sapiens	Inhibition	%	1.73
	8172724	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.82	CHEMBL3905	Homo sapiens	Inhibition	%	6.82
	8172725	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.82	CHEMBL3905	Homo sapiens	Inhibition	%	4.82
	8172948	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	12.14	CHEMBL3905	Homo sapiens	Inhibition	%	12.14
	8172949	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	10.63	CHEMBL3905	Homo sapiens	Inhibition	%	10.63
	8173084	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.09	CHEMBL3905	Homo sapiens	Inhibition	%	1.09
	8173085	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.19	CHEMBL3905	Homo sapiens	Inhibition	%	1.19
	8173473	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	48.99	CHEMBL3905	Homo sapiens	Inhibition	%	48.99
	8173474	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	43.2	CHEMBL3905	Homo sapiens	Inhibition	%	43.2
	8173614	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.62	CHEMBL3905	Homo sapiens	Inhibition	%	4.62
	8173615	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.58	CHEMBL3905	Homo sapiens	Inhibition	%	3.58
	8173925	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.15	CHEMBL3905	Homo sapiens	Inhibition	%	8.15
	8173926	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.07	CHEMBL3905	Homo sapiens	Inhibition	%	5.07
	8174281	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	12.29	CHEMBL3905	Homo sapiens	Inhibition	%	12.29
	8174282	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	7.81	CHEMBL3905	Homo sapiens	Inhibition	%	7.81
	8174429	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	37.01	CHEMBL3905	Homo sapiens	Inhibition	%	37.01
	8174430	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	34.04	CHEMBL3905	Homo sapiens	Inhibition	%	34.04
	8174775	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.9	CHEMBL3905	Homo sapiens	Inhibition	%	5.9
	8174776	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.52	CHEMBL3905	Homo sapiens	Inhibition	%	2.52
	8174918	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.39	CHEMBL3905	Homo sapiens	Inhibition	%	3.39
	8174919	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.8	CHEMBL3905	Homo sapiens	Inhibition	%	1.8
	8175142	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	7.23	CHEMBL3905	Homo sapiens	Inhibition	%	7.23
	8175143	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.79	CHEMBL3905	Homo sapiens	Inhibition	%	5.79
	8175278	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.07	CHEMBL3905	Homo sapiens	Inhibition	%	4.07
	8175279	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.28	CHEMBL3905	Homo sapiens	Inhibition	%	2.28
	8175534	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	6.77	CHEMBL3905	Homo sapiens	Inhibition	%	6.77
	8175535	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.42	CHEMBL3905	Homo sapiens	Inhibition	%	4.42
	8175921	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	13.56	CHEMBL3905	Homo sapiens	Inhibition	%	13.56
	8175922	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	9.71	CHEMBL3905	Homo sapiens	Inhibition	%	9.71
	8176074	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.24	CHEMBL3905	Homo sapiens	Inhibition	%	4.24
	8176075	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.4	CHEMBL3905	Homo sapiens	Inhibition	%	2.4
	8176447	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	55.86	CHEMBL3905	Homo sapiens	Inhibition	%	55.86
	8176448	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	50.69	CHEMBL3905	Homo sapiens	Inhibition	%	50.69
	8176579	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	10.54	CHEMBL3905	Homo sapiens	Inhibition	%	10.54
	8176580	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.45	CHEMBL3905	Homo sapiens	Inhibition	%	7.45
	8176803	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	30.05	CHEMBL3905	Homo sapiens	Inhibition	%	30.05
	8176804	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	23.23	CHEMBL3905	Homo sapiens	Inhibition	%	23.23
	8176933	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.2	CHEMBL3905	Homo sapiens	Inhibition	%	2.2
	8176934	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.89	CHEMBL3905	Homo sapiens	Inhibition	%	0.89
	8177299	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	21.94	CHEMBL3905	Homo sapiens	Inhibition	%	21.94
	8177300	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	16.96	CHEMBL3905	Homo sapiens	Inhibition	%	16.96
	8177437	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.65	CHEMBL3905	Homo sapiens	Inhibition	%	1.65
	8177438	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.05	CHEMBL3905	Homo sapiens	Inhibition	%	1.05
	8177661	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.81	CHEMBL3905	Homo sapiens	Inhibition	%	10.81
	8177662	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	7.67	CHEMBL3905	Homo sapiens	Inhibition	%	7.67
	8177825	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	87.53	CHEMBL3905	Homo sapiens	Inhibition	%	87.53
	8177826	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	84.97	CHEMBL3905	Homo sapiens	Inhibition	%	84.97
	8177965	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.95	CHEMBL3905	Homo sapiens	Inhibition	%	2.95
	8177966	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.54	CHEMBL3905	Homo sapiens	Inhibition	%	1.54
	8178189	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	11.11	CHEMBL3905	Homo sapiens	Inhibition	%	11.11
	8178190	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	9.06	CHEMBL3905	Homo sapiens	Inhibition	%	9.06
	8178277	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	15.57	CHEMBL3905	Homo sapiens	Inhibition	%	15.57
	8178278	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	12.58	CHEMBL3905	Homo sapiens	Inhibition	%	12.58
	8178628	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	46.24	CHEMBL3905	Homo sapiens	Inhibition	%	46.24
	8178629	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	41.85	CHEMBL3905	Homo sapiens	Inhibition	%	41.85
	8178777	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.78	CHEMBL3905	Homo sapiens	Inhibition	%	0.78
	8178778	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.33	CHEMBL3905	Homo sapiens	Inhibition	%	0.33
	8179001	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.7	CHEMBL3905	Homo sapiens	Inhibition	%	1.7
	8179002	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.4	CHEMBL3905	Homo sapiens	Inhibition	%	2.4
	8179124	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.67	CHEMBL3905	Homo sapiens	Inhibition	%	5.67
	8179125	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.23	CHEMBL3905	Homo sapiens	Inhibition	%	2.23
	8179492	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	5.87	CHEMBL3905	Homo sapiens	Inhibition	%	5.87
	8179493	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.02	CHEMBL3905	Homo sapiens	Inhibition	%	3.02
	8179629	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	7.45	CHEMBL3905	Homo sapiens	Inhibition	%	7.45
	8179630	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.7	CHEMBL3905	Homo sapiens	Inhibition	%	4.7
	8179853	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.64	CHEMBL3905	Homo sapiens	Inhibition	%	4.64
	8179854	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.71	CHEMBL3905	Homo sapiens	Inhibition	%	2.71
	8179886	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	21.62	CHEMBL3905	Homo sapiens	Inhibition	%	21.62
	8179887	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	17.34	CHEMBL3905	Homo sapiens	Inhibition	%	17.34
	8180110	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.18	CHEMBL3905	Homo sapiens	Inhibition	%	5.18
	8180111	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.24	CHEMBL3905	Homo sapiens	Inhibition	%	2.24
	8180264	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	51.34	CHEMBL3905	Homo sapiens	Inhibition	%	51.34
	8180265	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	46.79	CHEMBL3905	Homo sapiens	Inhibition	%	46.79
	8180420	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.22	CHEMBL3905	Homo sapiens	Inhibition	%	6.22
	8180421	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.38	CHEMBL3905	Homo sapiens	Inhibition	%	4.38
	8180644	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.56	CHEMBL3905	Homo sapiens	Inhibition	%	5.56
	8180645	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.34	CHEMBL3905	Homo sapiens	Inhibition	%	2.34
	8180792	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.6	CHEMBL3905	Homo sapiens	Inhibition	%	3.6
	8180793	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.71	CHEMBL3905	Homo sapiens	Inhibition	%	2.71
	8181149	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	93.2	CHEMBL3905	Homo sapiens	Inhibition	%	93.2
	8181150	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	91.89	CHEMBL3905	Homo sapiens	Inhibition	%	91.89
	8181280	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	16.26	CHEMBL3905	Homo sapiens	Inhibition	%	16.26
	8181281	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	12.26	CHEMBL3905	Homo sapiens	Inhibition	%	12.26
	8181504	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.53	CHEMBL3905	Homo sapiens	Inhibition	%	1.53
	8181505	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.71	CHEMBL3905	Homo sapiens	Inhibition	%	0.71
	8181644	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	78.36	CHEMBL3905	Homo sapiens	Inhibition	%	78.36
	8181645	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	73.92	CHEMBL3905	Homo sapiens	Inhibition	%	73.92
	8182007	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	35.28	CHEMBL3905	Homo sapiens	Inhibition	%	35.28
	8182008	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	31.51	CHEMBL3905	Homo sapiens	Inhibition	%	31.51
	8182170	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	9.43	CHEMBL3905	Homo sapiens	Inhibition	%	9.43
	8182171	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	7.37	CHEMBL3905	Homo sapiens	Inhibition	%	7.37
	8182534	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.77	CHEMBL3905	Homo sapiens	Inhibition	%	2.77
	8182535	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.22	CHEMBL3905	Homo sapiens	Inhibition	%	1.22
	8182626	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.87	CHEMBL3905	Homo sapiens	Inhibition	%	3.87
	8182627	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.48	CHEMBL3905	Homo sapiens	Inhibition	%	1.48
	8182850	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.57	CHEMBL3905	Homo sapiens	Inhibition	%	4.57
	8182851	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.94	CHEMBL3905	Homo sapiens	Inhibition	%	3.94
	8182972	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	19.56	CHEMBL3905	Homo sapiens	Inhibition	%	19.56
	8182973	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	14.58	CHEMBL3905	Homo sapiens	Inhibition	%	14.58
	8183345	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	20.24	CHEMBL3905	Homo sapiens	Inhibition	%	20.24
	8183346	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	15.94	CHEMBL3905	Homo sapiens	Inhibition	%	15.94
	8183474	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.68	CHEMBL3905	Homo sapiens	Inhibition	%	3.68
	8183475	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.7	CHEMBL3905	Homo sapiens	Inhibition	%	1.7
	8183698	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.84	CHEMBL3905	Homo sapiens	Inhibition	%	6.84
	8183699	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.96	CHEMBL3905	Homo sapiens	Inhibition	%	4.96
	8183840	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	17.72	CHEMBL3905	Homo sapiens	Inhibition	%	17.72
	8183841	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	14.68	CHEMBL3905	Homo sapiens	Inhibition	%	14.68
	8184200	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.93	CHEMBL3905	Homo sapiens	Inhibition	%	7.93
	8184201	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	6.38	CHEMBL3905	Homo sapiens	Inhibition	%	6.38
	8184466	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.72	CHEMBL3905	Homo sapiens	Inhibition	%	4.72
	8184467	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.51	CHEMBL3905	Homo sapiens	Inhibition	%	3.51
	8184613	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.95	CHEMBL3905	Homo sapiens	Inhibition	%	2.95
	8184614	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.43	CHEMBL3905	Homo sapiens	Inhibition	%	1.43
	8184994	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	32.47	CHEMBL3905	Homo sapiens	Inhibition	%	32.47
	8184995	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	26.03	CHEMBL3905	Homo sapiens	Inhibition	%	26.03
	8185143	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	22.38	CHEMBL3905	Homo sapiens	Inhibition	%	22.38
	8185144	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	17.35	CHEMBL3905	Homo sapiens	Inhibition	%	17.35
	8185498	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	96.71	CHEMBL3905	Homo sapiens	Inhibition	%	96.71
	8185499	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	96.16	CHEMBL3905	Homo sapiens	Inhibition	%	96.16
	8185853	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	8.14	CHEMBL3905	Homo sapiens	Inhibition	%	8.14
	8185854	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	6.94	CHEMBL3905	Homo sapiens	Inhibition	%	6.94
	8185992	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.94	CHEMBL3905	Homo sapiens	Inhibition	%	5.94
	8185993	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.77	CHEMBL3905	Homo sapiens	Inhibition	%	2.77
	8186357	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.17	CHEMBL3905	Homo sapiens	Inhibition	%	6.17
	8186358	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.08	CHEMBL3905	Homo sapiens	Inhibition	%	3.08
	8186521	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	39.44	CHEMBL3905	Homo sapiens	Inhibition	%	39.44
	8186522	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	32.95	CHEMBL3905	Homo sapiens	Inhibition	%	32.95
	8186884	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.13	CHEMBL3905	Homo sapiens	Inhibition	%	2.13
	8186885	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.38	CHEMBL3905	Homo sapiens	Inhibition	%	0.38
	8187206	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	14.77	CHEMBL3905	Homo sapiens	Inhibition	%	14.77
	8187207	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	10.39	CHEMBL3905	Homo sapiens	Inhibition	%	10.39
	8187330	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	48.71	CHEMBL3905	Homo sapiens	Inhibition	%	48.71
	8187331	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	43.92	CHEMBL3905	Homo sapiens	Inhibition	%	43.92
	8187554	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.95	CHEMBL3905	Homo sapiens	Inhibition	%	7.95
	8187555	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.18	CHEMBL3905	Homo sapiens	Inhibition	%	3.18
	8187702	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	68.22	CHEMBL3905	Homo sapiens	Inhibition	%	68.22
	8187703	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	63.61	CHEMBL3905	Homo sapiens	Inhibition	%	63.61
	8188055	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	37.08	CHEMBL3905	Homo sapiens	Inhibition	%	37.08
	8188056	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	30.79	CHEMBL3905	Homo sapiens	Inhibition	%	30.79
	8188198	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.69	CHEMBL3905	Homo sapiens	Inhibition	%	4.69
	8188199	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.56	CHEMBL3905	Homo sapiens	Inhibition	%	1.56
	8188557	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	54.1	CHEMBL3905	Homo sapiens	Inhibition	%	54.1
	8188558	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	48.08	CHEMBL3905	Homo sapiens	Inhibition	%	48.08
	8188831	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.55	CHEMBL3905	Homo sapiens	Inhibition	%	7.55
	8188832	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.46	CHEMBL3905	Homo sapiens	Inhibition	%	5.46
	8188979	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	7.02	CHEMBL3905	Homo sapiens	Inhibition	%	7.02
	8188980	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.65	CHEMBL3905	Homo sapiens	Inhibition	%	4.65
	8189203	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	15.22	CHEMBL3905	Homo sapiens	Inhibition	%	15.22
	8189204	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	11.2	CHEMBL3905	Homo sapiens	Inhibition	%	11.2
	8189359	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	78.78	CHEMBL3905	Homo sapiens	Inhibition	%	78.78
	8189360	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	72.68	CHEMBL3905	Homo sapiens	Inhibition	%	72.68
	8189508	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.07	CHEMBL3905	Homo sapiens	Inhibition	%	-0.07
	8189509	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.59	CHEMBL3905	Homo sapiens	Inhibition	%	-0.59
	8189732	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.62	CHEMBL3905	Homo sapiens	Inhibition	%	-0.62
	8189733	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-1.18	CHEMBL3905	Homo sapiens	Inhibition	%	-1.18
	8189864	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	7.93	CHEMBL3905	Homo sapiens	Inhibition	%	7.93
	8189865	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.05	CHEMBL3905	Homo sapiens	Inhibition	%	5.05
	8190220	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	Inhibition	%	6.0
	8190221	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.58	CHEMBL3905	Homo sapiens	Inhibition	%	4.58
	8190360	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	9.06	CHEMBL3905	Homo sapiens	Inhibition	%	9.06
	8190361	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.33	CHEMBL3905	Homo sapiens	Inhibition	%	5.33
	8190584	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	11.71	CHEMBL3905	Homo sapiens	Inhibition	%	11.71
	8190585	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	Inhibition	%	10.0
	8190721	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	21.34	CHEMBL3905	Homo sapiens	Inhibition	%	21.34
	8190722	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	17.69	CHEMBL3905	Homo sapiens	Inhibition	%	17.69
	8190885	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.92	CHEMBL3905	Homo sapiens	Inhibition	%	6.92
	8190886	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.2	CHEMBL3905	Homo sapiens	Inhibition	%	5.2
	8191109	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.95	CHEMBL3905	Homo sapiens	Inhibition	%	6.95
	8191110	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.98	CHEMBL3905	Homo sapiens	Inhibition	%	5.98
	8191247	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.57	CHEMBL3905	Homo sapiens	Inhibition	%	5.57
	8191248	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.36	CHEMBL3905	Homo sapiens	Inhibition	%	2.36
	8191567	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	60.99	CHEMBL3905	Homo sapiens	Inhibition	%	60.99
	8191568	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	57.0	CHEMBL3905	Homo sapiens	Inhibition	%	57.0
	8191913	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	9.21	CHEMBL3905	Homo sapiens	Inhibition	%	9.21
	8191914	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.1	CHEMBL3905	Homo sapiens	Inhibition	%	7.1
	8192062	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.99	CHEMBL3905	Homo sapiens	Inhibition	%	3.99
	8192063	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.75	CHEMBL3905	Homo sapiens	Inhibition	%	1.75
	8192415	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.62	CHEMBL3905	Homo sapiens	Inhibition	%	4.62
	8192416	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.67	CHEMBL3905	Homo sapiens	Inhibition	%	2.67
	8192559	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	8.22	CHEMBL3905	Homo sapiens	Inhibition	%	8.22
	8192560	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.78	CHEMBL3905	Homo sapiens	Inhibition	%	6.78
	8192783	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	7.42	CHEMBL3905	Homo sapiens	Inhibition	%	7.42
	8192784	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.73	CHEMBL3905	Homo sapiens	Inhibition	%	3.73
	8192919	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	76.49	CHEMBL3905	Homo sapiens	Inhibition	%	76.49
	8192920	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	73.26	CHEMBL3905	Homo sapiens	Inhibition	%	73.26
	8193191	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	15.28	CHEMBL3905	Homo sapiens	Inhibition	%	15.28
	8193192	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.98	CHEMBL3905	Homo sapiens	Inhibition	%	11.98
	8193560	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	58.55	CHEMBL3905	Homo sapiens	Inhibition	%	58.55
	8193561	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	52.73	CHEMBL3905	Homo sapiens	Inhibition	%	52.73
	8193717	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.77	CHEMBL3905	Homo sapiens	Inhibition	%	5.77
	8193718	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.69	CHEMBL3905	Homo sapiens	Inhibition	%	3.69
	8194090	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.31	CHEMBL3905	Homo sapiens	Inhibition	%	1.31
	8194091	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.13	CHEMBL3905	Homo sapiens	Inhibition	%	1.13
	8194221	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	26.91	CHEMBL3905	Homo sapiens	Inhibition	%	26.91
	8194222	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	21.76	CHEMBL3905	Homo sapiens	Inhibition	%	21.76
	8194445	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	39.74	CHEMBL3905	Homo sapiens	Inhibition	%	39.74
	8194446	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	32.63	CHEMBL3905	Homo sapiens	Inhibition	%	32.63
	8194576	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	14.36	CHEMBL3905	Homo sapiens	Inhibition	%	14.36
	8194577	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	9.46	CHEMBL3905	Homo sapiens	Inhibition	%	9.46
	8194943	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	48.79	CHEMBL3905	Homo sapiens	Inhibition	%	48.79
	8194944	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	43.0	CHEMBL3905	Homo sapiens	Inhibition	%	43.0
	8195076	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.64	CHEMBL3905	Homo sapiens	Inhibition	%	5.64
	8195077	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.08	CHEMBL3905	Homo sapiens	Inhibition	%	3.08
	8195464	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	5.67	CHEMBL3905	Homo sapiens	Inhibition	%	5.67
	8195465	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.95	CHEMBL3905	Homo sapiens	Inhibition	%	2.95
	8195603	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.57	CHEMBL3905	Homo sapiens	Inhibition	%	9.57
	8195604	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	7.59	CHEMBL3905	Homo sapiens	Inhibition	%	7.59
	8195827	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.03	CHEMBL3905	Homo sapiens	Inhibition	%	6.03
	8195828	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.09	CHEMBL3905	Homo sapiens	Inhibition	%	3.09
	8195925	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.25	CHEMBL3905	Homo sapiens	Inhibition	%	2.25
	8195926	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.9	CHEMBL3905	Homo sapiens	Inhibition	%	0.9
	8196266	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.18	CHEMBL3905	Homo sapiens	Inhibition	%	5.18
	8196267	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.45	CHEMBL3905	Homo sapiens	Inhibition	%	2.45
	8196416	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.8	CHEMBL3905	Homo sapiens	Inhibition	%	5.8
	8196417	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.91	CHEMBL3905	Homo sapiens	Inhibition	%	4.91
	8196640	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	10.79	CHEMBL3905	Homo sapiens	Inhibition	%	10.79
	8196641	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	8.55	CHEMBL3905	Homo sapiens	Inhibition	%	8.55
	8196768	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	7.5	CHEMBL3905	Homo sapiens	Inhibition	%	7.5
	8196769	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	7.12	CHEMBL3905	Homo sapiens	Inhibition	%	7.12
	8197133	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	18.88	CHEMBL3905	Homo sapiens	Inhibition	%	18.88
	8197134	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	14.95	CHEMBL3905	Homo sapiens	Inhibition	%	14.95
	8197270	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.55	CHEMBL3905	Homo sapiens	Inhibition	%	2.55
	8197271	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.62	CHEMBL3905	Homo sapiens	Inhibition	%	0.62
	8197545	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	7.55	CHEMBL3905	Homo sapiens	Inhibition	%	7.55
	8197546	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	Inhibition	%	5.0
	8197909	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.15	CHEMBL3905	Homo sapiens	Inhibition	%	3.15
	8197910	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.45	CHEMBL3905	Homo sapiens	Inhibition	%	2.45
	8198066	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	11.56	CHEMBL3905	Homo sapiens	Inhibition	%	11.56
	8198067	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	8.12	CHEMBL3905	Homo sapiens	Inhibition	%	8.12
	8198290	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.56	CHEMBL3905	Homo sapiens	Inhibition	%	3.56
	8198291	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.97	CHEMBL3905	Homo sapiens	Inhibition	%	1.97
	8198428	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.07	CHEMBL3905	Homo sapiens	Inhibition	%	-0.07
	8198429	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.52	CHEMBL3905	Homo sapiens	Inhibition	%	0.52
	8198782	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	83.88	CHEMBL3905	Homo sapiens	Inhibition	%	83.88
	8198783	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	80.83	CHEMBL3905	Homo sapiens	Inhibition	%	80.83
	8198913	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.82	CHEMBL3905	Homo sapiens	Inhibition	%	6.82
	8198914	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.14	CHEMBL3905	Homo sapiens	Inhibition	%	5.14
	8199285	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	9.84	CHEMBL3905	Homo sapiens	Inhibition	%	9.84
	8199286	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.8	CHEMBL3905	Homo sapiens	Inhibition	%	7.8
	8199419	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.19	CHEMBL3905	Homo sapiens	Inhibition	%	7.19
	8199420	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.79	CHEMBL3905	Homo sapiens	Inhibition	%	5.79
	8199643	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.26	CHEMBL3905	Homo sapiens	Inhibition	%	6.26
	8199644	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.8	CHEMBL3905	Homo sapiens	Inhibition	%	2.8
	8199806	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	18.88	CHEMBL3905	Homo sapiens	Inhibition	%	18.88
	8199807	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	16.17	CHEMBL3905	Homo sapiens	Inhibition	%	16.17
	8200168	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.58	CHEMBL3905	Homo sapiens	Inhibition	%	6.58
	8200169	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.31	CHEMBL3905	Homo sapiens	Inhibition	%	3.31
	8200272	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	5.17	CHEMBL3905	Homo sapiens	Inhibition	%	5.17
	8200273	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.68	CHEMBL3905	Homo sapiens	Inhibition	%	3.68
	8200496	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	7.57	CHEMBL3905	Homo sapiens	Inhibition	%	7.57
	8200497	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.2	CHEMBL3905	Homo sapiens	Inhibition	%	4.2
	8200611	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	10.34	CHEMBL3905	Homo sapiens	Inhibition	%	10.34
	8200612	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.65	CHEMBL3905	Homo sapiens	Inhibition	%	8.65
	8200985	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	50.09	CHEMBL3905	Homo sapiens	Inhibition	%	50.09
	8200986	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	44.41	CHEMBL3905	Homo sapiens	Inhibition	%	44.41
	8201115	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.29	CHEMBL3905	Homo sapiens	Inhibition	%	4.29
	8201116	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.41	CHEMBL3905	Homo sapiens	Inhibition	%	2.41
	8201474	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.43	CHEMBL3905	Homo sapiens	Inhibition	%	5.43
	8201475	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.33	CHEMBL3905	Homo sapiens	Inhibition	%	4.33
	8201607	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	5.91	CHEMBL3905	Homo sapiens	Inhibition	%	5.91
	8201608	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	4.08	CHEMBL3905	Homo sapiens	Inhibition	%	4.08
	8201831	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	Inhibition	%	2.0
	8201832	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.52	CHEMBL3905	Homo sapiens	Inhibition	%	0.52
	8201886	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	Inhibition	%	9.0
	8201887	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.99	CHEMBL3905	Homo sapiens	Inhibition	%	5.99
	8202110	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	6.53	CHEMBL3905	Homo sapiens	Inhibition	%	6.53
	8202111	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.88	CHEMBL3905	Homo sapiens	Inhibition	%	3.88
	8202250	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	25.61	CHEMBL3905	Homo sapiens	Inhibition	%	25.61
	8202251	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	21.15	CHEMBL3905	Homo sapiens	Inhibition	%	21.15
	8202641	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	7.36	CHEMBL3905	Homo sapiens	Inhibition	%	7.36
	8202642	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.29	CHEMBL3905	Homo sapiens	Inhibition	%	4.29
	8202766	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.32	CHEMBL3905	Homo sapiens	Inhibition	%	6.32
	8202767	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.14	CHEMBL3905	Homo sapiens	Inhibition	%	5.14
	8203120	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.54	CHEMBL3905	Homo sapiens	Inhibition	%	5.54
	8203121	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.53	CHEMBL3905	Homo sapiens	Inhibition	%	7.53
	8203251	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.94	CHEMBL3905	Homo sapiens	Inhibition	%	6.94
	8203252	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.26	CHEMBL3905	Homo sapiens	Inhibition	%	4.26
	8203475	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	41.3	CHEMBL3905	Homo sapiens	Inhibition	%	41.3
	8203476	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	36.28	CHEMBL3905	Homo sapiens	Inhibition	%	36.28
	8203621	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	32.08	CHEMBL3905	Homo sapiens	Inhibition	%	32.08
	8203622	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	28.73	CHEMBL3905	Homo sapiens	Inhibition	%	28.73
	8203979	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	7.71	CHEMBL3905	Homo sapiens	Inhibition	%	7.71
	8203980	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	7.49	CHEMBL3905	Homo sapiens	Inhibition	%	7.49
	8204145	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	13.67	CHEMBL3905	Homo sapiens	Inhibition	%	13.67
	8204146	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	13.58	CHEMBL3905	Homo sapiens	Inhibition	%	13.58
	8204506	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	72.8	CHEMBL3905	Homo sapiens	Inhibition	%	72.8
	8204507	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	65.17	CHEMBL3905	Homo sapiens	Inhibition	%	65.17
	8204835	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	40.69	CHEMBL3905	Homo sapiens	Inhibition	%	40.69
	8204836	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	35.4	CHEMBL3905	Homo sapiens	Inhibition	%	35.4
	8204950	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	16.8	CHEMBL3905	Homo sapiens	Inhibition	%	16.8
	8204951	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	12.63	CHEMBL3905	Homo sapiens	Inhibition	%	12.63
	8205323	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.58	CHEMBL3905	Homo sapiens	Inhibition	%	3.58
	8205324	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.01	CHEMBL3905	Homo sapiens	Inhibition	%	2.01
	8205459	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	22.55	CHEMBL3905	Homo sapiens	Inhibition	%	22.55
	8205460	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	19.3	CHEMBL3905	Homo sapiens	Inhibition	%	19.3
	8205683	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.8	CHEMBL3905	Homo sapiens	Inhibition	%	3.8
	8205684	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.33	CHEMBL3905	Homo sapiens	Inhibition	%	2.33
	8205822	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	8.06	CHEMBL3905	Homo sapiens	Inhibition	%	8.06
	8205823	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.23	CHEMBL3905	Homo sapiens	Inhibition	%	5.23
	8206178	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	21.41	CHEMBL3905	Homo sapiens	Inhibition	%	21.41
	8206179	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	16.79	CHEMBL3905	Homo sapiens	Inhibition	%	16.79
	8206454	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	6.94	CHEMBL3905	Homo sapiens	Inhibition	%	6.94
	8206455	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.94	CHEMBL3905	Homo sapiens	Inhibition	%	4.94
	8206597	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.87	CHEMBL3905	Homo sapiens	Inhibition	%	0.87
	8206598	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.59	CHEMBL3905	Homo sapiens	Inhibition	%	0.59
	8206821	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	6.57	CHEMBL3905	Homo sapiens	Inhibition	%	6.57
	8206822	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	4.62	CHEMBL3905	Homo sapiens	Inhibition	%	4.62
	8207001	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.87	CHEMBL3905	Homo sapiens	Inhibition	%	4.87
	8207002	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.03	CHEMBL3905	Homo sapiens	Inhibition	%	3.03
	8207127	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	8.49	CHEMBL3905	Homo sapiens	Inhibition	%	8.49
	8207128	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.44	CHEMBL3905	Homo sapiens	Inhibition	%	7.44
	8207351	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.27	CHEMBL3905	Homo sapiens	Inhibition	%	7.27
	8207352	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.14	CHEMBL3905	Homo sapiens	Inhibition	%	5.14
	8207481	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.24	CHEMBL3905	Homo sapiens	Inhibition	%	8.24
	8207482	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.49	CHEMBL3905	Homo sapiens	Inhibition	%	5.49
	8207837	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	83.63	CHEMBL3905	Homo sapiens	Inhibition	%	83.63
	8207838	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	80.74	CHEMBL3905	Homo sapiens	Inhibition	%	80.74
	8207982	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.49	CHEMBL3905	Homo sapiens	Inhibition	%	5.49
	8207983	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.77	CHEMBL3905	Homo sapiens	Inhibition	%	2.77
	8208338	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.64	CHEMBL3905	Homo sapiens	Inhibition	%	6.64
	8208339	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.87	CHEMBL3905	Homo sapiens	Inhibition	%	3.87
	8208504	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	57.17	CHEMBL3905	Homo sapiens	Inhibition	%	57.17
	8208505	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	53.38	CHEMBL3905	Homo sapiens	Inhibition	%	53.38
	8208728	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	6.74	CHEMBL3905	Homo sapiens	Inhibition	%	6.74
	8208729	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.2	CHEMBL3905	Homo sapiens	Inhibition	%	4.2
	8208861	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	94.33	CHEMBL3905	Homo sapiens	Inhibition	%	94.33
	8208862	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	91.89	CHEMBL3905	Homo sapiens	Inhibition	%	91.89
	8209190	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	14.8	CHEMBL3905	Homo sapiens	Inhibition	%	14.8
	8209191	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	10.57	CHEMBL3905	Homo sapiens	Inhibition	%	10.57
	8209306	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	63.93	CHEMBL3905	Homo sapiens	Inhibition	%	63.93
	8209307	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	59.58	CHEMBL3905	Homo sapiens	Inhibition	%	59.58
	8209530	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.59	CHEMBL3905	Homo sapiens	Inhibition	%	4.59
	8209531	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.14	CHEMBL3905	Homo sapiens	Inhibition	%	2.14
	8209680	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.39	CHEMBL3905	Homo sapiens	Inhibition	%	2.39
	8209681	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.12	CHEMBL3905	Homo sapiens	Inhibition	%	3.12
	8210040	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.05	CHEMBL3905	Homo sapiens	Inhibition	%	6.05
	8210041	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.84	CHEMBL3905	Homo sapiens	Inhibition	%	4.84
	8210181	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.32	CHEMBL3905	Homo sapiens	Inhibition	%	6.32
	8210182	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.03	CHEMBL3905	Homo sapiens	Inhibition	%	4.03
	8210405	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	7.19	CHEMBL3905	Homo sapiens	Inhibition	%	7.19
	8210406	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	6.24	CHEMBL3905	Homo sapiens	Inhibition	%	6.24
	8210541	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.07	CHEMBL3905	Homo sapiens	Inhibition	%	0.07
	8210542	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.46	CHEMBL3905	Homo sapiens	Inhibition	%	-0.46
	8210800	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.85	CHEMBL3905	Homo sapiens	Inhibition	%	3.85
	8210801	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.14	CHEMBL3905	Homo sapiens	Inhibition	%	2.14
	8211168	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	9.46	CHEMBL3905	Homo sapiens	Inhibition	%	9.46
	8211169	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.71	CHEMBL3905	Homo sapiens	Inhibition	%	6.71
	8211338	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.51	CHEMBL3905	Homo sapiens	Inhibition	%	6.51
	8211339	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.22	CHEMBL3905	Homo sapiens	Inhibition	%	2.22
	8211685	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	16.11	CHEMBL3905	Homo sapiens	Inhibition	%	16.11
	8211686	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	13.24	CHEMBL3905	Homo sapiens	Inhibition	%	13.24
	8211814	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	9.57	CHEMBL3905	Homo sapiens	Inhibition	%	9.57
	8211815	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.94	CHEMBL3905	Homo sapiens	Inhibition	%	6.94
	8212170	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.16	CHEMBL3905	Homo sapiens	Inhibition	%	5.16
	8212171	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.95	CHEMBL3905	Homo sapiens	Inhibition	%	2.95
	8212311	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.64	CHEMBL3905	Homo sapiens	Inhibition	%	3.64
	8212312	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.53	CHEMBL3905	Homo sapiens	Inhibition	%	0.53
	8212535	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.61	CHEMBL3905	Homo sapiens	Inhibition	%	6.61
	8212536	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.7	CHEMBL3905	Homo sapiens	Inhibition	%	3.7
	8212668	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	15.17	CHEMBL3905	Homo sapiens	Inhibition	%	15.17
	8212669	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	11.22	CHEMBL3905	Homo sapiens	Inhibition	%	11.22
	8213062	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	30.84	CHEMBL3905	Homo sapiens	Inhibition	%	30.84
	8213063	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	26.16	CHEMBL3905	Homo sapiens	Inhibition	%	26.16
	8213191	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.73	CHEMBL3905	Homo sapiens	Inhibition	%	3.73
	8213192	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.39	CHEMBL3905	Homo sapiens	Inhibition	%	2.39
	8213519	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	62.48	CHEMBL3905	Homo sapiens	Inhibition	%	62.48
	8213520	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	55.78	CHEMBL3905	Homo sapiens	Inhibition	%	55.78
	8213856	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.44	CHEMBL3905	Homo sapiens	Inhibition	%	4.44
	8213857	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.06	CHEMBL3905	Homo sapiens	Inhibition	%	3.06
	8214003	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.87	CHEMBL3905	Homo sapiens	Inhibition	%	2.87
	8214004	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.42	CHEMBL3905	Homo sapiens	Inhibition	%	1.42
	8214227	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.71	CHEMBL3905	Homo sapiens	Inhibition	%	3.71
	8214228	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.29	CHEMBL3905	Homo sapiens	Inhibition	%	3.29
	8214364	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	6.61	CHEMBL3905	Homo sapiens	Inhibition	%	6.61
	8214365	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.21	CHEMBL3905	Homo sapiens	Inhibition	%	5.21
	8214722	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	61.18	CHEMBL3905	Homo sapiens	Inhibition	%	61.18
	8214723	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	56.45	CHEMBL3905	Homo sapiens	Inhibition	%	56.45
	8214874	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.67	CHEMBL3905	Homo sapiens	Inhibition	%	1.67
	8214875	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.82	CHEMBL3905	Homo sapiens	Inhibition	%	1.82
	8215125	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	8.64	CHEMBL3905	Homo sapiens	Inhibition	%	8.64
	8215126	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.87	CHEMBL3905	Homo sapiens	Inhibition	%	4.87
	8215502	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	19.65	CHEMBL3905	Homo sapiens	Inhibition	%	19.65
	8215503	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	14.74	CHEMBL3905	Homo sapiens	Inhibition	%	14.74
	8215666	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.33	CHEMBL3905	Homo sapiens	Inhibition	%	4.33
	8215667	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.03	CHEMBL3905	Homo sapiens	Inhibition	%	2.03
	8216009	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.36	CHEMBL3905	Homo sapiens	Inhibition	%	4.36
	8216010	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.42	CHEMBL3905	Homo sapiens	Inhibition	%	2.42
	8216128	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	16.23	CHEMBL3905	Homo sapiens	Inhibition	%	16.23
	8216129	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.98	CHEMBL3905	Homo sapiens	Inhibition	%	12.98
	8216352	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.8	CHEMBL3905	Homo sapiens	Inhibition	%	5.8
	8216353	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.92	CHEMBL3905	Homo sapiens	Inhibition	%	2.92
	8216488	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.45	CHEMBL3905	Homo sapiens	Inhibition	%	6.45
	8216489	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.74	CHEMBL3905	Homo sapiens	Inhibition	%	3.74
	8216850	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.51	CHEMBL3905	Homo sapiens	Inhibition	%	5.51
	8216851	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.43	CHEMBL3905	Homo sapiens	Inhibition	%	3.43
	8216984	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.2	CHEMBL3905	Homo sapiens	Inhibition	%	7.2
	8216985	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.09	CHEMBL3905	Homo sapiens	Inhibition	%	3.09
	8217208	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.98	CHEMBL3905	Homo sapiens	Inhibition	%	5.98
	8217209	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.48	CHEMBL3905	Homo sapiens	Inhibition	%	5.48
	8217382	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.36	CHEMBL3905	Homo sapiens	Inhibition	%	3.36
	8217383	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.38	CHEMBL3905	Homo sapiens	Inhibition	%	1.38
	8217513	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.88	CHEMBL3905	Homo sapiens	Inhibition	%	4.88
	8217514	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.2	CHEMBL3905	Homo sapiens	Inhibition	%	4.2
	8217737	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	20.45	CHEMBL3905	Homo sapiens	Inhibition	%	20.45
	8217738	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	15.12	CHEMBL3905	Homo sapiens	Inhibition	%	15.12
	8217838	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.02	CHEMBL3905	Homo sapiens	Inhibition	%	0.02
	8217839	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.02	CHEMBL3905	Homo sapiens	Inhibition	%	-2.02
	8218177	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.26	CHEMBL3905	Homo sapiens	Inhibition	%	6.26
	8218178	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.81	CHEMBL3905	Homo sapiens	Inhibition	%	2.81
	8218528	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	56.91	CHEMBL3905	Homo sapiens	Inhibition	%	56.91
	8218529	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	51.05	CHEMBL3905	Homo sapiens	Inhibition	%	51.05
	8218671	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	27.95	CHEMBL3905	Homo sapiens	Inhibition	%	27.95
	8218672	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	23.95	CHEMBL3905	Homo sapiens	Inhibition	%	23.95
	8219026	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	90.46	CHEMBL3905	Homo sapiens	Inhibition	%	90.46
	8219027	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	88.85	CHEMBL3905	Homo sapiens	Inhibition	%	88.85
	8219186	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.31	CHEMBL3905	Homo sapiens	Inhibition	%	1.31
	8219187	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.54	CHEMBL3905	Homo sapiens	Inhibition	%	1.54
	8219410	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	10.15	CHEMBL3905	Homo sapiens	Inhibition	%	10.15
	8219436	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.23	CHEMBL3905	Homo sapiens	Inhibition	%	5.23
	8219437	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.71	CHEMBL3905	Homo sapiens	Inhibition	%	2.71
	8219660	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	9.61	CHEMBL3905	Homo sapiens	Inhibition	%	9.61
	8219661	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.84	CHEMBL3905	Homo sapiens	Inhibition	%	5.84
	8219821	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.38	CHEMBL3905	Homo sapiens	Inhibition	%	5.38
	8219822	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.09	CHEMBL3905	Homo sapiens	Inhibition	%	3.09
	8219990	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.23	CHEMBL3905	Homo sapiens	Inhibition	%	6.23
	8219991	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.87	CHEMBL3905	Homo sapiens	Inhibition	%	1.87
	8220214	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.92	CHEMBL3905	Homo sapiens	Inhibition	%	6.92
	8220215	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.52	CHEMBL3905	Homo sapiens	Inhibition	%	5.52
	8220343	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.54	CHEMBL3905	Homo sapiens	Inhibition	%	9.54
	8220344	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	Inhibition	%	7.0
	8220681	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	6.03	CHEMBL3905	Homo sapiens	Inhibition	%	6.03
	8220682	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.3	CHEMBL3905	Homo sapiens	Inhibition	%	3.3
	8220819	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.08	CHEMBL3905	Homo sapiens	Inhibition	%	6.08
	8220820	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.38	CHEMBL3905	Homo sapiens	Inhibition	%	2.38
	8221043	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	12.0	CHEMBL3905	Homo sapiens	Inhibition	%	12.0
	8221044	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	9.08	CHEMBL3905	Homo sapiens	Inhibition	%	9.08
	8221179	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.56	CHEMBL3905	Homo sapiens	Inhibition	%	1.56
	8221180	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.71	CHEMBL3905	Homo sapiens	Inhibition	%	0.71
	8221536	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.91	CHEMBL3905	Homo sapiens	Inhibition	%	4.91
	8221537	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.03	CHEMBL3905	Homo sapiens	Inhibition	%	3.03
	8221701	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.98	CHEMBL3905	Homo sapiens	Inhibition	%	2.98
	8221702	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.09	CHEMBL3905	Homo sapiens	Inhibition	%	2.09
	8222056	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	65.62	CHEMBL3905	Homo sapiens	Inhibition	%	65.62
	8222057	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	60.93	CHEMBL3905	Homo sapiens	Inhibition	%	60.93
	8222154	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.5	CHEMBL3905	Homo sapiens	Inhibition	%	-0.5
	8222155	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.81	CHEMBL3905	Homo sapiens	Inhibition	%	-0.81
	8222378	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	11.29	CHEMBL3905	Homo sapiens	Inhibition	%	11.29
	8222379	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	7.74	CHEMBL3905	Homo sapiens	Inhibition	%	7.74
	8222512	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	8.56	CHEMBL3905	Homo sapiens	Inhibition	%	8.56
	8222513	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.8	CHEMBL3905	Homo sapiens	Inhibition	%	6.8
	8222854	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	88.06	CHEMBL3905	Homo sapiens	Inhibition	%	88.06
	8222855	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	86.29	CHEMBL3905	Homo sapiens	Inhibition	%	86.29
	8222998	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	48.39	CHEMBL3905	Homo sapiens	Inhibition	%	48.39
	8222999	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	43.31	CHEMBL3905	Homo sapiens	Inhibition	%	43.31
	8223222	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	94.8	CHEMBL3905	Homo sapiens	Inhibition	%	94.8
	8223223	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	93.18	CHEMBL3905	Homo sapiens	Inhibition	%	93.18
	8223351	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	5.73	CHEMBL3905	Homo sapiens	Inhibition	%	5.73
	8223352	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.48	CHEMBL3905	Homo sapiens	Inhibition	%	3.48
	8223513	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.34	CHEMBL3905	Homo sapiens	Inhibition	%	7.34
	8223736	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.58	CHEMBL3905	Homo sapiens	Inhibition	%	0.58
	8223737	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.18	CHEMBL3905	Homo sapiens	Inhibition	%	0.18
	8223986	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.65	CHEMBL3905	Homo sapiens	Inhibition	%	6.65
	8223987	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.79	CHEMBL3905	Homo sapiens	Inhibition	%	3.79
	8224148	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.54	CHEMBL3905	Homo sapiens	Inhibition	%	5.54
	8224149	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.61	CHEMBL3905	Homo sapiens	Inhibition	%	7.61
	8224542	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.46	CHEMBL3905	Homo sapiens	Inhibition	%	6.46
	8224543	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.59	CHEMBL3905	Homo sapiens	Inhibition	%	4.59
	8224677	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.54	CHEMBL3905	Homo sapiens	Inhibition	%	5.54
	8224678	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.41	CHEMBL3905	Homo sapiens	Inhibition	%	3.41
	8225015	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.29	CHEMBL3905	Homo sapiens	Inhibition	%	5.29
	8225016	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.46	CHEMBL3905	Homo sapiens	Inhibition	%	3.46
	8225373	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.83	CHEMBL3905	Homo sapiens	Inhibition	%	6.83
	8225374	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.6	CHEMBL3905	Homo sapiens	Inhibition	%	3.6
	8225511	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.63	CHEMBL3905	Homo sapiens	Inhibition	%	4.63
	8225512	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.36	CHEMBL3905	Homo sapiens	Inhibition	%	2.36
	8225870	CHEMBL1962137	GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.65	CHEMBL3905	Homo sapiens	Inhibition	%	8.65
	8225871	CHEMBL1962139	GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.2	CHEMBL3905	Homo sapiens	Inhibition	%	6.2
	8226028	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.67	CHEMBL3905	Homo sapiens	Inhibition	%	1.67
	8226029	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.01	CHEMBL3905	Homo sapiens	Inhibition	%	1.01
	8226377	CHEMBL1962136	GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.62	CHEMBL3905	Homo sapiens	Inhibition	%	3.62
	8226378	CHEMBL1962138	GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.64	CHEMBL3905	Homo sapiens	Inhibition	%	3.64
active	9583047	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
inactive	9583048	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583049	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
active	9583050	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	7.943	CHEMBL3905	Homo sapiens	pKi		8.1
inactive	9583051	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583052	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
active	9583053	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	25.12	CHEMBL3905	Homo sapiens	pKi		7.6
inactive	9583054	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583055	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583056	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583057	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583058	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583059	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583060	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583061	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583062	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583063	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583064	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)c2c(N)noc12		CHEMBL1973178	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9583065	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1988778	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
inactive	9583066	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583067	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583068	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
active	9583069	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9583070	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583071	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583072	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583073	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583074	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583075	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583076	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583077	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583078	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583079	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583080	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	3.162	CHEMBL3905	Homo sapiens	pKi		8.5
inactive	9583081	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583082	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583083	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
active	9583084	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	25.12	CHEMBL3905	Homo sapiens	pKi		7.6
active	9583085	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583086	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583087	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583088	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583089	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583090	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583091	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583092	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583093	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583094	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583095	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
inactive	9583096	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583097	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583098	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583099	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583100	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583101	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583102	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583103	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9583104	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583105	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	1.585	CHEMBL3905	Homo sapiens	pKi		8.8
inactive	9583106	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583107	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9583108	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	10.0	CHEMBL3905	Homo sapiens	pKi		8.0
inactive	9583109	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583110	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9583111	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
inactive	9583112	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583113	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583114	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)c(F)c3)c12		CHEMBL2000652	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9583115	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583116	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9583117	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583118	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	25.12	CHEMBL3905	Homo sapiens	pKi		7.6
active	9583119	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
inactive	9583120	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583121	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583122	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583123	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
active	9583124	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
inactive	9583125	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583126	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583127	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583128	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583129	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583130	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583131	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583132	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	6.31	CHEMBL3905	Homo sapiens	pKi		8.2
inactive	9583133	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583134	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	5.012	CHEMBL3905	Homo sapiens	pKi		8.3
inactive	9583135	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583136	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583137	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583138	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
active	9583139	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	3.981	CHEMBL3905	Homo sapiens	pKi		8.4
inactive	9583140	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583141	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583142	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9583143	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583144	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583145	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583146	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583147	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
inactive	9583148	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583149	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583150	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
inactive	9583151	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583152	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Ki	nM	199.53	CHEMBL3905	Homo sapiens	pKi		6.7
inactive	9583153	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583154	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583155	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583156	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583157	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583158	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583159	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583160	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583161	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583162	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	39.81	CHEMBL3905	Homo sapiens	pKi		7.4
inactive	9583163	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583164	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583165	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583166	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583167	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
active	9583168	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
active	9583169	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
active	9583170	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	6.31	CHEMBL3905	Homo sapiens	pKi		8.2
inactive	9583171	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583172	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583173	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
inactive	9583174	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
active	9583175	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
inactive	9583176	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583177	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583178	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583179	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9583180	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583181	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	50.12	CHEMBL3905	Homo sapiens	pKi		7.3
inactive	9583182	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9583183	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	31.62	CHEMBL3905	Homo sapiens	pKi		7.5
active	9586748	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
active	9586749	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	2.512	CHEMBL3905	Homo sapiens	pKi		8.6
inactive	9586750	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586751	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586752	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586753	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
active	9586754	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
inactive	9586755	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586756	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586757	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586758	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	1995.26	CHEMBL3905	Homo sapiens	pKi		5.7
inactive	9586759	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586760	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
inactive	9586761	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586762	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	2.512	CHEMBL3905	Homo sapiens	pKi		8.6
inactive	9586763	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586764	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586765	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	199.53	CHEMBL3905	Homo sapiens	pKi		6.7
active	9586766	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1993996	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9586767	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586768	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
active	9586769	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
active	9586770	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	12.59	CHEMBL3905	Homo sapiens	pKi		7.9
inactive	9586771	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586772	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586773	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586774	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	6.31	CHEMBL3905	Homo sapiens	pKi		8.2
inactive	9586775	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586776	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586777	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586778	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	6.31	CHEMBL3905	Homo sapiens	pKi		8.2
inactive	9586779	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586780	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586781	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586782	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586783	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586784	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586785	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586786	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
active	9586787	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9586788	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586789	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
inactive	9586790	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586791	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586792	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586793	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586794	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	1.259	CHEMBL3905	Homo sapiens	pKi		8.9
inactive	9586795	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586796	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586797	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586798	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586799	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586800	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586801	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586802	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
active	9586803	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL373798	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
active	9586804	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	19.95	CHEMBL3905	Homo sapiens	pKi		7.7
inactive	9586805	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586806	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586807	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586808	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
inactive	9586809	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586810	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586811	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9586812	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
inactive	9586813	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586814	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586815	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586816	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586817	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586818	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9586819	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586820	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9586821	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
inactive	9586822	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586823	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586824	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586825	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586826	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9586827	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586828	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586829	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
inactive	9586830	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586831	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	3.981	CHEMBL3905	Homo sapiens	pKi		8.4
inactive	9586832	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586833	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586834	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586835	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586836	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586837	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586838	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9586839	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9586840	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9586841	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586842	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586843	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	15.85	CHEMBL3905	Homo sapiens	pKi		7.8
inactive	9586844	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586845	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
inactive	9586846	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586847	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586848	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586849	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)c1		CHEMBL1996255	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
inactive	9586850	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586851	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586852	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586853	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586854	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586855	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586856	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586857	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
active	9586858	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9586859	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
inactive	9586860	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586861	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586862	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586863	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9586864	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586865	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9586866	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586867	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586868	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9586869	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586870	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586871	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586872	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
inactive	9586873	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586874	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586875	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586876	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	199.53	CHEMBL3905	Homo sapiens	pKi		6.7
active	9586877	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586878	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586879	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586880	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586881	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586882	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
active	9586883	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
inactive	9586884	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586885	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586886	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
inactive	9586887	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586888	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4c3c(N)nn4C)cc2)c1		CHEMBL1985491	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586889	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	6.31	CHEMBL3905	Homo sapiens	pKi		8.2
inactive	9586890	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586891	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586892	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586893	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586894	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586895	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586896	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586897	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586898	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9586899	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	6.31	CHEMBL3905	Homo sapiens	pKi		8.2
active	9586900	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9586901	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586902	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586903	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586904	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9586905	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	25.12	CHEMBL3905	Homo sapiens	pKi		7.6
active	9586906	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
inactive	9586907	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586908	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9586909	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
inactive	9586910	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586911	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
inactive	9586912	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586913	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586914	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586915	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	39.81	CHEMBL3905	Homo sapiens	pKi		7.4
active	9586916	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
active	9586917	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	1.995	CHEMBL3905	Homo sapiens	pKi		8.7
active	9586918	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
inactive	9586919	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586920	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586921	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586922	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586923	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586924	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586925	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586926	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586927	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586928	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
inactive	9586929	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586930	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586931	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586932	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586933	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c12		CHEMBL1980904	=	Ki	nM	39.81	CHEMBL3905	Homo sapiens	pKi		7.4
active	9586934	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	25.12	CHEMBL3905	Homo sapiens	pKi		7.6
inactive	9586935	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586936	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
active	9586937	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL271441	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
inactive	9586938	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586939	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586940	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586941	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586942	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	199.53	CHEMBL3905	Homo sapiens	pKi		6.7
inactive	9586943	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586944	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586945	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586946	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586947	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586948	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL273187	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
inactive	9586949	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586950	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	2.512	CHEMBL3905	Homo sapiens	pKi		8.6
inactive	9586951	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586952	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)ccc1F		CHEMBL1986979	=	Ki	nM	199.53	CHEMBL3905	Homo sapiens	pKi		6.7
inactive	9586953	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586954	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586955	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
inactive	9586956	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586957	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586958	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586959	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586960	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586961	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
inactive	9586962	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586963	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586964	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586965	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
inactive	9586966	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586967	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
active	9586968	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9586969	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	12.59	CHEMBL3905	Homo sapiens	pKi		7.9
inactive	9586970	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9586971	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586972	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586973	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	3.981	CHEMBL3905	Homo sapiens	pKi		8.4
inactive	9586974	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586975	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586976	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586977	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586978	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9586979	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9586980	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9586981	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
active	9586982	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	1.995	CHEMBL3905	Homo sapiens	pKi		8.7
inactive	9590549	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590550	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590551	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590552	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590553	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	50.12	CHEMBL3905	Homo sapiens	pKi		7.3
inactive	9590554	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590555	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590556	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590557	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590558	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590559	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9590560	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590561	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	15.85	CHEMBL3905	Homo sapiens	pKi		7.8
inactive	9590562	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590563	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590564	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590565	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590566	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590567	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590568	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
inactive	9590569	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590570	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9590571	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590572	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590573	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590574	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590575	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590576	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590577	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590578	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590579	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590580	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590581	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590582	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590583	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590584	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590585	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590586	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9590587	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590588	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590589	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590590	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590591	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590592	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590593	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590594	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1966836	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
inactive	9590595	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590596	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590597	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
inactive	9590598	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590599	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590600	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590601	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590602	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590603	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590604	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9590605	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	15.85	CHEMBL3905	Homo sapiens	pKi		7.8
active	9590606	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9590607	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
inactive	9590608	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590609	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
active	9590610	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL272938	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
inactive	9590611	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590612	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590613	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9590614	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9590615	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590616	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590617	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590618	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590619	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590620	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590621	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
inactive	9590622	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590623	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	12.59	CHEMBL3905	Homo sapiens	pKi		7.9
active	9590624	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
inactive	9590625	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590626	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590627	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590628	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590629	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	10.0	CHEMBL3905	Homo sapiens	pKi		8.0
inactive	9590630	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590631	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590632	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
active	9590633	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL403402	=	Ki	nM	50.12	CHEMBL3905	Homo sapiens	pKi		7.3
active	9590634	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9590635	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590636	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
active	9590637	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9590638	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590639	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590640	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590641	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
inactive	9590642	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590643	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9590644	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
inactive	9590645	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590646	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590647	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590648	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9590649	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590650	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590651	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590652	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590653	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590654	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590655	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	31.62	CHEMBL3905	Homo sapiens	pKi		7.5
active	9590656	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
inactive	9590657	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590658	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590659	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590660	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
active	9590661	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
inactive	9590662	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590663	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590664	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590665	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590666	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590667	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL273187	=	Ki	nM	63.1	CHEMBL3905	Homo sapiens	pKi		7.2
active	9590668	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	398.11	CHEMBL3905	Homo sapiens	pKi		6.4
inactive	9590669	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590670	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	3.981	CHEMBL3905	Homo sapiens	pKi		8.4
inactive	9590671	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590672	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590673	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
inactive	9590674	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590675	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590676	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	199.53	CHEMBL3905	Homo sapiens	pKi		6.7
inactive	9590677	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590678	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590679	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590680	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590681	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590682	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9590683	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)c1		CHEMBL409349	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
inactive	9590684	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590685	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590686	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9590687	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	79.43	CHEMBL3905	Homo sapiens	pKi		7.1
inactive	9590688	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590689	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590690	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590691	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
inactive	9590692	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590693	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9590694	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590695	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	1.995	CHEMBL3905	Homo sapiens	pKi		8.7
inactive	9590696	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590697	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1994638	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
active	9590698	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1985888	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
inactive	9590699	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590700	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
inactive	9590701	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590702	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590703	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590704	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590705	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590706	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590707	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
active	9590708	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
active	9590709	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	31.62	CHEMBL3905	Homo sapiens	pKi		7.5
inactive	9590710	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590711	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590712	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9590713	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590714	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	=	Ki	nM	251.19	CHEMBL3905	Homo sapiens	pKi		6.6
inactive	9590715	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590716	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590717	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590718	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590719	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590720	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	31.62	CHEMBL3905	Homo sapiens	pKi		7.5
active	9590721	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	10.0	CHEMBL3905	Homo sapiens	pKi		8.0
inactive	9590722	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590723	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	3.981	CHEMBL3905	Homo sapiens	pKi		8.4
active	9590724	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	31.62	CHEMBL3905	Homo sapiens	pKi		7.5
inactive	9590725	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590726	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	1258.93	CHEMBL3905	Homo sapiens	pKi		5.9
inactive	9590727	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590728	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
inactive	9590729	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590730	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590731	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590732	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590733	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590734	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590735	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590736	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590737	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590738	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	10.0	CHEMBL3905	Homo sapiens	pKi		8.0
inactive	9590739	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590740	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590741	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590742	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590743	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	=	Ki	nM	794.33	CHEMBL3905	Homo sapiens	pKi		6.1
active	9590744	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9590745	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590746	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590747	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9590748	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590749	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590750	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590751	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590752	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590753	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	25.12	CHEMBL3905	Homo sapiens	pKi		7.6
active	9590754	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
active	9590755	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
inactive	9590756	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590757	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590758	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590759	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590760	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590761	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590762	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590763	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590764	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	19.95	CHEMBL3905	Homo sapiens	pKi		7.7
inactive	9590765	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590766	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
inactive	9590767	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590768	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	10.0	CHEMBL3905	Homo sapiens	pKi		8.0
inactive	9590769	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590770	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	630.96	CHEMBL3905	Homo sapiens	pKi		6.2
inactive	9590771	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590772	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)c(F)c3)c12		CHEMBL2000652	=	Ki	nM	158.49	CHEMBL3905	Homo sapiens	pKi		6.8
inactive	9590773	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590774	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590775	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590776	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590777	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9590778	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9590779	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	pKi		6.0
active	9590780	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	316.23	CHEMBL3905	Homo sapiens	pKi		6.5
active	9590781	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	=	Ki	nM	6.31	CHEMBL3905	Homo sapiens	pKi		8.2
inactive	9590782	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9590783	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9594351	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9594352	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9594353	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL374044	=	Ki	nM	125.89	CHEMBL3905	Homo sapiens	pKi		6.9
inactive	9594354	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9594355	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cncc21		CHEMBL404366	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
active	9594356	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1.995	CHEMBL3905	Homo sapiens	pKi		8.7
inactive	9594357	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
inactive	9594358	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9594359	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	501.19	CHEMBL3905	Homo sapiens	pKi		6.3
inactive	9594360	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1584.89	CHEMBL3905	Homo sapiens	pKi		5.8
active	9594361	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	100.0	CHEMBL3905	Homo sapiens	pKi		7.0
active	9594362	CHEMBL1963745	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: LYN	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	199.53	CHEMBL3905	Homo sapiens	pKi		6.7
	10838613	CHEMBL2014453	Inhibition of LYNa at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	10838614	CHEMBL2014454	Inhibition of LYNb at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	10850691	CHEMBL2019864	Inhibition of human Lyn at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	10850694	CHEMBL2019867	Inhibition of human Lyn	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	=	IC50	nM	352.0	CHEMBL3905	Homo sapiens	IC50	nM	352.0
	10867529	CHEMBL2027419	Inhibition of Lyn at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	10923951	CHEMBL2044290	Inhibition of LYN incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	IC50	nM	1360.0	CHEMBL3905	Homo sapiens	IC50	uM	1.36
	10923972	CHEMBL2044289	Inhibition of LYN at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	43.0	CHEMBL3905	Homo sapiens	INH	%	43.0
	10926100	CHEMBL2046129	Inhibition of human Lyn assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	101.0	CHEMBL3905	Homo sapiens	Activity	%	101.0
	10926101	CHEMBL2046129	Inhibition of human Lyn assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	98.0	CHEMBL3905	Homo sapiens	Activity	%	98.0
	10941279	CHEMBL2049847	Inhibition of LYN	B	CC(C)C[C@H]1CN(c2ccc(C(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046643	>	IC50	nM	2000.0	CHEMBL3905	Homo sapiens	IC50	uM	2.0
	10949779	CHEMBL2050663	Inhibition of Lyn A using ATP preincubated with compound for 5 mins measured after 10 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	=	IC50	nM	7100.0	CHEMBL3905	Homo sapiens	IC50	nM	7100.0
	10949782	CHEMBL2050660	Inhibition of Lyn B using ATP preincubated with compound for 5 mins measured after 10 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	=	IC50	nM	3000.0	CHEMBL3905	Homo sapiens	IC50	nM	3000.0
	10952738	CHEMBL2060645	Inhibition of LYN	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	IC50	nM	624.0	CHEMBL3905	Homo sapiens	IC50	nM	624.0
	10962873	CHEMBL2060387	Inhibition of LYN assessed as remaining enzyme activity at 10 uM	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	Activity	%	0.0	CHEMBL3905	Homo sapiens	Activity	%	0.0
	10984771	CHEMBL2072067	Inhibition of human Lyn at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	>	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	12036417	CHEMBL2150253	Inhibition of LYN B after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	=	IC50	nM	3300.0	CHEMBL3905	Homo sapiens	IC50	nM	3300.0
	12036418	CHEMBL2150254	Inhibition of LYN A after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	=	IC50	nM	3600.0	CHEMBL3905	Homo sapiens	IC50	nM	3600.0
	12046349	CHEMBL2157161	Inhibition of Lyn at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-0.5	CHEMBL3905	Homo sapiens	INH	%	-0.5
	12046350	CHEMBL2157162	Inhibition of LynB at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-2.7	CHEMBL3905	Homo sapiens	INH	%	-2.7
	12074642	CHEMBL2161204	Inhibition of Lyn A at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	12074643	CHEMBL2161205	Inhibition of Lyn B at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	12108551	CHEMBL2173385	Inhibition of Lyn	B	CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4c(c3)NC(=O)C(F)(F)O4)n2)c1		CHEMBL2170582	=	Ki	nM	30.0	CHEMBL3905	Homo sapiens	Ki	nM	30.0
	12166117	CHEMBL2211590	Binding affinity to LYN at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL3905	Homo sapiens	Activity	%	50.0
	12172374	CHEMBL2210639	Inhibition of LYN assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	73.0	CHEMBL3905	Homo sapiens	Activity	%	73.0
	12183869	CHEMBL2211519	Inhibition of LYN	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	pIC50		5.0
	12195497	CHEMBL2210055	Inhibition of recombinant LYN after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	>	Ki	nM	1600.0	CHEMBL3905	Homo sapiens	Ki	nM	1600.0
	12234579	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	73.0	CHEMBL3905	Homo sapiens	Residual Activity	%	73.0
	12234580	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	82.0	CHEMBL3905	Homo sapiens	Residual Activity	%	82.0
	12234581	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	62.0	CHEMBL3905	Homo sapiens	Residual Activity	%	62.0
	12234582	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	89.0	CHEMBL3905	Homo sapiens	Residual Activity	%	89.0
	12234583	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12234584	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	95.0	CHEMBL3905	Homo sapiens	Residual Activity	%	95.0
	12234585	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12234586	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12234587	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	91.0	CHEMBL3905	Homo sapiens	Residual Activity	%	91.0
	12234588	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	8.0	CHEMBL3905	Homo sapiens	Residual Activity	%	8.0
	12234589	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	78.0	CHEMBL3905	Homo sapiens	Residual Activity	%	78.0
	12234590	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	95.0	CHEMBL3905	Homo sapiens	Residual Activity	%	95.0
	12234591	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	28.0	CHEMBL3905	Homo sapiens	Residual Activity	%	28.0
	12234592	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12234593	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	27.0	CHEMBL3905	Homo sapiens	Residual Activity	%	27.0
	12234594	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	50.0	CHEMBL3905	Homo sapiens	Residual Activity	%	50.0
	12234595	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	73.0	CHEMBL3905	Homo sapiens	Residual Activity	%	73.0
	12234596	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	83.0	CHEMBL3905	Homo sapiens	Residual Activity	%	83.0
	12234597	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	69.0	CHEMBL3905	Homo sapiens	Residual Activity	%	69.0
	12234598	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	65.0	CHEMBL3905	Homo sapiens	Residual Activity	%	65.0
	12234599	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	61.0	CHEMBL3905	Homo sapiens	Residual Activity	%	61.0
	12234600	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	35.0	CHEMBL3905	Homo sapiens	Residual Activity	%	35.0
	12234601	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL3905	Homo sapiens	Residual Activity	%	90.0
	12234602	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	30.0	CHEMBL3905	Homo sapiens	Residual Activity	%	30.0
	12234603	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	77.0	CHEMBL3905	Homo sapiens	Residual Activity	%	77.0
	12234604	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	3.0	CHEMBL3905	Homo sapiens	Residual Activity	%	3.0
	12234605	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234606	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	7.0	CHEMBL3905	Homo sapiens	Residual Activity	%	7.0
	12234607	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL3905	Homo sapiens	Residual Activity	%	98.0
	12234608	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	86.0	CHEMBL3905	Homo sapiens	Residual Activity	%	86.0
	12234609	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	90.0	CHEMBL3905	Homo sapiens	Residual Activity	%	90.0
	12234610	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	-1.0
	12234611	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL3905	Homo sapiens	Residual Activity	%	96.0
	12234612	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	103.0	CHEMBL3905	Homo sapiens	Residual Activity	%	103.0
	12234613	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	104.0	CHEMBL3905	Homo sapiens	Residual Activity	%	104.0
	12234614	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	99.0	CHEMBL3905	Homo sapiens	Residual Activity	%	99.0
	12234615	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234616	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	86.0	CHEMBL3905	Homo sapiens	Residual Activity	%	86.0
	12234617	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	91.0	CHEMBL3905	Homo sapiens	Residual Activity	%	91.0
	12234618	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	21.0	CHEMBL3905	Homo sapiens	Residual Activity	%	21.0
	12234619	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	102.0	CHEMBL3905	Homo sapiens	Residual Activity	%	102.0
	12234620	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	105.0	CHEMBL3905	Homo sapiens	Residual Activity	%	105.0
	12234621	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	21.0	CHEMBL3905	Homo sapiens	Residual Activity	%	21.0
	12234622	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12234623	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12234624	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	105.0	CHEMBL3905	Homo sapiens	Residual Activity	%	105.0
	12234625	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	93.0	CHEMBL3905	Homo sapiens	Residual Activity	%	93.0
	12234626	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	46.0	CHEMBL3905	Homo sapiens	Residual Activity	%	46.0
	12234627	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	84.0	CHEMBL3905	Homo sapiens	Residual Activity	%	84.0
	12234628	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	99.0	CHEMBL3905	Homo sapiens	Residual Activity	%	99.0
	12234629	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	63.0	CHEMBL3905	Homo sapiens	Residual Activity	%	63.0
	12234630	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12234631	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	46.0	CHEMBL3905	Homo sapiens	Residual Activity	%	46.0
	12234632	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL3905	Homo sapiens	Residual Activity	%	82.0
	12234633	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	94.0	CHEMBL3905	Homo sapiens	Residual Activity	%	94.0
	12234634	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	98.0	CHEMBL3905	Homo sapiens	Residual Activity	%	98.0
	12234635	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	32.0	CHEMBL3905	Homo sapiens	Residual Activity	%	32.0
	12234636	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	83.0	CHEMBL3905	Homo sapiens	Residual Activity	%	83.0
	12234637	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	68.0	CHEMBL3905	Homo sapiens	Residual Activity	%	68.0
	12234638	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	95.0	CHEMBL3905	Homo sapiens	Residual Activity	%	95.0
	12234639	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	81.0	CHEMBL3905	Homo sapiens	Residual Activity	%	81.0
	12234640	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234641	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	93.0	CHEMBL3905	Homo sapiens	Residual Activity	%	93.0
	12234642	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	85.0	CHEMBL3905	Homo sapiens	Residual Activity	%	85.0
	12234643	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	97.0	CHEMBL3905	Homo sapiens	Residual Activity	%	97.0
	12234644	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	86.0	CHEMBL3905	Homo sapiens	Residual Activity	%	86.0
	12234645	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	85.0	CHEMBL3905	Homo sapiens	Residual Activity	%	85.0
	12234646	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	107.0	CHEMBL3905	Homo sapiens	Residual Activity	%	107.0
	12234647	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	99.0	CHEMBL3905	Homo sapiens	Residual Activity	%	99.0
	12234648	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12234649	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	74.0	CHEMBL3905	Homo sapiens	Residual Activity	%	74.0
	12234650	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	41.0	CHEMBL3905	Homo sapiens	Residual Activity	%	41.0
	12234651	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	79.0	CHEMBL3905	Homo sapiens	Residual Activity	%	79.0
	12234652	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	21.0	CHEMBL3905	Homo sapiens	Residual Activity	%	21.0
	12234653	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	29.0	CHEMBL3905	Homo sapiens	Residual Activity	%	29.0
	12234654	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	23.0	CHEMBL3905	Homo sapiens	Residual Activity	%	23.0
	12234655	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	100.0	CHEMBL3905	Homo sapiens	Residual Activity	%	100.0
	12234656	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12234657	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	67.0	CHEMBL3905	Homo sapiens	Residual Activity	%	67.0
	12234658	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12234659	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	78.0	CHEMBL3905	Homo sapiens	Residual Activity	%	78.0
	12234660	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	40.0	CHEMBL3905	Homo sapiens	Residual Activity	%	40.0
	12234661	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	72.0	CHEMBL3905	Homo sapiens	Residual Activity	%	72.0
	12234662	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	99.0	CHEMBL3905	Homo sapiens	Residual Activity	%	99.0
	12234663	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	3.0	CHEMBL3905	Homo sapiens	Residual Activity	%	3.0
	12234664	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	97.0	CHEMBL3905	Homo sapiens	Residual Activity	%	97.0
	12234665	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	52.0	CHEMBL3905	Homo sapiens	Residual Activity	%	52.0
	12234666	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	47.0	CHEMBL3905	Homo sapiens	Residual Activity	%	47.0
	12234667	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL3905	Homo sapiens	Residual Activity	%	92.0
	12234668	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	8.0	CHEMBL3905	Homo sapiens	Residual Activity	%	8.0
	12234669	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	80.0	CHEMBL3905	Homo sapiens	Residual Activity	%	80.0
	12234670	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	66.0	CHEMBL3905	Homo sapiens	Residual Activity	%	66.0
	12234671	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	9.0	CHEMBL3905	Homo sapiens	Residual Activity	%	9.0
	12234672	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	69.0	CHEMBL3905	Homo sapiens	Residual Activity	%	69.0
	12234673	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	75.0	CHEMBL3905	Homo sapiens	Residual Activity	%	75.0
	12234674	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	83.0	CHEMBL3905	Homo sapiens	Residual Activity	%	83.0
	12234675	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	89.0	CHEMBL3905	Homo sapiens	Residual Activity	%	89.0
	12234676	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	92.0	CHEMBL3905	Homo sapiens	Residual Activity	%	92.0
	12234677	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	80.0	CHEMBL3905	Homo sapiens	Residual Activity	%	80.0
	12234678	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	71.0	CHEMBL3905	Homo sapiens	Residual Activity	%	71.0
	12234679	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	57.0	CHEMBL3905	Homo sapiens	Residual Activity	%	57.0
	12234680	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL3905	Homo sapiens	Residual Activity	%	3.0
	12234681	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	93.0	CHEMBL3905	Homo sapiens	Residual Activity	%	93.0
	12234682	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12234683	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234684	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	53.0	CHEMBL3905	Homo sapiens	Residual Activity	%	53.0
	12234685	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	49.0	CHEMBL3905	Homo sapiens	Residual Activity	%	49.0
	12234686	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	88.0	CHEMBL3905	Homo sapiens	Residual Activity	%	88.0
	12234687	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	93.0	CHEMBL3905	Homo sapiens	Residual Activity	%	93.0
	12234688	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12234689	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	75.0	CHEMBL3905	Homo sapiens	Residual Activity	%	75.0
	12234690	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12234691	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	5.0	CHEMBL3905	Homo sapiens	Residual Activity	%	5.0
	12234692	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	89.0	CHEMBL3905	Homo sapiens	Residual Activity	%	89.0
	12234693	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	91.0	CHEMBL3905	Homo sapiens	Residual Activity	%	91.0
	12234694	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	82.0	CHEMBL3905	Homo sapiens	Residual Activity	%	82.0
	12234695	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	16.0	CHEMBL3905	Homo sapiens	Residual Activity	%	16.0
	12234696	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL3905	Homo sapiens	Residual Activity	%	97.0
	12234697	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	50.0	CHEMBL3905	Homo sapiens	Residual Activity	%	50.0
	12234698	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	98.0	CHEMBL3905	Homo sapiens	Residual Activity	%	98.0
	12234699	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	50.0	CHEMBL3905	Homo sapiens	Residual Activity	%	50.0
	12234700	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234701	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	20.0	CHEMBL3905	Homo sapiens	Residual Activity	%	20.0
	12234702	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	63.0	CHEMBL3905	Homo sapiens	Residual Activity	%	63.0
	12234703	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	4.0	CHEMBL3905	Homo sapiens	Residual Activity	%	4.0
	12234704	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	93.0	CHEMBL3905	Homo sapiens	Residual Activity	%	93.0
	12234705	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	11.0	CHEMBL3905	Homo sapiens	Residual Activity	%	11.0
	12234706	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	84.0	CHEMBL3905	Homo sapiens	Residual Activity	%	84.0
	12234707	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	37.0	CHEMBL3905	Homo sapiens	Residual Activity	%	37.0
	12234708	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234709	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	74.0	CHEMBL3905	Homo sapiens	Residual Activity	%	74.0
	12234710	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12234711	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	70.0	CHEMBL3905	Homo sapiens	Residual Activity	%	70.0
	12234712	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	87.0	CHEMBL3905	Homo sapiens	Residual Activity	%	87.0
	12234713	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12234714	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	9.0	CHEMBL3905	Homo sapiens	Residual Activity	%	9.0
	12234715	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	75.0	CHEMBL3905	Homo sapiens	Residual Activity	%	75.0
	12234716	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	20.0	CHEMBL3905	Homo sapiens	Residual Activity	%	20.0
	12234717	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	4.0	CHEMBL3905	Homo sapiens	Residual Activity	%	4.0
	12234718	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	89.0	CHEMBL3905	Homo sapiens	Residual Activity	%	89.0
	12234719	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	65.0	CHEMBL3905	Homo sapiens	Residual Activity	%	65.0
	12234720	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	86.0	CHEMBL3905	Homo sapiens	Residual Activity	%	86.0
	12234721	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	96.0	CHEMBL3905	Homo sapiens	Residual Activity	%	96.0
	12234722	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	14.0	CHEMBL3905	Homo sapiens	Residual Activity	%	14.0
	12234723	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	83.0	CHEMBL3905	Homo sapiens	Residual Activity	%	83.0
	12234724	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	81.0	CHEMBL3905	Homo sapiens	Residual Activity	%	81.0
	12234725	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	12.0	CHEMBL3905	Homo sapiens	Residual Activity	%	12.0
	12234726	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	65.0	CHEMBL3905	Homo sapiens	Residual Activity	%	65.0
	12234727	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	19.0	CHEMBL3905	Homo sapiens	Residual Activity	%	19.0
	12234728	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	86.0	CHEMBL3905	Homo sapiens	Residual Activity	%	86.0
	12234729	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	72.0	CHEMBL3905	Homo sapiens	Residual Activity	%	72.0
	12234730	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	70.0	CHEMBL3905	Homo sapiens	Residual Activity	%	70.0
	12234731	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	79.0	CHEMBL3905	Homo sapiens	Residual Activity	%	79.0
	12234732	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	78.0	CHEMBL3905	Homo sapiens	Residual Activity	%	78.0
	12234733	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	90.0	CHEMBL3905	Homo sapiens	Residual Activity	%	90.0
	12234734	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	24.0	CHEMBL3905	Homo sapiens	Residual Activity	%	24.0
	12234735	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	66.0	CHEMBL3905	Homo sapiens	Residual Activity	%	66.0
	12234736	CHEMBL2219249	Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234737	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	13.0	CHEMBL3905	Homo sapiens	Residual Activity	%	13.0
	12234738	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	32.0	CHEMBL3905	Homo sapiens	Residual Activity	%	32.0
	12234739	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	18.0	CHEMBL3905	Homo sapiens	Residual Activity	%	18.0
	12234740	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	87.0	CHEMBL3905	Homo sapiens	Residual Activity	%	87.0
	12234741	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	5.0	CHEMBL3905	Homo sapiens	Residual Activity	%	5.0
	12234742	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	82.0	CHEMBL3905	Homo sapiens	Residual Activity	%	82.0
	12234743	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12234744	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12234745	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	32.0	CHEMBL3905	Homo sapiens	Residual Activity	%	32.0
	12234746	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12234747	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	51.0	CHEMBL3905	Homo sapiens	Residual Activity	%	51.0
	12234748	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	87.0	CHEMBL3905	Homo sapiens	Residual Activity	%	87.0
	12234749	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	5.0	CHEMBL3905	Homo sapiens	Residual Activity	%	5.0
	12234750	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12234751	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	3.0	CHEMBL3905	Homo sapiens	Residual Activity	%	3.0
	12234752	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	26.0	CHEMBL3905	Homo sapiens	Residual Activity	%	26.0
	12234753	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	73.0	CHEMBL3905	Homo sapiens	Residual Activity	%	73.0
	12234754	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	65.0	CHEMBL3905	Homo sapiens	Residual Activity	%	65.0
	12234755	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	46.0	CHEMBL3905	Homo sapiens	Residual Activity	%	46.0
	12234756	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	20.0	CHEMBL3905	Homo sapiens	Residual Activity	%	20.0
	12234757	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	31.0	CHEMBL3905	Homo sapiens	Residual Activity	%	31.0
	12234758	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	7.0	CHEMBL3905	Homo sapiens	Residual Activity	%	7.0
	12234759	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	73.0	CHEMBL3905	Homo sapiens	Residual Activity	%	73.0
	12234760	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12234761	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	69.0	CHEMBL3905	Homo sapiens	Residual Activity	%	69.0
	12234762	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12234763	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	-1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	-1.0
	12234764	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	-2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	-2.0
	12234765	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	100.0	CHEMBL3905	Homo sapiens	Residual Activity	%	100.0
	12234766	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	39.0	CHEMBL3905	Homo sapiens	Residual Activity	%	39.0
	12234767	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	24.0	CHEMBL3905	Homo sapiens	Residual Activity	%	24.0
	12234768	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12234769	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	53.0	CHEMBL3905	Homo sapiens	Residual Activity	%	53.0
	12234770	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	90.0	CHEMBL3905	Homo sapiens	Residual Activity	%	90.0
	12234771	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	83.0	CHEMBL3905	Homo sapiens	Residual Activity	%	83.0
	12234772	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	90.0	CHEMBL3905	Homo sapiens	Residual Activity	%	90.0
	12234773	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12234774	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	131.0	CHEMBL3905	Homo sapiens	Residual Activity	%	131.0
	12234775	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	76.0	CHEMBL3905	Homo sapiens	Residual Activity	%	76.0
	12234776	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	22.0	CHEMBL3905	Homo sapiens	Residual Activity	%	22.0
	12234777	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	67.0	CHEMBL3905	Homo sapiens	Residual Activity	%	67.0
	12234778	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	98.0	CHEMBL3905	Homo sapiens	Residual Activity	%	98.0
	12234779	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	9.0	CHEMBL3905	Homo sapiens	Residual Activity	%	9.0
	12234780	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL3905	Homo sapiens	Residual Activity	%	4.0
	12234781	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12234782	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	91.0	CHEMBL3905	Homo sapiens	Residual Activity	%	91.0
	12234783	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	94.0	CHEMBL3905	Homo sapiens	Residual Activity	%	94.0
	12234784	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	8.0	CHEMBL3905	Homo sapiens	Residual Activity	%	8.0
	12234785	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	64.0	CHEMBL3905	Homo sapiens	Residual Activity	%	64.0
	12237394	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	57.0	CHEMBL3905	Homo sapiens	Residual Activity	%	57.0
	12237395	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	13.0	CHEMBL3905	Homo sapiens	Residual Activity	%	13.0
	12237396	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237397	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12237398	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	46.0	CHEMBL3905	Homo sapiens	Residual Activity	%	46.0
	12237399	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	70.0	CHEMBL3905	Homo sapiens	Residual Activity	%	70.0
	12237400	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL3905	Homo sapiens	Residual Activity	%	95.0
	12237401	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12237402	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	46.0	CHEMBL3905	Homo sapiens	Residual Activity	%	46.0
	12237403	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	30.0	CHEMBL3905	Homo sapiens	Residual Activity	%	30.0
	12237404	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	74.0	CHEMBL3905	Homo sapiens	Residual Activity	%	74.0
	12237405	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	23.0	CHEMBL3905	Homo sapiens	Residual Activity	%	23.0
	12237406	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12237407	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	70.0	CHEMBL3905	Homo sapiens	Residual Activity	%	70.0
	12237408	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	72.0	CHEMBL3905	Homo sapiens	Residual Activity	%	72.0
	12237409	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	82.0	CHEMBL3905	Homo sapiens	Residual Activity	%	82.0
	12237410	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	63.0	CHEMBL3905	Homo sapiens	Residual Activity	%	63.0
	12237411	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	57.0	CHEMBL3905	Homo sapiens	Residual Activity	%	57.0
	12237412	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	71.0	CHEMBL3905	Homo sapiens	Residual Activity	%	71.0
	12237413	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	89.0	CHEMBL3905	Homo sapiens	Residual Activity	%	89.0
	12237414	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237415	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	75.0	CHEMBL3905	Homo sapiens	Residual Activity	%	75.0
	12237416	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12237417	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	22.0	CHEMBL3905	Homo sapiens	Residual Activity	%	22.0
	12237418	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	9.0	CHEMBL3905	Homo sapiens	Residual Activity	%	9.0
	12237419	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	4.0	CHEMBL3905	Homo sapiens	Residual Activity	%	4.0
	12237420	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12237421	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	65.0	CHEMBL3905	Homo sapiens	Residual Activity	%	65.0
	12237422	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	3.0	CHEMBL3905	Homo sapiens	Residual Activity	%	3.0
	12237423	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	58.0	CHEMBL3905	Homo sapiens	Residual Activity	%	58.0
	12237424	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	-1.0
	12237425	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	59.0	CHEMBL3905	Homo sapiens	Residual Activity	%	59.0
	12237426	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	11.0	CHEMBL3905	Homo sapiens	Residual Activity	%	11.0
	12237427	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	69.0	CHEMBL3905	Homo sapiens	Residual Activity	%	69.0
	12237428	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	100.0	CHEMBL3905	Homo sapiens	Residual Activity	%	100.0
	12237429	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12237430	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	85.0	CHEMBL3905	Homo sapiens	Residual Activity	%	85.0
	12237431	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	29.0	CHEMBL3905	Homo sapiens	Residual Activity	%	29.0
	12237432	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	13.0	CHEMBL3905	Homo sapiens	Residual Activity	%	13.0
	12237433	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	86.0	CHEMBL3905	Homo sapiens	Residual Activity	%	86.0
	12237434	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12237435	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	84.0	CHEMBL3905	Homo sapiens	Residual Activity	%	84.0
	12237436	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	33.0	CHEMBL3905	Homo sapiens	Residual Activity	%	33.0
	12237437	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	4.0	CHEMBL3905	Homo sapiens	Residual Activity	%	4.0
	12237438	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	59.0	CHEMBL3905	Homo sapiens	Residual Activity	%	59.0
	12237439	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	38.0	CHEMBL3905	Homo sapiens	Residual Activity	%	38.0
	12237440	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	73.0	CHEMBL3905	Homo sapiens	Residual Activity	%	73.0
	12237441	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	66.0	CHEMBL3905	Homo sapiens	Residual Activity	%	66.0
	12237442	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	94.0	CHEMBL3905	Homo sapiens	Residual Activity	%	94.0
	12237443	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	71.0	CHEMBL3905	Homo sapiens	Residual Activity	%	71.0
	12237444	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	68.0	CHEMBL3905	Homo sapiens	Residual Activity	%	68.0
	12237445	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	19.0	CHEMBL3905	Homo sapiens	Residual Activity	%	19.0
	12237446	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12237447	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	80.0	CHEMBL3905	Homo sapiens	Residual Activity	%	80.0
	12237448	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	10.0	CHEMBL3905	Homo sapiens	Residual Activity	%	10.0
	12237449	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	5.0	CHEMBL3905	Homo sapiens	Residual Activity	%	5.0
	12237450	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	38.0	CHEMBL3905	Homo sapiens	Residual Activity	%	38.0
	12237451	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	37.0	CHEMBL3905	Homo sapiens	Residual Activity	%	37.0
	12237452	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	65.0	CHEMBL3905	Homo sapiens	Residual Activity	%	65.0
	12237453	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	61.0	CHEMBL3905	Homo sapiens	Residual Activity	%	61.0
	12237454	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237455	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	23.0	CHEMBL3905	Homo sapiens	Residual Activity	%	23.0
	12237456	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12237457	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12237458	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	62.0	CHEMBL3905	Homo sapiens	Residual Activity	%	62.0
	12237459	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	88.0	CHEMBL3905	Homo sapiens	Residual Activity	%	88.0
	12237460	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL3905	Homo sapiens	Residual Activity	%	92.0
	12237461	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237462	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	65.0	CHEMBL3905	Homo sapiens	Residual Activity	%	65.0
	12237463	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	6.0	CHEMBL3905	Homo sapiens	Residual Activity	%	6.0
	12237464	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	74.0	CHEMBL3905	Homo sapiens	Residual Activity	%	74.0
	12237465	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	14.0	CHEMBL3905	Homo sapiens	Residual Activity	%	14.0
	12237466	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237467	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12237468	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	47.0	CHEMBL3905	Homo sapiens	Residual Activity	%	47.0
	12237469	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	-1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	-1.0
	12237470	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	81.0	CHEMBL3905	Homo sapiens	Residual Activity	%	81.0
	12237471	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	0.0	CHEMBL3905	Homo sapiens	Residual Activity	%	0.0
	12237472	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	56.0	CHEMBL3905	Homo sapiens	Residual Activity	%	56.0
	12237473	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	11.0	CHEMBL3905	Homo sapiens	Residual Activity	%	11.0
	12237474	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237475	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	78.0	CHEMBL3905	Homo sapiens	Residual Activity	%	78.0
	12237476	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237477	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	30.0	CHEMBL3905	Homo sapiens	Residual Activity	%	30.0
	12237478	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	84.0	CHEMBL3905	Homo sapiens	Residual Activity	%	84.0
	12237479	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	-1.0
	12237480	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	-1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	-1.0
	12237481	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	67.0	CHEMBL3905	Homo sapiens	Residual Activity	%	67.0
	12237482	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237483	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12237484	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	50.0	CHEMBL3905	Homo sapiens	Residual Activity	%	50.0
	12237485	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	67.0	CHEMBL3905	Homo sapiens	Residual Activity	%	67.0
	12237486	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	49.0	CHEMBL3905	Homo sapiens	Residual Activity	%	49.0
	12237487	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	87.0	CHEMBL3905	Homo sapiens	Residual Activity	%	87.0
	12237488	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	2.0	CHEMBL3905	Homo sapiens	Residual Activity	%	2.0
	12237489	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL3905	Homo sapiens	Residual Activity	%	96.0
	12237490	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	36.0	CHEMBL3905	Homo sapiens	Residual Activity	%	36.0
	12237491	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	4.0	CHEMBL3905	Homo sapiens	Residual Activity	%	4.0
	12237492	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	15.0	CHEMBL3905	Homo sapiens	Residual Activity	%	15.0
	12237493	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	3.0	CHEMBL3905	Homo sapiens	Residual Activity	%	3.0
	12237494	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	95.0	CHEMBL3905	Homo sapiens	Residual Activity	%	95.0
	12237495	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	17.0	CHEMBL3905	Homo sapiens	Residual Activity	%	17.0
	12237496	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	63.0	CHEMBL3905	Homo sapiens	Residual Activity	%	63.0
	12237497	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	66.0	CHEMBL3905	Homo sapiens	Residual Activity	%	66.0
	12237498	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	70.0	CHEMBL3905	Homo sapiens	Residual Activity	%	70.0
	12237499	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	62.0	CHEMBL3905	Homo sapiens	Residual Activity	%	62.0
	12237500	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	11.0	CHEMBL3905	Homo sapiens	Residual Activity	%	11.0
	12237501	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	11.0	CHEMBL3905	Homo sapiens	Residual Activity	%	11.0
	12237502	CHEMBL2219250	Millipore: Percentage of residual kinase activity of LYN at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	1.0	CHEMBL3905	Homo sapiens	Residual Activity	%	1.0
	12617271	CHEMBL2319228	Inhibition of human LYN using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL2311806	=	IC50	nM	3534.0	CHEMBL3905	Homo sapiens	IC50	nM	3534.0
	12617290	CHEMBL2319228	Inhibition of human LYN using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311807	=	IC50	nM	15150.0	CHEMBL3905	Homo sapiens	IC50	nM	15150.0
	12617309	CHEMBL2319228	Inhibition of human LYN using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311808	=	IC50	nM	45420.0	CHEMBL3905	Homo sapiens	IC50	nM	45420.0
	12617328	CHEMBL2319228	Inhibition of human LYN using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	1281.0	CHEMBL3905	Homo sapiens	IC50	nM	1281.0
	12626691	CHEMBL2316969	Inhibition of LYN (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	INH	%	80.0
	12647927	CHEMBL2329183	Inhibition of LYN (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	57.0	CHEMBL3905	Homo sapiens	INH	%	57.0
	12647928	CHEMBL2329183	Inhibition of LYN (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	31.0	CHEMBL3905	Homo sapiens	INH	%	31.0
	12647929	CHEMBL2329183	Inhibition of LYN (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	12647930	CHEMBL2329183	Inhibition of LYN (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	32.0	CHEMBL3905	Homo sapiens	INH	%	32.0
	12649606	CHEMBL2329535	Inhibition of LYN (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	91.0	CHEMBL3905	Homo sapiens	INH	%	91.0
	12649607	CHEMBL2329535	Inhibition of LYN (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	59.0	CHEMBL3905	Homo sapiens	INH	%	59.0
	12649608	CHEMBL2329535	Inhibition of LYN (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	63.0	CHEMBL3905	Homo sapiens	INH	%	63.0
	12660157	CHEMBL2329209	Inhibition of LYNB (unknown origin) at 1 uM	B	COc1cc(Oc2ccccc2)ccc1-c1nc([C@H]2C[C@@](C)(O)C2)n2ccnc(N)c12		CHEMBL2325940	>	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	INH	%	80.0
	12662207	CHEMBL2330904	Inhibition of Lyn (unknown origin)	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1		CHEMBL2326002	>	Ki	nM	1000.0	CHEMBL3905	Homo sapiens	Ki	nM	1000.0
	12693217	CHEMBL2343901	Inhibition of LYN (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	12718794	CHEMBL2350678	Inhibition of LYNA (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	4.0	CHEMBL3905	Homo sapiens	IC50	nM	4.0
	12718816	CHEMBL2350701	Inhibition of LYNA (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	25.0	CHEMBL3905	Homo sapiens	INH	%	25.0
	12718839	CHEMBL2350992	Inhibition of LYN-A (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	12728089	CHEMBL2351303	Inhibition of LYNA (unknown origin) incubated for 5 mins prior to ATP addition measured after 10 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	=	IC50	nM	9800.0	CHEMBL3905	Homo sapiens	IC50	nM	9800.0
	12728092	CHEMBL2351307	Inhibition of LYNB (unknown origin) incubated for 5 mins prior to ATP addition measured after 10 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	=	IC50	nM	3000.0	CHEMBL3905	Homo sapiens	IC50	nM	3000.0
	12728790	CHEMBL2351180	Inhibition of LYNB (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	91.0	CHEMBL3905	Homo sapiens	Activity	%	91.0
	12728791	CHEMBL2351181	Inhibition of LYNA (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	93.0	CHEMBL3905	Homo sapiens	Activity	%	93.0
	12729034	CHEMBL2351940	Inhibition of LYNB (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL3905	Homo sapiens	Activity	%	96.0
	12729035	CHEMBL2351941	Inhibition of LYNA (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL3905	Homo sapiens	Activity	%	98.0
	12729914	CHEMBL2350059	Inhibition of LYN-B (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	78.0	CHEMBL3905	Homo sapiens	Activity	%	78.0
	12729915	CHEMBL2350061	Inhibition of LYN (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	78.0	CHEMBL3905	Homo sapiens	Activity	%	78.0
	12730177	CHEMBL2351180	Inhibition of LYNB (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	87.0	CHEMBL3905	Homo sapiens	Activity	%	87.0
	12730178	CHEMBL2351181	Inhibition of LYNA (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	102.0	CHEMBL3905	Homo sapiens	Activity	%	102.0
	13281371	CHEMBL2378437	Inhibition of LYN (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	42.0	CHEMBL3905	Homo sapiens	INH	%	42.0
	13281372	CHEMBL2378437	Inhibition of LYN (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	74.0	CHEMBL3905	Homo sapiens	INH	%	74.0
	13281373	CHEMBL2378437	Inhibition of LYN (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	79.0	CHEMBL3905	Homo sapiens	INH	%	79.0
	13281374	CHEMBL2378437	Inhibition of LYN (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	13281375	CHEMBL2378437	Inhibition of LYN (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	-6.0	CHEMBL3905	Homo sapiens	INH	%	-6.0
	13281376	CHEMBL2378437	Inhibition of LYN (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	93.0	CHEMBL3905	Homo sapiens	INH	%	93.0
	13365832	CHEMBL2405541	Inhibition of TEL-fused LYN (unknown origin) by cell-based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2306.0	CHEMBL3905	Homo sapiens	IC50	nM	2306.0
	13367214	CHEMBL2406330	Inhibition of LYN (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	840.0	CHEMBL3905	Homo sapiens	IC50	uM	0.84
	13375817	CHEMBL2404330	Inhibition of LYNB (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	13375818	CHEMBL2404329	Inhibition of LYNA (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	13415143	CHEMBL2423378	Inhibition of LYN (unknown origin) at 1 uM	B	Cn1cc(-c2ccncc2)c(-c2ccc(F)cc2)n1		CHEMBL2420700	=	Inhibition	%	70.5	CHEMBL3905	Homo sapiens	INH	%	70.5
	13419786	CHEMBL2424115	Inhibition of LYN (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	14000.0	CHEMBL3905	Homo sapiens	IC50	uM	14.0
	13419787	CHEMBL2424115	Inhibition of LYN (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1	Outside typical range	CHEMBL2420909	=	IC50	nM	178000.0	CHEMBL3905	Homo sapiens	IC50	uM	178.0
	13421183	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13421184	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	17.0	CHEMBL3905	Homo sapiens	INH	%	17.0
	13421185	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	14.0	CHEMBL3905	Homo sapiens	INH	%	14.0
	13421186	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	26.0	CHEMBL3905	Homo sapiens	INH	%	26.0
	13421187	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	13421188	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	13421189	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	13421190	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	44.0	CHEMBL3905	Homo sapiens	INH	%	44.0
	13421191	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	13421192	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13421193	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	72.0	CHEMBL3905	Homo sapiens	INH	%	72.0
	13421194	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	25.0	CHEMBL3905	Homo sapiens	INH	%	25.0
	13421195	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	39.0	CHEMBL3905	Homo sapiens	INH	%	39.0
	13421196	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	23.0	CHEMBL3905	Homo sapiens	INH	%	23.0
	13421197	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	26.0	CHEMBL3905	Homo sapiens	INH	%	26.0
	13421198	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	34.0	CHEMBL3905	Homo sapiens	INH	%	34.0
	13421199	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	13421200	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	21.0	CHEMBL3905	Homo sapiens	INH	%	21.0
	13421201	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	13421202	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	19.0	CHEMBL3905	Homo sapiens	INH	%	19.0
	13421203	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	13421204	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	13421205	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	13421206	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	11.0	CHEMBL3905	Homo sapiens	INH	%	11.0
	13421207	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	18.0	CHEMBL3905	Homo sapiens	INH	%	18.0
	13421208	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	13421209	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	13421210	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	13421211	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	33.0	CHEMBL3905	Homo sapiens	INH	%	33.0
	13421212	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	65.0	CHEMBL3905	Homo sapiens	INH	%	65.0
	13421213	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	70.0	CHEMBL3905	Homo sapiens	INH	%	70.0
	13421214	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	20.0	CHEMBL3905	Homo sapiens	INH	%	20.0
	13421215	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	52.0	CHEMBL3905	Homo sapiens	INH	%	52.0
	13421216	CHEMBL2424320	Inhibition of LYN (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	72.0	CHEMBL3905	Homo sapiens	INH	%	72.0
	13442337	CHEMBL2429505	Competitive binding affinity to LYN (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13445472	CHEMBL2429505	Competitive binding affinity to LYN (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13448527	CHEMBL2429505	Competitive binding affinity to LYN (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13448663	CHEMBL2429505	Competitive binding affinity to LYN (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13451458	CHEMBL2429505	Competitive binding affinity to LYN (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13454643	CHEMBL2429505	Competitive binding affinity to LYN (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	13836289	CHEMBL3090897	Inhibition of LYN (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	13872108	CHEMBL3101417	Inhibition of human Lyn assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	123.0	CHEMBL3905	Homo sapiens	Activity	%	123.0
	13954763	CHEMBL3132490	Inhibition of human LYN assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	61.0	CHEMBL3905	Homo sapiens	Activity	%	61.0
	13954774	CHEMBL3132490	Inhibition of human LYN assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	46.0	CHEMBL3905	Homo sapiens	Activity	%	46.0
	13954781	CHEMBL3132490	Inhibition of human LYN assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	39.0	CHEMBL3905	Homo sapiens	Activity	%	39.0
	13965714	CHEMBL3135926	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	13966092	CHEMBL3137080	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	31.5	CHEMBL3905	Homo sapiens	INH	%	31.5
	13973994	CHEMBL3135894	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	13974085	CHEMBL3134923	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	13974176	CHEMBL3137116	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	42.0	CHEMBL3905	Homo sapiens	INH	%	42.0
	13974267	CHEMBL3136245	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	32.0	CHEMBL3905	Homo sapiens	INH	%	32.0
	13975005	CHEMBL3135301	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	13975096	CHEMBL3136868	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	13975187	CHEMBL3135641	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	13975278	CHEMBL3137161	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	0.5	CHEMBL3905	Homo sapiens	INH	%	0.5
	13975921	CHEMBL3136395	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	51.0	CHEMBL3905	Homo sapiens	INH	%	51.0
	13976014	CHEMBL3135214	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	18.0	CHEMBL3905	Homo sapiens	INH	%	18.0
	13976105	CHEMBL3136776	Inhibition of human full length LYN expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	65.5	CHEMBL3905	Homo sapiens	INH	%	65.5
	14553640	CHEMBL3225780	Inhibition of LYN (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	86.6	CHEMBL3905	Homo sapiens	Activity	%	86.6
	14582540	CHEMBL3242541	Inhibition of human Lyn assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	98.0	CHEMBL3905	Homo sapiens	Activity	%	98.0
	14645337	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1		CHEMBL2177736	=	IC50	nM	238.0	CHEMBL3905	Homo sapiens	IC50	nM	238.0
	14645338	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	IC50	nM	732.0	CHEMBL3905	Homo sapiens	IC50	nM	732.0
Not Determined	14645339	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc(-n3nccn3)c2)n1		CHEMBL3262355		IC50			CHEMBL3905	Homo sapiens	IC50		
	14645340	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1		CHEMBL3262356	=	IC50	nM	112.0	CHEMBL3905	Homo sapiens	IC50	nM	112.0
	14645341	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	Cc1c[nH]c2c(Nc3nc(N[C@@H]4CCCC[C@@H]4N)cc4nc[nH]c(=O)c34)cccc12		CHEMBL3262357	=	IC50	nM	44.0	CHEMBL3905	Homo sapiens	IC50	nM	44.0
	14645342	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3c(Cl)c[nH]c23)n1		CHEMBL3262358	=	IC50	nM	1003.0	CHEMBL3905	Homo sapiens	IC50	nM	1003.0
	14645343	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	Cn1ccc2cccc(Nc3nc(N[C@@H]4CCCC[C@@H]4N)cc4nc[nH]c(=O)c34)c21		CHEMBL3262359	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	14645344	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3[nH]ccc23)n1		CHEMBL3262616	=	IC50	nM	32.0	CHEMBL3905	Homo sapiens	IC50	nM	32.0
	14645345	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	N[C@H]1COCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1		CHEMBL3262617	=	IC50	nM	230.0	CHEMBL3905	Homo sapiens	IC50	nM	230.0
	14645346	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	C[C@H](N)CNc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1		CHEMBL3262618	=	IC50	nM	84.0	CHEMBL3905	Homo sapiens	IC50	nM	84.0
	14645347	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	O=c1[nH]cnc2cc(N[C@@H]3CCCNC3)nc(Nc3cccc4cc[nH]c34)c12		CHEMBL3262619	=	IC50	nM	315.0	CHEMBL3905	Homo sapiens	IC50	nM	315.0
	14645348	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	Cc1c[nH]c2c(Nc3nc(N[C@@H]4CCOC[C@@H]4N)cc4nc[nH]c(=O)c34)cccc12		CHEMBL3262620	=	IC50	nM	69.0	CHEMBL3905	Homo sapiens	IC50	nM	69.0
	14645349	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	Cc1nc2cc(N[C@@H]3CCCC[C@@H]3N)nc(Nc3cccc4c(C)c[nH]c34)c2c(=O)[nH]1		CHEMBL3262621	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	14645350	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	Cn1cc2c(Nc3nc(N[C@@H]4CCOC[C@@H]4N)cc4cc[nH]c(=O)c34)cccc2n1		CHEMBL3262622	=	IC50	nM	190.0	CHEMBL3905	Homo sapiens	IC50	nM	190.0
	14645351	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	N[C@H]1CCCC[C@H]1Nc1cc2cc[nH]c(=O)c2c(Nc2cccc3c(Cl)c[nH]c23)n1		CHEMBL3262623	=	IC50	nM	1800.0	CHEMBL3905	Homo sapiens	IC50	nM	1800.0
	14645352	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	N[C@H]1COCC[C@H]1Nc1cc2cc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1		CHEMBL3262624	=	IC50	nM	1195.0	CHEMBL3905	Homo sapiens	IC50	nM	1195.0
	14645353	CHEMBL3268709	Inhibition of Lyn (unknown origin)	B	Cc1c[nH]c2c(Nc3nc(N[C@@H]4CCCC[C@@H]4N)cc4cc[nH]c(=O)c34)cccc12		CHEMBL3262625	=	IC50	nM	550.0	CHEMBL3905	Homo sapiens	IC50	nM	550.0
	14664215	CHEMBL3270887	Inhibition of LYN (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	INH	%	80.0
	14664216	CHEMBL3270887	Inhibition of LYN (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	81.0	CHEMBL3905	Homo sapiens	INH	%	81.0
	14664217	CHEMBL3270887	Inhibition of LYN (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	88.0	CHEMBL3905	Homo sapiens	INH	%	88.0
	14710308	CHEMBL3292176	Inhibition of human Lyn assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4ccccc4)c23)C1=O		CHEMBL3290628	=	Activity	%	92.0	CHEMBL3905	Homo sapiens	Activity	%	92.0
	14710309	CHEMBL3292176	Inhibition of human Lyn assessed as residual activity at 10 uM relative to control	B	CC1=CC(=O)N(Nc2nc(-c3cccs3)nc3scc(-c4cccc(OCCN5CCCCC5)c4)c23)C1=O.Cl		CHEMBL3290631	=	Activity	%	81.0	CHEMBL3905	Homo sapiens	Activity	%	81.0
	14751781	CHEMBL3300958	Inhibition of LYN (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	14751782	CHEMBL3300958	Inhibition of LYN (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	15008048	CHEMBL3369093	Inhibition of human Lyn at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	15008049	CHEMBL3369093	Inhibition of human Lyn at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	4.0	CHEMBL3905	Homo sapiens	INH	%	4.0
	15008050	CHEMBL3369093	Inhibition of human Lyn at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	15009801	CHEMBL3361640	Inhibition of LYN (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	8.1	CHEMBL3905	Homo sapiens	INH	%	8.1
	15018630	CHEMBL3361522	Inhibition of LYN (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	7.3	CHEMBL3905	Homo sapiens	INH	%	7.3
	15019180	CHEMBL3364373	Inhibition of LYN A (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	15022498	CHEMBL3371352	Inhibition of Lyn (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	62.0	CHEMBL3905	Homo sapiens	INH	%	62.0
	15025413	CHEMBL3362521	Inhibition of Lyn (unknown origin) at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	15036848	CHEMBL3381085	Inhibition of LYN (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	15036849	CHEMBL3381085	Inhibition of LYN (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	15036850	CHEMBL3381085	Inhibition of LYN (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	15036851	CHEMBL3381085	Inhibition of LYN (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	15036852	CHEMBL3381085	Inhibition of LYN (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
Active	15119518	CHEMBL3388036	Inhibition of Lyn phosphorylation in human Rec1 cells at 2.5 uM incubated for 6 hrs by Western blotting method	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Active	15119519	CHEMBL3388036	Inhibition of Lyn phosphorylation in human Rec1 cells at 2.5 uM incubated for 6 hrs by Western blotting method	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Active	15119520	CHEMBL3388036	Inhibition of Lyn phosphorylation in human Rec1 cells at 2.5 uM incubated for 6 hrs by Western blotting method	B	CN1CCN(c2ccc(Nc3nc(N)c4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3331534		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Dose-dependent effect	15119525	CHEMBL3388032	Inhibition of Lyn phosphorylation in human Rec1 cells at 0.1 to 5 uM incubated for 6 hrs by Western blotting method	B	CN1CCN(c2ccc(Nc3nc(N)c4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3331534		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	15119530	CHEMBL3388029	Inhibition of Lyn (unknown origin) assessed as enzyme residual activity at 10 uM by radiometric protein kinase assay	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2c(N)nc(Nc3ccc(OCCN4CCOCC4)cc3)nc21		CHEMBL3331536	=	Activity	%	0.0	CHEMBL3905	Homo sapiens	Activity	%	0.0
	15119531	CHEMBL3388029	Inhibition of Lyn (unknown origin) assessed as enzyme residual activity at 10 uM by radiometric protein kinase assay	B	Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2c(N)nc(Nc3ccc(NCCN4CCOCC4)cc3)nc21		CHEMBL3331535	=	Activity	%	0.0	CHEMBL3905	Homo sapiens	Activity	%	0.0
	15119532	CHEMBL3388029	Inhibition of Lyn (unknown origin) assessed as enzyme residual activity at 10 uM by radiometric protein kinase assay	B	CN1CCN(c2ccc(Nc3nc(N)c4cc(-c5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3331534	=	Activity	%	-1.0	CHEMBL3905	Homo sapiens	Activity	%	-1.0
	15122474	CHEMBL3367692	Inhibition of human Lyn assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	20.0	CHEMBL3905	Homo sapiens	Activity	%	20.0
	15126963	CHEMBL3367692	Inhibition of human Lyn assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	5.0	CHEMBL3905	Homo sapiens	Activity	%	5.0
	15126995	CHEMBL3367692	Inhibition of human Lyn assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	113.0	CHEMBL3905	Homo sapiens	Activity	%	113.0
	15150053	CHEMBL3395942	Inhibition of LYN (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	15150054	CHEMBL3395942	Inhibition of LYN (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	15150055	CHEMBL3395942	Inhibition of LYN (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	15150056	CHEMBL3395942	Inhibition of LYN (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	15150057	CHEMBL3395942	Inhibition of LYN (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	15192387	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	15192388	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	21.0	CHEMBL3905	Homo sapiens	INH	%	21.0
	15192389	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	1.0	CHEMBL3905	Homo sapiens	INH	%	1.0
	15192390	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	12.0	CHEMBL3905	Homo sapiens	INH	%	12.0
	15192391	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	15192392	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	15192393	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	15192394	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	15192395	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	15192396	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	15192397	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	4.0	CHEMBL3905	Homo sapiens	INH	%	4.0
	15192398	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	15192399	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	15192400	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	15192401	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	15192402	CHEMBL3413725	Inhibition of LYN (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	15609952	CHEMBL3580042	Inhibition of human Lyn assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	15.0	CHEMBL3905	Homo sapiens	Activity	%	15.0
	15616230	CHEMBL3583135	Inhibition of Tel-fused LYN (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	4900.0	CHEMBL3905	Homo sapiens	IC50	uM	4.9
	15616231	CHEMBL3583135	Inhibition of Tel-fused LYN (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	3400.0	CHEMBL3905	Homo sapiens	IC50	uM	3.4
	15616232	CHEMBL3583135	Inhibition of Tel-fused LYN (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	Fc1cccc([C@H]2CCCN2c2ccc3ncc(-c4ccccn4)n3n2)c1		CHEMBL3582439	=	IC50	nM	6400.0	CHEMBL3905	Homo sapiens	IC50	uM	6.4
	15616233	CHEMBL3583135	Inhibition of Tel-fused LYN (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	7500.0	CHEMBL3905	Homo sapiens	IC50	uM	7.5
	15622557	CHEMBL3588272	Inhibition of human recombinant LynB at 1 uM	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	Inhibition	%	85.0	CHEMBL3905	Homo sapiens	INH	%	85.0
	15622558	CHEMBL3588271	Inhibition of human recombinant LynA at 1 uM	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	Inhibition	%	82.0	CHEMBL3905	Homo sapiens	INH	%	82.0
	15622568	CHEMBL3588351	Inhibition of human recombinant LynA	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	82.0	CHEMBL3905	Homo sapiens	IC50	nM	82.0
	15622569	CHEMBL3588352	Inhibition of human recombinant LynB	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	54.0	CHEMBL3905	Homo sapiens	IC50	nM	54.0
	15649713	CHEMBL3595392	Inhibition of human LYNB at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	88.0	CHEMBL3905	Homo sapiens	INH	%	88.0
	15649721	CHEMBL3595202	Inhibition of human LYNA at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	96.0	CHEMBL3905	Homo sapiens	INH	%	96.0
	15656301	CHEMBL3598815	Inhibition of LYN (unknown origin) at 0.1 uM	B	CN1CCc2cc(-c3cnc4[nH]cc(C(=O)c5ccccc5Cl)c4c3)ccc2C1		CHEMBL3597011	>	Inhibition	%	95.0	CHEMBL3905	Homo sapiens	INH	%	95.0
	15685897	CHEMBL3607973	Inhibition of human LYN	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	15723403	CHEMBL3620006	Inhibition of Lyn (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	97.8	CHEMBL3905	Homo sapiens	INH	%	97.8
Not Active	15723404	CHEMBL3620006	Inhibition of Lyn (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	15723445	CHEMBL3620299	Inhibition of Lyn (unknown origin) after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	IC50	nM	65.9	CHEMBL3905	Homo sapiens	IC50	nM	65.9
	15723446	CHEMBL3620299	Inhibition of Lyn (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.0	CHEMBL3905	Homo sapiens	IC50	nM	1.0
	15730417	CHEMBL3627432	Inhibition of LYNa (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4F)c23)CC1		CHEMBL3621496	=	IC50	nM	68.0	CHEMBL3905	Homo sapiens	IC50	nM	68.0
	15730418	CHEMBL3627432	Inhibition of LYNa (unknown origin)	B	CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1C		CHEMBL3621515	=	IC50	nM	204.0	CHEMBL3905	Homo sapiens	IC50	nM	204.0
	15730419	CHEMBL3627432	Inhibition of LYNa (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(N(C)C)cc5)c4F)c23)CC1		CHEMBL3622193	=	IC50	nM	824.0	CHEMBL3905	Homo sapiens	IC50	nM	824.0
	15735992	CHEMBL3624356	Inhibition of human recombinant Lyn	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	15736136	CHEMBL3627533	Inhibition of human Lyn at 0.1 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	<	Inhibition	%	25.0	CHEMBL3905	Homo sapiens	INH	%	25.0
	15745907	CHEMBL3624481	Inhibition of recombinant Lyn (unknown origin) at 1 uM after 40 mins by scintillation counting analysis in presence of [gamma33P]-ATP	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C		CHEMBL3623290	=	Inhibition	%	74.0	CHEMBL3905	Homo sapiens	INH	%	74.0
	15756930	CHEMBL3631280	Inhibition of LYN B (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	94.85	CHEMBL3905	Homo sapiens	INH	%	94.85
	15756931	CHEMBL3631279	Inhibition of LYN (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	98.17	CHEMBL3905	Homo sapiens	INH	%	98.17
	15757792	CHEMBL3631279	Inhibition of LYN (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	100.12	CHEMBL3905	Homo sapiens	INH	%	100.12
	15757793	CHEMBL3631280	Inhibition of LYN B (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.96	CHEMBL3905	Homo sapiens	INH	%	99.96
	15758771	CHEMBL3631279	Inhibition of LYN (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	61.64	CHEMBL3905	Homo sapiens	INH	%	61.64
	15758772	CHEMBL3631280	Inhibition of LYN B (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	41.49	CHEMBL3905	Homo sapiens	INH	%	41.49
273862	16263541	CHEMBL3707745	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 M. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 M. Reactions were carried out in 10 M ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
306884	16263721	CHEMBL3707752	Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30 C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	2.3	CHEMBL3905	Homo sapiens	IC50	nM	2.3
281027	16311627	CHEMBL3707748	Millipore Kinase Panel Assay: Employing the Milipore panel of purified kinases EXAMPLE 87 (IC50=1 nM) inhibited 98% of purified Syk kinase activity at 50 nM. IC50 values were determined for those kinases that were inhibited by >80% at 300 nM in the Millipore kinase panel.	B	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1		CHEMBL2177736	=	IC50	nM	199.0	CHEMBL3905	Homo sapiens	IC50	nM	199.0
213467	16312489	CHEMBL3707976	In Vitro Inhibition Assay: Measurements were performed in a reaction volume of 50 L using 96-well assay plates. Kinase enzyme, inhibitor, ATP (at the Km for the kinase), and 1 M peptide substrate (Biotin-AVLESEEELYSSARQ-NH2) were incubated in a reaction buffer composed of 20 mM Tris, 50 mM NaCl, MgCl2 (5-25 mM depending on the kinase), MnCl2 (0-10 mM), 1 mM DTT, 0.1 mM EDTA, 0.01% bovine serum albumin, 0.005% Tween-20, and 10% DMSO at pH 7.4 for one hour. The reaction was quenched by the addition of 1.2 equivalents of EDTA (relative to divalent cation) in 25 L of 1 Lance buffer (Perkin-Elmer). Streptavidin-APC (Perkin-Elmer) and Eu-labeled p-Tyr100 antibody (Perkin-Elmer) in 1 Lance buffer were added in a 25 L volume to give final concentrations of 100 nM and 2.5 nM, respectively, and the mixture was allowed to incubate for one hour. The TR-FRET signal was measured on a multimode plate reader with an excitation wavelength (Ex) of 330 nm and detection wavelengths (Em) of 615 and 665 nm. Activity was determined by the ratio of the fluorescence at 665 nm to that at 615 nm. For each compound, enzyme activity was measured at various concentrations of compound. Negative control reactions were performed in the absence of inhibitor in replicates of six, and two no-enzyme controls were used to determine baseline fluorescence levels.	B	C=CC(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3182647	=	Ki	nM	14.0	CHEMBL3905	Homo sapiens	Ki	nM	14.0
273894	16334090	CHEMBL3707745	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 M. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 M. Reactions were carried out in 10 M ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	24.32	CHEMBL3905	Homo sapiens	IC50	nM	24.32
306883	16347132	CHEMBL3707752	Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30 C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	4.3	CHEMBL3905	Homo sapiens	IC50	nM	4.3
	16370654	CHEMBL3734203	Inhibition of Lyn (unknown origin)	B	CCCS(=O)(=O)Nc1ccc(Cl)c(C(=O)Nc2ccc(NC(C)=O)nc2)c1F		CHEMBL3732214	<=	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	16376459	CHEMBL3734483	Inhibition of recombinant human LYN using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	16381049	CHEMBL3736805	Inhibition of human recombinant LynB by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	170.0	CHEMBL3905	Homo sapiens	IC50	uM	0.17
	16398506	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	16398507	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	16398508	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	16398509	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	16398510	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	4.0	CHEMBL3905	Homo sapiens	INH	%	4.0
	16398511	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	16398512	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	24.0	CHEMBL3905	Homo sapiens	INH	%	24.0
	16398513	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	31.0	CHEMBL3905	Homo sapiens	INH	%	31.0
	16398514	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	34.0	CHEMBL3905	Homo sapiens	INH	%	34.0
	16398515	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	24.0	CHEMBL3905	Homo sapiens	INH	%	24.0
	16398516	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	16398517	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	16398518	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	4.0	CHEMBL3905	Homo sapiens	INH	%	4.0
	16398519	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	16398520	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	16398521	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	54.0	CHEMBL3905	Homo sapiens	INH	%	54.0
	16398522	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	33.0	CHEMBL3905	Homo sapiens	INH	%	33.0
	16398523	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	21.0	CHEMBL3905	Homo sapiens	INH	%	21.0
	16398524	CHEMBL3744316	Inhibition of LYN (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	34.0	CHEMBL3905	Homo sapiens	INH	%	34.0
	16413470	CHEMBL3742710	Inhibition of LYN (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	16421929	CHEMBL3750411	Inhibition of LYN (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	16425426	CHEMBL3749833	Inhibition of LYN (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	23.1	CHEMBL3905	Homo sapiens	INH	%	23.1
	16431887	CHEMBL3747980	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	16431888	CHEMBL3747981	Inhibition of human LYN B using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	16450897	CHEMBL3762913	Inhibition of LYN (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	89.9	CHEMBL3905	Homo sapiens	INH	%	89.9
	16450898	CHEMBL3760622	Inhibition of LYNB (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	89.4	CHEMBL3905	Homo sapiens	INH	%	89.4
	16451737	CHEMBL3762913	Inhibition of LYN (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	94.0	CHEMBL3905	Homo sapiens	INH	%	94.0
	16458438	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	16458439	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	38.0	CHEMBL3905	Homo sapiens	INH	%	38.0
	16458440	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	31.0	CHEMBL3905	Homo sapiens	INH	%	31.0
	16458441	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	47.0	CHEMBL3905	Homo sapiens	INH	%	47.0
	16458442	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	57.0	CHEMBL3905	Homo sapiens	INH	%	57.0
	16458443	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	61.0	CHEMBL3905	Homo sapiens	INH	%	61.0
	16458444	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	40.0	CHEMBL3905	Homo sapiens	INH	%	40.0
	16458445	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	24.0	CHEMBL3905	Homo sapiens	INH	%	24.0
	16458446	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	16458447	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	16458448	CHEMBL3761584	Inhibition of LYN A (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	16458449	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	16458450	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	41.0	CHEMBL3905	Homo sapiens	INH	%	41.0
	16458451	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	37.0	CHEMBL3905	Homo sapiens	INH	%	37.0
	16458452	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	57.0	CHEMBL3905	Homo sapiens	INH	%	57.0
	16458453	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	62.0	CHEMBL3905	Homo sapiens	INH	%	62.0
	16458454	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	57.0	CHEMBL3905	Homo sapiens	INH	%	57.0
	16458455	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	56.0	CHEMBL3905	Homo sapiens	INH	%	56.0
	16458456	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	22.0	CHEMBL3905	Homo sapiens	INH	%	22.0
	16458457	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	16458458	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	15.0	CHEMBL3905	Homo sapiens	INH	%	15.0
	16458459	CHEMBL3761585	Inhibition of LYN B (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	16465895	CHEMBL3767835	Inhibition of human LYN at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	5.4	CHEMBL3905	Homo sapiens	INH	%	5.4
	16474696	CHEMBL3767316	Inhibition of LYN (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	27.8	CHEMBL3905	Homo sapiens	INH	%	27.8
	16495119	CHEMBL3776237	Inhibition of LYN (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-14.0	CHEMBL3905	Homo sapiens	Activity	%	-14.0
	16496038	CHEMBL3776237	Inhibition of LYN (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-7.0	CHEMBL3905	Homo sapiens	Activity	%	-7.0
	16508225	CHEMBL3776237	Inhibition of LYN (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	7.0	CHEMBL3905	Homo sapiens	Activity	%	7.0
	16540851	CHEMBL3789999	Inhibition of LYN (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	1400.0	CHEMBL3905	Homo sapiens	IC50	uM	1.4
	16540852	CHEMBL3789999	Inhibition of LYN (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	=	IC50	nM	9800.0	CHEMBL3905	Homo sapiens	IC50	uM	9.8
	16578357	CHEMBL3804616	Inhibition of partial length wild type human LYN expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	93.0	CHEMBL3905	Homo sapiens	Activity	%	93.0
	16593609	CHEMBL3811749	Inhibition of GST-tagged full length human recombinant LYNA expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	>=	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	INH	%	80.0
	16593616	CHEMBL3811755	Inhibition of GST-tagged full length human recombinant LYNA expressed in baculovirus using Fluorescein-Poly GT as substrate	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	IC50	nM	37.0	CHEMBL3905	Homo sapiens	IC50	nM	37.0
	16614524	CHEMBL3816722	Inhibition of human LYN at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	24.0	CHEMBL3905	Homo sapiens	INH	%	24.0
	16614525	CHEMBL3816723	Inhibition of human LYN B at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	16618172	CHEMBL3817259	Inhibition of full length recombinant human C-terminal His-tagged cytoplasmic LYN B expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	16618173	CHEMBL3817258	Inhibition of LYN (unknown origin) at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	16619683	CHEMBL3820251	Inhibition of recombinant human full length His-tagged LynB expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL3905	Homo sapiens	INH	%	75.0
	16621522	CHEMBL3820660	Inhibition of LYNA (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL3905	Homo sapiens	IC50	nM	30000.0
	16622229	CHEMBL3820660	Inhibition of LYNA (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.1	CHEMBL3905	Homo sapiens	IC50	nM	2.1
	16627536	CHEMBL3820344	Inhibition of full length recombinant human N-terminal His6-tagged LYN expressed in Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	16627537	CHEMBL3820344	Inhibition of full length recombinant human N-terminal His6-tagged LYN expressed in Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	16737952	CHEMBL3856669	Inhibition of LYN (unknown origin) assessed as remaining activity at 10 uM in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	58.0	CHEMBL3905	Homo sapiens	Activity	%	58.0
	16739403	CHEMBL3857060	Inhibition of recombinant full length human N-terminal GST tagged LYN A expressed in insect cells at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	16739404	CHEMBL3857060	Inhibition of recombinant full length human N-terminal GST tagged LYN A expressed in insect cells at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	37.0	CHEMBL3905	Homo sapiens	INH	%	37.0
	16739405	CHEMBL3857060	Inhibition of recombinant full length human N-terminal GST tagged LYN A expressed in insect cells at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	16739406	CHEMBL3857061	Inhibition of His tagged C-terminal recombinant full length human LYN B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	41.0	CHEMBL3905	Homo sapiens	INH	%	41.0
	16739407	CHEMBL3857061	Inhibition of His tagged C-terminal recombinant full length human LYN B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	46.0	CHEMBL3905	Homo sapiens	INH	%	46.0
	16739408	CHEMBL3857061	Inhibition of His tagged C-terminal recombinant full length human LYN B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	16781503	CHEMBL3865549	Inhibition of N-terminal his6-tagged recombinant full-length human LYN expressed in baculovirus infected Sf21 cells	B	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	IC50	nM	31.0	CHEMBL3905	Homo sapiens	IC50	nM	31.0
	16781511	CHEMBL3865541	Inhibition of N-terminal his6-tagged recombinant full-length human LYN expressed in baculovirus infected Sf21 cells at 100 nM	B	CCS(=O)(=O)c1cc(Nc2ncc(F)c(N(Cc3ccccc3C#N)c3cc(CO)ccc3C)n2)ccc1N1CCN(C)CC1		CHEMBL3923175	=	Inhibition	%	91.0	CHEMBL3905	Homo sapiens	INH	%	91.0
	16804175	CHEMBL3869766	Inhibition of human recombinant full length C-terminal His-tagged LYN B cytoplasmic domain expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	59.0	CHEMBL3905	Homo sapiens	INH	%	59.0
	16817235	CHEMBL3871912	Activity at LYN (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Km	nM	1000000.0	CHEMBL3905	Homo sapiens	Km	uM	1000.0
	16817243	CHEMBL3871920	Inhibition of LYN (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ki	nM	490.0	CHEMBL3905	Homo sapiens	Ki	uM	0.49
	16817251	CHEMBL3871928	Ratio of Km to Ki for LYN (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	>	Ratio	10'-4No_unit	100.0	CHEMBL3905	Homo sapiens	Ratio	10'-4No_unit	100.0
	16880720	CHEMBL3880857	Inhibition of human Lyn after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	IC50	nM	35.0	CHEMBL3905	Homo sapiens	IC50	nM	35.0
	16880745	CHEMBL3880872	Inhibition of human Lyn assessed as remaining activity at 0.1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	Activity	%	15.0	CHEMBL3905	Homo sapiens	Activity	%	15.0
	16880746	CHEMBL3880872	Inhibition of human Lyn assessed as remaining activity at 0.1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097999	=	Activity	%	45.0	CHEMBL3905	Homo sapiens	Activity	%	45.0
	16880747	CHEMBL3880873	Inhibition of human Lyn assessed as remaining activity at 1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097700	=	Activity	%	2.0	CHEMBL3905	Homo sapiens	Activity	%	2.0
	16880748	CHEMBL3880873	Inhibition of human Lyn assessed as remaining activity at 1 uM after 40 mins in presence of [gamma33P-ATP] by scintillation counting	B	CCNc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\[C@@H](C)[C@H](C)OC2=O		CHEMBL1097999	=	Activity	%	2.0	CHEMBL3905	Homo sapiens	Activity	%	2.0
	16894634	CHEMBL3882044	Inhibition of Lyn (unknown origin) at 5 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	=	Inhibition	%	95.0	CHEMBL3905	Homo sapiens	INH	%	95.0
	16894877	CHEMBL3882097	Inhibition of Lyn (unknown origin)	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCCC(=O)NO)CC2)n1		CHEMBL3901629	<=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	uM	0.1
	16894878	CHEMBL3882097	Inhibition of Lyn (unknown origin)	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCCCCC(=O)NO)CC2)n1		CHEMBL3904339	<=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	uM	0.1
	16894879	CHEMBL3882097	Inhibition of Lyn (unknown origin)	B	Cc1nc(NCCNCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3965755	<=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	uM	0.1
	16894880	CHEMBL3882097	Inhibition of Lyn (unknown origin)	B	Cc1nc(NCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3984972	<=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	uM	0.1
	16894881	CHEMBL3882097	Inhibition of Lyn (unknown origin)	B	Cc1nc(NCCCCCCC(=O)NO)cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)n1		CHEMBL3889939	<=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	uM	0.1
342614	17720005	CHEMBL3887542	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	16.2	CHEMBL3905	Homo sapiens	IC50	nM	16.2
342635	17720026	CHEMBL3887542	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	1.2	CHEMBL3905	Homo sapiens	IC50	nM	1.2
385006	17758428	CHEMBL3888248	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	16.2	CHEMBL3905	Homo sapiens	IC50	nM	16.2
385027	17758449	CHEMBL3888248	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	1.2	CHEMBL3905	Homo sapiens	IC50	nM	1.2
412031	17776746	CHEMBL3888674	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	=	IC50	nM	1370.0	CHEMBL3905	Homo sapiens	IC50	nM	1370.0
Active	17910024	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	97.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	97.0
Inactive	17910025	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910026	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910027	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	1328.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1328.0
Inactive	17910028	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910029	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	63.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	63.0
Inactive	17910030	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910031	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910032	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910033	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910034	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910035	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910036	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910037	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	2019.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	2019.0
Active	17910038	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	357.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	357.0
Inactive	17910039	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910040	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910041	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910042	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910043	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910044	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910045	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910046	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910047	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910048	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910049	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910050	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910051	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910052	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910053	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910054	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	480.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	480.0
Inactive	17910055	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910056	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910057	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910058	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910059	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910060	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910061	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910062	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910063	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910064	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910065	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910066	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	1527.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1527.0
Active	17910067	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	2445.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	2445.0
Active	17910068	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	239.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	239.0
Inactive	17910069	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910070	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910071	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910072	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910073	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910074	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17910075	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	=	Kd	nM	6.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	6.0
Inactive	17910076	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910077	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910078	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910079	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910080	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910081	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910082	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910083	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910084	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910085	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	1545.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1545.0
Inactive	17910086	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910087	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910088	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910089	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910090	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	121.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	121.0
Inactive	17910091	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910092	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910093	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910094	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910095	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910096	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910097	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910098	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910099	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910100	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910101	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910102	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910103	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910104	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910105	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	1607.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1607.0
Inactive	17910106	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910107	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910108	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910109	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910110	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910111	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910112	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910113	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910114	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910115	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	1130.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1130.0
Inactive	17910116	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910117	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910118	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910119	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910120	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910121	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	112.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	112.0
Inactive	17910122	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910123	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910124	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910125	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910126	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910127	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910128	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910129	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910130	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910131	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910132	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910133	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	Kd	nM	2764.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	2764.0
Inactive	17910134	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910135	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910136	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910137	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910138	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910139	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910140	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910141	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	890.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	890.0
Inactive	17910142	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910143	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910144	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910145	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910146	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	3536.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	3536.0
Inactive	17910147	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910148	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910149	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910150	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910151	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910152	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910153	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910154	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910155	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910156	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	452.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	452.0
Inactive	17910157	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910158	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910159	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910160	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910161	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910162	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910163	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910164	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910165	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	2479.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	2479.0
Inactive	17910166	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910167	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910168	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910169	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	786.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	786.0
Inactive	17910170	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910171	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910172	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910173	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910174	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910175	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	8.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	8.0
Inactive	17910176	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910177	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910178	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910179	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910180	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910181	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910182	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910183	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	148.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	148.0
Inactive	17910184	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910185	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910186	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910187	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910188	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910189	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910190	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910191	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910192	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910193	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	771.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	771.0
Inactive	17910194	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910195	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910196	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910197	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910198	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910199	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910200	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	2496.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	2496.0
Inactive	17910201	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910202	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910203	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910204	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910205	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910206	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910207	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910208	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910209	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910210	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910211	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910212	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910213	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	331.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	331.0
Inactive	17910214	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910215	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910216	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910217	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910218	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910219	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910220	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910221	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910222	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910223	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910224	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910225	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	1333.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1333.0
Inactive	17910226	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910227	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	113.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	113.0
Inactive	17910228	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910229	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	462.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	462.0
Inactive	17910230	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910231	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910232	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910233	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910234	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910235	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910236	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910237	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	887.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	887.0
Inactive	17910238	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910239	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910240	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910241	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910242	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910243	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910244	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910245	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	3633.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	3633.0
Active	17910246	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1416.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1416.0
Active	17910247	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	27.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	27.0
Inactive	17910248	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910249	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910250	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910251	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910252	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910253	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910254	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	1353.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1353.0
Inactive	17910255	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Active	17910256	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1420.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	1420.0
Inactive	17910257	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910258	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910259	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910260	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910261	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910262	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910263	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910264	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910265	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910266	CHEMBL3991750	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3905	Homo sapiens	Kd apparent	nM	30000.0
	17979955	CHEMBL3998349	Inhibition of recombinant human Lyn using peptide substrate poly[Glu:Tyr] (4:1) in presence of [33-P]ATP by kinase hotspot assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.24	CHEMBL3905	Homo sapiens	IC50	nM	0.24
	18012400	CHEMBL4004220	Inhibition of LYN (unknown origin)	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL3905	Homo sapiens	IC50	uM	50.0
	18053027	CHEMBL4011874	Inhibition of LYN-A (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.4	CHEMBL3905	Homo sapiens	INH	%	1.4
	18053028	CHEMBL4011875	Inhibition of LYN-B (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-2.4	CHEMBL3905	Homo sapiens	INH	%	-2.4
	18064289	CHEMBL4013844	Inhibition of human LYN-B preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	631.0	CHEMBL3905	Homo sapiens	IC50	nM	631.0
	18064290	CHEMBL4013845	Inhibition of human LYN-A preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	=	IC50	nM	639.0	CHEMBL3905	Homo sapiens	IC50	nM	639.0
	18064303	CHEMBL4013858	Inhibition of human LYN-B at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	18064304	CHEMBL4013859	Inhibition of human LYN-A at 1 uM preincubated for 15 mins followed by peptide substrate addition measured after 3 hrs by caliper capillary electrophoresis method relative to control	B	C=CC(=O)N1CCN(CCCn2c(=O)c(-c3c(Cl)c(OC)cc(OC)c3Cl)cc3cnc(NC)nc32)CC1		CHEMBL4068509	>	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	18092337	CHEMBL4020193	Inhibition of recombinant human LYN using TK-substrate-biotin after 40 mins by HTRF assay	B	Fc1cccc(Cl)c1CNc1nc(-c2ccco2)n[nH]1		CHEMBL1354522	=	IC50	nM	500.0	CHEMBL3905	Homo sapiens	IC50	uM	0.5
	18114280	CHEMBL4025214	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	92.0	CHEMBL3905	Homo sapiens	Activity	%	92.0
	18138934	CHEMBL4030443	Inhibition of Lyn (unknown origin) at 10 uM relative to control	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	Inhibition	%	31.0	CHEMBL3905	Homo sapiens	INH	%	31.0
	18153084	CHEMBL4034367	Inhibition of LYN Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-3.5	CHEMBL3905	Homo sapiens	INH	%	-3.5
	18153293	CHEMBL4034366	Inhibition of LYN activation loop (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	>	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	18156548	CHEMBL4035097	Inhibition of LYN B (unknown origin)	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2c(Cl)cc(Cl)cc2Cl)nc2ccc(N)cc12		CHEMBL4090364	=	IC50	nM	10500.0	CHEMBL3905	Homo sapiens	IC50	uM	10.5
	18172342	CHEMBL4038036	Inhibition of recombinant human LYN-A expressed in bacterial expression system at 100 nM by KINOMEscan assay relative to control	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	>	Inhibition	%	90.0	CHEMBL3905	Homo sapiens	INH	%	90.0
	18172343	CHEMBL4038037	Inhibition of recombinant human LYN-B expressed in bacterial expression system at 100 nM by KINOMEscan assay relative to control	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	>	Inhibition	%	90.0	CHEMBL3905	Homo sapiens	INH	%	90.0
	18203738	CHEMBL4044025	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	7.6	CHEMBL3905	Homo sapiens	Activity	%	7.6
	18211633	CHEMBL4045727	Inhibition of LYN conserved Lys1 (VAVKTLKPGTMSVQAFLEEANLMK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-11.3	CHEMBL3905	Homo sapiens	INH	%	-11.3
	18211644	CHEMBL4045726	Inhibition of LYN activation Loop (EGAKFPIKWTAPEAINFGCFTIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	5.0	CHEMBL3905	Homo sapiens	INH	%	5.0
	18211871	CHEMBL4045967	Inhibition of LYN activation Loop (EGAKFPIKWTAPEAINFGCFTIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	6.1	CHEMBL3905	Homo sapiens	INH	%	6.1
	18211872	CHEMBL4045968	Inhibition of LYN conserved Lys1 (VAVKTLKPGTMSVQAFLEEANLMK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-11.8	CHEMBL3905	Homo sapiens	INH	%	-11.8
	18231700	CHEMBL4050192	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-32P]ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.39	CHEMBL3905	Homo sapiens	IC50	10'-9M	1.39
Not Determined	18231730	CHEMBL4050192	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-32P]ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339		IC50			CHEMBL3905	Homo sapiens	IC50		
	18248606	CHEMBL4053889	Inhibition of LYN-B (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	15.0	CHEMBL3905	Homo sapiens	INH	%	15.0
	18253537	CHEMBL4055052	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	86.0	CHEMBL3905	Homo sapiens	Activity	%	86.0
	18253538	CHEMBL4055052	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3905	Homo sapiens	Activity	%	100.0
	18265882	CHEMBL4057332	Inhibition of LYN (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	32.3	CHEMBL3905	Homo sapiens	INH	%	32.3
	18265883	CHEMBL4057333	Inhibition of LYNB (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	24.3	CHEMBL3905	Homo sapiens	INH	%	24.3
	18266138	CHEMBL4057588	Inhibition of LYN (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	6.7	CHEMBL3905	Homo sapiens	INH	%	6.7
	18266139	CHEMBL4057589	Inhibition of LYNB (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	3.0	CHEMBL3905	Homo sapiens	INH	%	3.0
	18266210	CHEMBL4057660	Inhibition of LYN (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	-0.3	CHEMBL3905	Homo sapiens	INH	%	-0.3
	18268071	CHEMBL4057966	Inhibition of LYNB (unknown origin)	B	CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4069387	=	IC50	nM	646.0	CHEMBL3905	Homo sapiens	IC50	nM	646.0
	18268072	CHEMBL4057966	Inhibition of LYNB (unknown origin)	B	CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4075954	=	IC50	nM	1045.0	CHEMBL3905	Homo sapiens	IC50	nM	1045.0
	18268073	CHEMBL4057966	Inhibition of LYNB (unknown origin)	B	COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4076024	=	IC50	nM	74.0	CHEMBL3905	Homo sapiens	IC50	nM	74.0
	18268074	CHEMBL4057966	Inhibition of LYNB (unknown origin)	B	COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4062498	=	IC50	nM	268.0	CHEMBL3905	Homo sapiens	IC50	nM	268.0
	18268075	CHEMBL4057966	Inhibition of LYNB (unknown origin)	B	Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4077588	=	IC50	nM	115.0	CHEMBL3905	Homo sapiens	IC50	nM	115.0
	18268076	CHEMBL4057966	Inhibition of LYNB (unknown origin)	B	Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4060757	=	IC50	nM	399.0	CHEMBL3905	Homo sapiens	IC50	nM	399.0
	18269004	CHEMBL4058135	Inhibition of recombinant human full length N-terminal His6-tagged LYN expressed in Sf21 insect cells preincubated for 5 mins followed by His-tagged Rb truncated protein substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	312.0	CHEMBL3905	Homo sapiens	IC50	nM	312.0
	18274244	CHEMBL4059319	Inhibition of human LYN	B	CC(=O)N1Cc2ncnc(Oc3ccc4c(ccn4C(=O)Nc4cc(C5CC5)on4)c3)c2C[C@@H]1C		CHEMBL4077373	<	IC50	nM	500.0	CHEMBL3905	Homo sapiens	IC50	nM	500.0
	18275010	CHEMBL4118382	Inhibition of LYN in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKTLKPGTMSVQAFLEEANLMK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	16.5	CHEMBL3905	Homo sapiens	INH	%	16.5
	18275011	CHEMBL4118382	Inhibition of LYN in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKTLKPGTMSVQAFLEEANLMK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	2.8	CHEMBL3905	Homo sapiens	INH	%	2.8
	18275012	CHEMBL4118382	Inhibition of LYN in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VAVKTLKPGTMSVQAFLEEANLMK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	-5.1	CHEMBL3905	Homo sapiens	INH	%	-5.1
	18282057	CHEMBL4120012	Inhibition of recombinant full length His-tagged human LYN expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	15.6	CHEMBL3905	Homo sapiens	INH	%	15.6
	18282376	CHEMBL4120012	Inhibition of recombinant full length His-tagged human LYN expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	17.9	CHEMBL3905	Homo sapiens	INH	%	17.9
	18282674	CHEMBL4120259	Inhibition of LYN (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	32.3	CHEMBL3905	Homo sapiens	INH	%	32.3
	18282755	CHEMBL4120340	Inhibition of LYNB (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	24.3	CHEMBL3905	Homo sapiens	INH	%	24.3
	18282890	CHEMBL4120475	Inhibition of LYN (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	13.7	CHEMBL3905	Homo sapiens	INH	%	13.7
	18282982	CHEMBL4120567	Inhibition of LYNB (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	10.7	CHEMBL3905	Homo sapiens	INH	%	10.7
	18283104	CHEMBL4120689	Inhibition of LYN (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	18283206	CHEMBL4120791	Inhibition of LYNB (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-0.3	CHEMBL3905	Homo sapiens	INH	%	-0.3
	18327488	CHEMBL4135585	Inhibition of Lyn (unknown origin)	B	COc1cc2ncc(C(=O)Nc3ccccc3C)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4162913	=	IC50	nM	50.0	CHEMBL3905	Homo sapiens	IC50	uM	0.05
	18327489	CHEMBL4135585	Inhibition of Lyn (unknown origin)	B	COc1cc2ncc(C(=O)Oc3ccccc3C)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4170854	=	IC50	nM	150.0	CHEMBL3905	Homo sapiens	IC50	uM	0.15
	18327490	CHEMBL4135585	Inhibition of Lyn (unknown origin)	B	COc1cc2ncc(-c3cccc(Cl)c3)n2cc1S(=O)(=O)C(C)(C)C		CHEMBL4166371	=	IC50	nM	9700.0	CHEMBL3905	Homo sapiens	IC50	uM	9.7
	18330815	CHEMBL4136283	Inhibition of recombinant LYN-A (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	92.0	CHEMBL3905	Homo sapiens	INH	%	92.0
	18379929	CHEMBL4145830	Inhibition of LYN (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	70.89	CHEMBL3905	Homo sapiens	INH	%	70.89
	18379981	CHEMBL4145882	Inhibition of LYN (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.473	CHEMBL3905	Homo sapiens	IC50	nM	0.473
	18380269	CHEMBL4145882	Inhibition of LYN (unknown origin)	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	IC50	nM	4200.0	CHEMBL3905	Homo sapiens	IC50	uM	4.2
	18415111	CHEMBL4152876	Inhibition of LYN (unknown origin)	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	IC50	nM	4400.0	CHEMBL3905	Homo sapiens	IC50	nM	4400.0
	18415139	CHEMBL4152871	Inhibition of LYN (unknown origin) by FRET assay	B	C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3647964	=	IC50	nM	200.0	CHEMBL3905	Homo sapiens	IC50	nM	200.0
	18434123	CHEMBL4156106	Inhibition of recombinant human full-length N-terminal GST-tagged LYN-A expressed in insect cells at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	21.0	CHEMBL3905	Homo sapiens	INH	%	21.0
	18434124	CHEMBL4156080	Inhibition of recombinant human full-length N-terminal His-tagged LYN-B expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	18434220	CHEMBL4156080	Inhibition of recombinant human full-length N-terminal His-tagged LYN-B expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	18434221	CHEMBL4156106	Inhibition of recombinant human full-length N-terminal GST-tagged LYN-A expressed in insect cells at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	14.0	CHEMBL3905	Homo sapiens	INH	%	14.0
	18434280	CHEMBL4156080	Inhibition of recombinant human full-length N-terminal His-tagged LYN-B expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	18434281	CHEMBL4156106	Inhibition of recombinant human full-length N-terminal GST-tagged LYN-A expressed in insect cells at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	28.0	CHEMBL3905	Homo sapiens	INH	%	28.0
	18434352	CHEMBL4156080	Inhibition of recombinant human full-length N-terminal His-tagged LYN-B expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	70.0	CHEMBL3905	Homo sapiens	INH	%	70.0
	18434353	CHEMBL4156106	Inhibition of recombinant human full-length N-terminal GST-tagged LYN-A expressed in insect cells at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	74.0	CHEMBL3905	Homo sapiens	INH	%	74.0
	18440280	CHEMBL4157104	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	99.0	CHEMBL3905	Homo sapiens	Activity	%	99.0
	18450263	CHEMBL4178309	Inhibition of recombinant human full length N-terminal GST-tagged LYN A expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-12.0	CHEMBL3905	Homo sapiens	Activity	%	-12.0
	18450313	CHEMBL4178309	Inhibition of recombinant human full length N-terminal GST-tagged LYN A expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-2.0	CHEMBL3905	Homo sapiens	Activity	%	-2.0
	18465744	CHEMBL4181667	Inhibition of Lyn (unknown origin)	B	CC(=O)Nc1cn2cc(-c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL4216073	=	IC50	nM	170.0	CHEMBL3905	Homo sapiens	IC50	uM	0.17
	18484236	CHEMBL4185883	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	97.0	CHEMBL3905	Homo sapiens	Activity	%	97.0
	18484720	CHEMBL4185883	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL3905	Homo sapiens	Activity	%	97.0
	18507732	CHEMBL4191030	Inhibition of recombinant full-length human Lyn at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	40.0	CHEMBL3905	Homo sapiens	INH	%	40.0
	18558652	CHEMBL4201066	Inhibition of human LYN at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	99.4	CHEMBL3905	Homo sapiens	INH	%	99.4
	18653549	CHEMBL4230129	Inhibition of LYNB (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	100.0	CHEMBL3905	Homo sapiens	INH	%	100.0
	18653550	CHEMBL4230129	Inhibition of LYNB (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	94.0	CHEMBL3905	Homo sapiens	INH	%	94.0
	18653551	CHEMBL4230128	Inhibition of LYNA (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL3905	Homo sapiens	INH	%	99.0
	18653552	CHEMBL4230128	Inhibition of LYNA (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	95.0	CHEMBL3905	Homo sapiens	INH	%	95.0
	18655452	CHEMBL4230783	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	97.0	CHEMBL3905	Homo sapiens	Activity	%	97.0
	18665391	CHEMBL4233348	Inhibition of LYN (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	nM	10000.0
	18674737	CHEMBL4235380	Inhibition of LYN (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL3905	Homo sapiens	Ki	nM	2000.0
	18674738	CHEMBL4235380	Inhibition of LYN (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL3905	Homo sapiens	Ki	nM	2000.0
	18674739	CHEMBL4235380	Inhibition of LYN (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL3905	Homo sapiens	Ki	nM	10000.0
	18694002	CHEMBL4253455	Inhibition of recombinant human full length GST-tagged Lyn-A expressed in insect cells at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	18694084	CHEMBL4253537	Inhibition of recombinant human full length GST-tagged Lyn-A expressed in insect cells at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	18708938	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	15.0	CHEMBL3905	Homo sapiens	INH	%	15.0
	18708967	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	18708996	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	18.0	CHEMBL3905	Homo sapiens	INH	%	18.0
	18709028	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	15.0	CHEMBL3905	Homo sapiens	INH	%	15.0
	18709057	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	27.0	CHEMBL3905	Homo sapiens	INH	%	27.0
	18709086	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	63.0	CHEMBL3905	Homo sapiens	INH	%	63.0
	18709115	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	42.0	CHEMBL3905	Homo sapiens	INH	%	42.0
	18709162	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	18709192	CHEMBL4256684	Inhibition of LYN (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	55.0	CHEMBL3905	Homo sapiens	INH	%	55.0
	18709221	CHEMBL4256658	Inhibition of LYN (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	56.0	CHEMBL3905	Homo sapiens	INH	%	56.0
	18709263	CHEMBL4256684	Inhibition of LYN (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	93.0	CHEMBL3905	Homo sapiens	INH	%	93.0
	18709296	CHEMBL4256684	Inhibition of LYN (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	86.0	CHEMBL3905	Homo sapiens	INH	%	86.0
	18737906	CHEMBL4261440	Inhibition of recombinant full length human Lyn using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	85.0	CHEMBL3905	Homo sapiens	IC50	nM	85.0
	18751028	CHEMBL4263846	Inhibition of LYNA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	12.0	CHEMBL3905	Homo sapiens	INH	%	12.0
	18751029	CHEMBL4263847	Inhibition of LYNB (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	9.0	CHEMBL3905	Homo sapiens	INH	%	9.0
	18752025	CHEMBL4264372	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	86.0	CHEMBL3905	Homo sapiens	Activity	%	86.0
	18761532	CHEMBL4266585	Inhibition of recombinant human N-terminal His6-tagged full length LYN expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	45.0	CHEMBL3905	Homo sapiens	INH	%	45.0
	18761803	CHEMBL4266585	Inhibition of recombinant human N-terminal His6-tagged full length LYN expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	11.0	CHEMBL3905	Homo sapiens	INH	%	11.0
	18761966	CHEMBL4266585	Inhibition of recombinant human N-terminal His6-tagged full length LYN expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	2.0	CHEMBL3905	Homo sapiens	INH	%	2.0
	18803892	CHEMBL4274924	Inhibition of Lyn (unknown origin) using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay	B	COc1cccc(-c2cn(-c3ccc(CCN4CCC(O)CC4)cc3)c3ncnc(N)c23)c1		CHEMBL475584	=	IC50	nM	0.4	CHEMBL3905	Homo sapiens	IC50	nM	0.4
	18803895	CHEMBL4274921	Inhibition of Lyn (unknown origin) at 0.1 mM using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay relative to control	B	Nc1nc2[nH]cc(CNC(=O)COc3ccc(Cl)cc3)c2c(=O)[nH]1		CHEMBL4292957	=	Inhibition	%	28.0	CHEMBL3905	Homo sapiens	INH	%	28.0
	18803896	CHEMBL4274921	Inhibition of Lyn (unknown origin) at 0.1 mM using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay relative to control	B	Cc1ccc(C(=O)NCc2c[nH]c3nc(N)[nH]c(=O)c23)s1		CHEMBL4285132	=	Inhibition	%	40.0	CHEMBL3905	Homo sapiens	INH	%	40.0
	18803897	CHEMBL4274921	Inhibition of Lyn (unknown origin) at 0.1 mM using Src-family kinase bisamide rhodamine 110 peptide substrate after 1 hr by fluorescence assay relative to control	B	COc1ccc(CCCC(=O)NCc2c[nH]c3nc(N)[nH]c(=O)c23)cc1OC		CHEMBL4277831	=	Inhibition	%	32.0	CHEMBL3905	Homo sapiens	INH	%	32.0
	18858036	CHEMBL4307882	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	98.0	CHEMBL3905	Homo sapiens	Activity	%	98.0
Not Active	18883548	CHEMBL4312743	Activity at human Lyn at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL3905	Homo sapiens	Activity		
	18892899	CHEMBL4314865	Inhibition of recombinant full-length human Lyn assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	119.0	CHEMBL3905	Homo sapiens	Activity	%	119.0
	18919412	CHEMBL4322771	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged LYN (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	63.0	CHEMBL3905	Homo sapiens	Kd	nM	63.0
	18919600	CHEMBL4322771	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged LYN (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	116.0	CHEMBL3905	Homo sapiens	Kd	nM	116.0
	18923173	CHEMBL4323946	Inhibition of recombinant full length human LYN using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4447631	=	IC50	nM	17.0	CHEMBL3905	Homo sapiens	IC50	nM	17.0
	18934081	CHEMBL4326613	Inhibition of human LYN at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	69.1	CHEMBL3905	Homo sapiens	INH	%	69.1
	18938045	CHEMBL4327749	Inhibition of human LYN assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.4	CHEMBL3905	Homo sapiens	Activity	%	97.4
	18938046	CHEMBL4327749	Inhibition of human LYN assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.27	CHEMBL3905	Homo sapiens	Activity	%	98.27
	18938047	CHEMBL4327750	Inhibition of human LYN-B assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.53	CHEMBL3905	Homo sapiens	Activity	%	101.53
	18938048	CHEMBL4327750	Inhibition of human LYN-B assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.32	CHEMBL3905	Homo sapiens	Activity	%	100.32
	18938594	CHEMBL4328113	Inhibition of human LYN assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3905	Homo sapiens	Activity	%	65.0
	18938595	CHEMBL4328114	Inhibition of human LYN-B assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3905	Homo sapiens	Activity	%	65.0
	18938974	CHEMBL4328477	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.805	CHEMBL3905	Homo sapiens	IC50	10'-10M	8.05
	18938975	CHEMBL4328478	Inhibition of human LYN-B using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.68	CHEMBL3905	Homo sapiens	IC50	10'-9M	2.68
	18958947	CHEMBL4333469	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	80.0	CHEMBL3905	Homo sapiens	Activity	%	80.0
	18964409	CHEMBL4335143	Inhibition of recombinant human Lyn assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	83.0	CHEMBL3905	Homo sapiens	Activity	%	83.0
	18964410	CHEMBL4335143	Inhibition of recombinant human Lyn assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL3905	Homo sapiens	Activity	%	92.0
	18971958	CHEMBL4336968	Inhibition of recombinant human Lyn assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	3.0	CHEMBL3905	Homo sapiens	Activity	%	3.0
	19018952	CHEMBL4347065	Inhibition of human recombinant LYN using biotinyl-beta amyloid beta amyloid beta AKVEKIGEGTYGVVYK as substrate measured after 120 mins in the presence of ATP by HTRF assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C[C@H]1CCCN1C[C@@H]1CO1		CHEMBL4525187	=	IC50	nM	10.0	CHEMBL3905	Homo sapiens	IC50	nM	10.0
	19021606	CHEMBL4347677	Inhibition of recombinant human LYN A at 20 nM using biotinyl-beta amyloid-beta amyloid-beta AKVEKIGEGTYGVVYK after 120 mins by HTRF method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	10.0	CHEMBL3905	Homo sapiens	INH	%	10.0
	19021607	CHEMBL4347678	Inhibition of recombinant human LYN A at 200 nM using biotinyl-beta amyloid-beta amyloid-beta AKVEKIGEGTYGVVYK after 120 mins by HTRF method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	11.0	CHEMBL3905	Homo sapiens	INH	%	11.0
	19032196	CHEMBL4349789	Inhibition of recombinant human full length N-terminal GST/His6-tagged LYN (M1 to P512) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-1.0	CHEMBL3905	Homo sapiens	INH	%	-1.0
Not Active	19039723	CHEMBL4351919	Inhibition of recombinant full-length human Lyn at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Active	19041165	CHEMBL4352426	Inhibition of human LYN at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Active	19041166	CHEMBL4352427	Inhibition of human LYN-B at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	19059660	CHEMBL4357961	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	2.8	CHEMBL3905	Homo sapiens	Activity	%	2.8
	19063672	CHEMBL4359459	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	>	Activity	%	90.0	CHEMBL3905	Homo sapiens	Activity	%	90.0
	19072940	CHEMBL4362116	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.65	CHEMBL3905	Homo sapiens	FC		0.65
	19072979	CHEMBL4362154	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.73	CHEMBL3905	Homo sapiens	FC		0.73
	19073018	CHEMBL4362116	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.62	CHEMBL3905	Homo sapiens	log2FC		-0.62
	19073057	CHEMBL4362154	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.45	CHEMBL3905	Homo sapiens	log2FC		-0.45
	19073119	CHEMBL4362116	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.72	CHEMBL3905	Homo sapiens	FC		0.72
	19073158	CHEMBL4362154	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.84	CHEMBL3905	Homo sapiens	FC		0.84
	19073197	CHEMBL4362116	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.48	CHEMBL3905	Homo sapiens	log2FC		-0.48
	19073236	CHEMBL4362154	Effect on LYN at Y397 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.25	CHEMBL3905	Homo sapiens	log2FC		-0.25
	19074032	CHEMBL4362318	Inhibition of LYN (unknown origin) using KVEKIGEGTYGVVYK as substrate in presence of [gamma33P]ATP as substrate in presence of [gamma33P]ATP by scintillation counting method	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Ki	nM	190.0	CHEMBL3905	Homo sapiens	Ki	uM	0.19
	19074033	CHEMBL4362318	Inhibition of LYN (unknown origin) using KVEKIGEGTYGVVYK as substrate in presence of [gamma33P]ATP as substrate in presence of [gamma33P]ATP by scintillation counting method	B	Nc1ncnc2c1c(-c1ccc(CO)cc1)nn2CC(Cl)c1ccccc1		CHEMBL4452230	=	Ki	nM	190.0	CHEMBL3905	Homo sapiens	Ki	uM	0.19
Active	19085618	CHEMBL4364835	Inhibition of LYN phosphorylation in human KARPAS299 cells at 10 uM incubated for 3 hrs by mass spectrometry-based global phospho-proteomic analysis	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4514156		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	19090225	CHEMBL4365799	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3905	Homo sapiens	Activity	%	100.0
	19091986	CHEMBL4366460	Inhibition of human LYN at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-1.62	CHEMBL3905	Homo sapiens	INH	%	-1.62
	19091987	CHEMBL4366461	Inhibition of human LYN-B at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	4.9	CHEMBL3905	Homo sapiens	INH	%	4.9
	19092276	CHEMBL4366696	Inhibition of LYN (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	43.0	CHEMBL3905	Homo sapiens	INH	%	43.0
	19114126	CHEMBL4371243	Inhibition of LYN (unknown origin)	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	=	IC50	nM	100.0	CHEMBL3905	Homo sapiens	IC50	nM	100.0
	19114513	CHEMBL4371407	Binding affinity to LYN in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	29.0	CHEMBL3905	Homo sapiens	Kd(free)	uM	0.029
	19114680	CHEMBL4371407	Binding affinity to LYN in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	11.0	CHEMBL3905	Homo sapiens	Kd(free)	uM	0.011
	19140826	CHEMBL4376590	Inhibition of recombinant human N-terminal GST-tagged LYN A expressed in insect cells at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	19140827	CHEMBL4376591	Inhibition of recombinant full length human GST-tagged LYN B expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	19144943	CHEMBL4377959	Inhibition of recombinant full-length human LYN at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	25.0	CHEMBL3905	Homo sapiens	INH	%	25.0
	19146837	CHEMBL4378955	Inhibition of recombinant full-length human Lyn at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1	Outside typical range	CHEMBL4459587	=	Inhibition	%	-14.0	CHEMBL3905	Homo sapiens	INH	%	-14.0
	19147908	CHEMBL4379382	Inhibition of recombinant full length human Lyn using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	19159488	CHEMBL4382592	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	57.0	CHEMBL3905	Homo sapiens	Activity	%	57.0
Active	19163636	CHEMBL4383850	Inhibition of human LYN at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 120 mins [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	19181071	CHEMBL4387282	Inhibition of recombinant full length human LYN at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	19181297	CHEMBL4387282	Inhibition of recombinant full length human LYN at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	7.0	CHEMBL3905	Homo sapiens	INH	%	7.0
	19191519	CHEMBL4389311	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	66.0	CHEMBL3905	Homo sapiens	INH	%	66.0
	19191974	CHEMBL4389788	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	72.0	CHEMBL3905	Homo sapiens	INH	%	72.0
	19200230	CHEMBL4391414	Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	83.0	CHEMBL3905	Homo sapiens	Activity	%	83.0
	19219424	CHEMBL4394711	Inhibition of LYN (unknown origin) incubated for 60 mins by HTRF assay	B	CC(=O)O.CNc1nc(Nc2cnc(C#N)c(O[C@@H]3CCCNC3)c2)ncc1-c1cnn(C)c1		CHEMBL4577258	=	IC50	nM	4297.5	CHEMBL3905	Homo sapiens	IC50	nM	4297.5
	19219496	CHEMBL4394711	Inhibition of LYN (unknown origin) incubated for 60 mins by HTRF assay	B	COc1cccc(OCCCN)c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1		CHEMBL3544911	>	IC50	nM	10000.0	CHEMBL3905	Homo sapiens	IC50	uM	10.0
	19242730	CHEMBL4400065	Inhibition of full length recombinant human LYN assessed as residual activity at 10 uM using poly (Glu,Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	86.0	CHEMBL3905	Homo sapiens	Activity	%	86.0
	19250394	CHEMBL4401417	Inhibition of full length human N-terminal 6His-tagged LYN expressed in baculovirus expression system at 100 nM relative to control	B	C=CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C)C(=O)N2		CHEMBL4553725	=	Inhibition	%	81.0	CHEMBL3905	Homo sapiens	INH	%	81.0
	19266483	CHEMBL4405433	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	19266484	CHEMBL4405434	Inhibition of LYN-B (unknown origin) at 1 uM relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	19276026	CHEMBL4408029	Inhibition of recombinant human full length LYN at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	58.0	CHEMBL3905	Homo sapiens	INH	%	58.0
	19294838	CHEMBL4412209	Inhibition of human LYN-B using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2cc(OC)c(OC)cc2Cl)nc2cc(Cl)ccc12		CHEMBL579353	>	IC50	nM	100000.0	CHEMBL3905	Homo sapiens	IC50	uM	100.0
	19294850	CHEMBL4412221	Inhibition of human LYN at 20 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2cc(OC)c(OC)cc2Cl)nc2cc(Cl)ccc12		CHEMBL579353	=	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	19295044	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4442304	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295045	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL4453032	=	Inhibition	%	6.0	CHEMBL3905	Homo sapiens	INH	%	6.0
	19295046	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c(OC(C)=O)c1		CHEMBL4517514	=	Inhibition	%	25.0	CHEMBL3905	Homo sapiens	INH	%	25.0
	19295047	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	Inhibition	%	19.0	CHEMBL3905	Homo sapiens	INH	%	19.0
	19295048	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL1092204	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295049	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL1092207	=	Inhibition	%	78.0	CHEMBL3905	Homo sapiens	INH	%	78.0
	19295050	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4459848	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	19295051	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4583163	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295052	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCCCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4559299	=	Inhibition	%	24.0	CHEMBL3905	Homo sapiens	INH	%	24.0
	19295053	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc3c2OCO3)nc2ccccc12		CHEMBL4468697	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295054	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc3c(c2)OCO3)nc2ccccc12		CHEMBL4470620	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295055	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2c(Br)ccc3c2OCO3)nc2ccccc12		CHEMBL4518551	=	Inhibition	%	32.0	CHEMBL3905	Homo sapiens	INH	%	32.0
	19295056	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cc3c(cc2Br)OCO3)nc2ccccc12		CHEMBL4576121	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295057	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc([N+](=O)[O-])c2)nc2ccccc12		CHEMBL4445408	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295058	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc([N+](=O)[O-])cc2)nc2ccccc12		CHEMBL4539405	=	Inhibition	%	52.0	CHEMBL3905	Homo sapiens	INH	%	52.0
	19295059	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc(Nc2ccccc2I)c2ccccc2n1		CHEMBL4455338	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	19295060	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(OC)c(Nc2nc(/C=C/c3ccccc3OC(C)=O)nc3ccccc23)c1		CHEMBL4458986	=	Inhibition	%	29.0	CHEMBL3905	Homo sapiens	INH	%	29.0
	19295061	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccccc2Cl)c2ccccc2n1		CHEMBL4550950	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295062	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc(O)cc2)c2ccccc2n1		CHEMBL4472770	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295063	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2cccc(O)c2)c2ccccc2n1		CHEMBL4459984	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295064	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482	=	Inhibition	%	61.0	CHEMBL3905	Homo sapiens	INH	%	61.0
	19295065	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(NCc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4470772	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295066	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)cc1		CHEMBL4571210	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295067	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	Inhibition	%	20.0	CHEMBL3905	Homo sapiens	INH	%	20.0
	19295068	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	Inhibition	%	56.0	CHEMBL3905	Homo sapiens	INH	%	56.0
	19295069	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1ccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)cc1		CHEMBL4553117	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295070	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)c1		CHEMBL4535076	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295071	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(NCCCN(C)C)c3ccccc3n2)cc1		CHEMBL186928	=	Inhibition	%	47.0	CHEMBL3905	Homo sapiens	INH	%	47.0
	19295072	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	19295073	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	98.0	CHEMBL3905	Homo sapiens	INH	%	98.0
	19295074	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Inhibition	%	37.0	CHEMBL3905	Homo sapiens	INH	%	37.0
	19295075	CHEMBL4412229	Inhibition of Lyn B (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL426161	=	Inhibition	%	100.0	CHEMBL3905	Homo sapiens	INH	%	100.0
	19295138	CHEMBL4412237	Inhibition of Lyn B (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	IC50	nM	1255.0	CHEMBL3905	Homo sapiens	IC50	nM	1255.0
	19295139	CHEMBL4412237	Inhibition of Lyn B (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482	=	IC50	nM	442.0	CHEMBL3905	Homo sapiens	IC50	nM	442.0
	19295140	CHEMBL4412237	Inhibition of Lyn B (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	IC50	nM	2.118	CHEMBL3905	Homo sapiens	IC50	nM	2.118
	19295141	CHEMBL4412237	Inhibition of Lyn B (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	IC50	nM	644.0	CHEMBL3905	Homo sapiens	IC50	nM	644.0
	19295142	CHEMBL4412237	Inhibition of Lyn B (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	1.2	CHEMBL3905	Homo sapiens	IC50	nM	1.2
	19303799	CHEMBL4414251	Inhibition of LYN (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	104.0	CHEMBL3905	Homo sapiens	Activity	%	104.0
	19306165	CHEMBL4414990	Inhibition of human LYN at 1 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 15 to 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method relative to control	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	Inhibition	%	35.0	CHEMBL3905	Homo sapiens	INH	%	35.0
	19312964	CHEMBL4416519	Inhibition of recombinant human N-terminal His6-tagged full length Lyn expressed in Sf21 insect cells at 10 uM using poly (Glu4-Tyr) (4:1) as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
Not Active	19369308	CHEMBL4424532	Competitive inhibition of human LYN expressed in baculovirus infected Sf9 insect cells using p-nitrophenol at 10 uM after 10 mins by Lineweaver-Burk plot analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Active	19369309	CHEMBL4424532	Competitive inhibition of human LYN expressed in baculovirus infected Sf9 insect cells using p-nitrophenol at 10 uM after 10 mins by Lineweaver-Burk plot analysis	B	C/C=C/C=C/C(=O)[C@]12C(=O)C(C)=C(O)[C@@](C)(O)[C@H]1[C@H]1/C(=C(O)\C=C\C=C\C)C(=O)[C@]2(C)C(=O)[C@@]1(C)O		CHEMBL518705		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Active	19369316	CHEMBL4424534	Inhibition of human LYN expressed in baculovirus infected Sf9 insect cells using p-nitrophenol at 10 uM after 10 mins by Lineweaver-Burk plot analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	19371139	CHEMBL4424891	Inhibition of full-length human N-terminal His6-tagged LYN expressed in baculovirus infected Sf21 insect cells using Poly (Glu4-Tyr) (4:1) as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL3905	Homo sapiens	IC50	nM	1000.0
	19411457	CHEMBL4427708	Inhibition of LYN A (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL3905	Homo sapiens	IC50	uM	5.0
	19411513	CHEMBL4427652	Inhibition of LYN A (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	19432589	CHEMBL4429387	Inhibition of partial length human LYN expressed in bacterial system	B	Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O		CHEMBL3918580	=	IC50	nM	160.0	CHEMBL3905	Homo sapiens	IC50	uM	0.16
	19435839	CHEMBL4430395	Inhibition of human LYN at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	-2.0	CHEMBL3905	Homo sapiens	INH	%	-2.0
	19435840	CHEMBL4430395	Inhibition of human LYN at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	-1.0	CHEMBL3905	Homo sapiens	INH	%	-1.0
	19435841	CHEMBL4430395	Inhibition of human LYN at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	20.0	CHEMBL3905	Homo sapiens	INH	%	20.0
	20600568	CHEMBL4603520	Inhibition of recombinant full length human GST-tagged LYN-A expressed in insect cells using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3905	Homo sapiens	IC50	uM	100.0
	20600569	CHEMBL4603521	Inhibition of recombinant full length human His-tagged LYN-A expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3905	Homo sapiens	IC50	uM	100.0
	20609573	CHEMBL4605810	Inhibition of LYN (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	=	IC50	nM	410.0	CHEMBL3905	Homo sapiens	IC50	uM	0.41
	20609574	CHEMBL4605810	Inhibition of LYN (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	67.0	CHEMBL3905	Homo sapiens	IC50	uM	0.067
	20609575	CHEMBL4605810	Inhibition of LYN (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	1500.0	CHEMBL3905	Homo sapiens	IC50	uM	1.5
	20651773	CHEMBL4615953	Inhibition of human LynB using His-tagged Rb truncated protein as substrate incubated for 30 mins in presence of ATP at Km concentration by HTRF assay	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cncc(CO)c3)cc12		CHEMBL4640019	<	IC50	nM	10.0	CHEMBL3905	Homo sapiens	IC50	uM	0.01
	20654888	CHEMBL4616954	Inhibition of LYN (unknown origin)	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Ki	nM	3467.37	CHEMBL3905	Homo sapiens	pKi		5.46
	20667005	CHEMBL4619607	Inhibition of human LYN using poly(Glu,Tyr)4:1 substrate and [gamma-33P]-ATP incubated for 40 mins by scintillation counting method	A	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C(=O)CCCc4cn(CCOCCOCCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640401	=	IC50	nM	44.2	CHEMBL3905	Homo sapiens	IC50	nM	44.2
	20667006	CHEMBL4619607	Inhibition of human LYN using poly(Glu,Tyr)4:1 substrate and [gamma-33P]-ATP incubated for 40 mins by scintillation counting method	A	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.9	CHEMBL3905	Homo sapiens	IC50	nM	1.9
	20681261	CHEMBL4623166	Inhibition of LYN (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4644718	=	IC50	nM	16.0	CHEMBL3905	Homo sapiens	IC50	nM	16.0
	20681262	CHEMBL4623166	Inhibition of LYN (unknown origin) using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	55.0	CHEMBL3905	Homo sapiens	IC50	nM	55.0
	20694150	CHEMBL4626229	Inhibition of LYN (unknown origin) at 1 uM relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	=	Inhibition	%	51.0	CHEMBL3905	Homo sapiens	INH	%	51.0
Active	20694323	CHEMBL4626288	Inhibition of LYN (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	20709564	CHEMBL4628912	Inhibition of Lyn (unknown origin)	B	Cc1cccc(Oc2cnc(O)nc2)c1		CHEMBL8030	=	EC50	nM	63.0	CHEMBL3905	Homo sapiens	EC50	nM	63.0
	22392091	CHEMBL4667186	Inhibition of LYN (unknown origin) by selectscreen kinase assay	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	8.0	CHEMBL3905	Homo sapiens	INH	%	8.0
	22423083	CHEMBL4674098	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL3905	Homo sapiens	INH	%	80.0
	22423497	CHEMBL4674324	Inhibition of human LYN-B using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	91.84	CHEMBL3905	Homo sapiens	Activity	%	91.84
	22423498	CHEMBL4674324	Inhibition of human LYN-B using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	87.91	CHEMBL3905	Homo sapiens	Activity	%	87.91
	22423499	CHEMBL4674325	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	53.06	CHEMBL3905	Homo sapiens	Activity	%	53.06
	22423500	CHEMBL4674325	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	48.06	CHEMBL3905	Homo sapiens	Activity	%	48.06
	22425204	CHEMBL4674899	Inhibition of human LYN at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CCCCCCCC(=O)Nc1nc2[nH]c(CN3CCN(Cc4cccc(F)c4)CC3)c(CN3CCN(Cc4cccc(F)c4)CC3)c2c(=O)[nH]1		CHEMBL4786524	=	Inhibition	%	70.3	CHEMBL3905	Homo sapiens	INH	%	70.3
	22751938	CHEMBL4700045	Binding affinity to LYN in human K562 cells at 1 mM incubated for 2 hrs by LC-MS/MS analysis based pull down assay relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccc(NCCCN)cc5nc43)cc2)cc1		CHEMBL4776609	=	FC		1721.0	CHEMBL3905	Homo sapiens	FC		1721.0
	22751953	CHEMBL4700060	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)cc1		CHEMBL4792853	=	Inhibition	%	0.5	CHEMBL3905	Homo sapiens	INH	%	0.5
	22751954	CHEMBL4700060	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccc(NCCCN)cc5nc43)cc2)cc1		CHEMBL4776609	=	Inhibition	%	0.85	CHEMBL3905	Homo sapiens	INH	%	0.85
Not Determined	22752723	CHEMBL4700184	Inhibition of human LYN by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		IC50			CHEMBL3905	Homo sapiens	IC50		
	22752724	CHEMBL4700184	Inhibition of human LYN by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	IC50	nM	24800.0	CHEMBL3905	Homo sapiens	IC50	uM	24.8
	22809750	CHEMBL4713285	Inhibition of recombinant full length human Lyn assessed as residual activity at 1 uM using poly[Glu:Tyr] 4:1 as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	26.0	CHEMBL3905	Homo sapiens	Activity	%	26.0
	22818113	CHEMBL4715336	Inhibition of recombinant human N-terminal His6-tagged full-length LYN expressed in Sf21 insect cells at 2 uM using Poly (Glu4-Tyr) (4:1) as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL3905	Homo sapiens	INH	%	50.0
	22820510	CHEMBL4716257	Inhibition of recombinant full length N-terminal His6-tagged human LYN expressed in Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	98.0	CHEMBL3905	Homo sapiens	Activity	%	98.0
	22820511	CHEMBL4716257	Inhibition of recombinant full length N-terminal His6-tagged human LYN expressed in Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	1.0	CHEMBL3905	Homo sapiens	Activity	%	1.0
	22823746	CHEMBL4717046	Inhibition of human LYNB	B	C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1		CHEMBL4103954	=	IC50	nM	131.0	CHEMBL3905	Homo sapiens	IC50	nM	131.0
	22823747	CHEMBL4717046	Inhibition of human LYNB	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1		CHEMBL4799627	=	IC50	nM	184.0	CHEMBL3905	Homo sapiens	IC50	nM	184.0
	22823748	CHEMBL4717046	Inhibition of human LYNB	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1		CHEMBL4094125	=	IC50	nM	399.0	CHEMBL3905	Homo sapiens	IC50	nM	399.0
	22836288	CHEMBL4718870	Inhibition of recombinant full length human GST-tagged LYN-A expressed in insect cells at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	22836289	CHEMBL4718870	Inhibition of recombinant full length human GST-tagged LYN-A expressed in insect cells at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	16.0	CHEMBL3905	Homo sapiens	INH	%	16.0
	22836290	CHEMBL4718870	Inhibition of recombinant full length human GST-tagged LYN-A expressed in insect cells at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	13.0	CHEMBL3905	Homo sapiens	INH	%	13.0
	22836291	CHEMBL4718870	Inhibition of recombinant full length human GST-tagged LYN-A expressed in insect cells at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	14.0	CHEMBL3905	Homo sapiens	INH	%	14.0
	22836292	CHEMBL4718870	Inhibition of recombinant full length human GST-tagged LYN-A expressed in insect cells at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	52.0	CHEMBL3905	Homo sapiens	INH	%	52.0
	22836293	CHEMBL4718870	Inhibition of recombinant full length human GST-tagged LYN-A expressed in insect cells at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	47.0	CHEMBL3905	Homo sapiens	INH	%	47.0
	22836294	CHEMBL4718871	Inhibition of recombinant full length human His-tagged LYN-B expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contro	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	22836295	CHEMBL4718871	Inhibition of recombinant full length human His-tagged LYN-B expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contro	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	49.0	CHEMBL3905	Homo sapiens	INH	%	49.0
	22836296	CHEMBL4718871	Inhibition of recombinant full length human His-tagged LYN-B expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contro	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	68.0	CHEMBL3905	Homo sapiens	INH	%	68.0
	22836297	CHEMBL4718871	Inhibition of recombinant full length human His-tagged LYN-B expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contro	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	44.0	CHEMBL3905	Homo sapiens	INH	%	44.0
	22836298	CHEMBL4718871	Inhibition of recombinant full length human His-tagged LYN-B expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contro	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	64.0	CHEMBL3905	Homo sapiens	INH	%	64.0
	22836299	CHEMBL4718871	Inhibition of recombinant full length human His-tagged LYN-B expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to contro	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	60.0	CHEMBL3905	Homo sapiens	INH	%	60.0
	22843240	CHEMBL4720256	Inhibition of recombinant human LYN using biotinyl-beta Abeta-Abeta AKVEKIGEGTYGVVYK as substrate incubate for 120 mins by LANCE assay	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	=	IC50	nM	259.0	CHEMBL3905	Homo sapiens	IC50	nM	259.0
	22843241	CHEMBL4720256	Inhibition of recombinant human LYN using biotinyl-beta Abeta-Abeta AKVEKIGEGTYGVVYK as substrate incubate for 120 mins by LANCE assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	200.0	CHEMBL3905	Homo sapiens	IC50	nM	200.0
	22843688	CHEMBL4720674	Inhibition of human LYN-B using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.964	CHEMBL3905	Homo sapiens	IC50	10^-10M	9.64
	22843690	CHEMBL4720676	Inhibition of human LYN using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.728	CHEMBL3905	Homo sapiens	IC50	10^-10M	7.28
	22844038	CHEMBL4721024	Inhibition of human LYN-B assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	65.74	CHEMBL3905	Homo sapiens	Activity	%	65.74
	22844040	CHEMBL4721026	Inhibition of human LYN assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	61.51	CHEMBL3905	Homo sapiens	Activity	%	61.51
	22844757	CHEMBL4721432	Inhibition of wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.68	CHEMBL3905	Homo sapiens	Activity	%	99.68
	22844758	CHEMBL4721433	Inhibition of human LYN B assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	97.52	CHEMBL3905	Homo sapiens	Activity	%	97.52
	22845479	CHEMBL4721760	Binding affinity to Nluc-tagged LYN (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	5.25	CHEMBL3905	Homo sapiens	deltaTm	degrees C	5.25
	22845499	CHEMBL4721780	Binding affinity to LYN (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.16	CHEMBL3905	Homo sapiens	IC50	nM	0.16
	22874823	CHEMBL4725514	Inhibition of human LYN assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	1.0	CHEMBL3905	Homo sapiens	Activity	%	1.0
	22874857	CHEMBL4725548	Inhibition of human LYN assessed as remaining enzyme activity at 0.1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	21.0	CHEMBL3905	Homo sapiens	Activity	%	21.0
	22874883	CHEMBL4725574	Inhibition of human LYN assessed as remaining enzyme activity at 0.01 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	32.0	CHEMBL3905	Homo sapiens	Activity	%	32.0
	22882858	CHEMBL4727426	Inhibition of LYNB (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4749037	=	IC50	nM	49.0	CHEMBL3905	Homo sapiens	IC50	nM	49.0
	22882859	CHEMBL4727426	Inhibition of LYNB (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4106978	=	IC50	nM	20.0	CHEMBL3905	Homo sapiens	IC50	nM	20.0
	22882860	CHEMBL4727426	Inhibition of LYNB (unknown origin)	B	CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21		CHEMBL4108687	=	IC50	nM	79.0	CHEMBL3905	Homo sapiens	IC50	nM	79.0
	22882861	CHEMBL4727426	Inhibition of LYNB (unknown origin)	B	COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12		CHEMBL4114929	=	IC50	nM	162.0	CHEMBL3905	Homo sapiens	IC50	nM	162.0
	22882862	CHEMBL4727426	Inhibition of LYNB (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12		CHEMBL4107779	=	IC50	nM	865.0	CHEMBL3905	Homo sapiens	IC50	nM	865.0
	22950578	CHEMBL4766145	Inhibition of human full length recombinant LYN using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	4.0	CHEMBL3905	Homo sapiens	IC50	uM	0.004
	22952887	CHEMBL4766824	Inhibition of recombinant human Lyn assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	1.0	CHEMBL3905	Homo sapiens	Activity	%	1.0
	22953095	CHEMBL4767032	Inhibition of recombinant human Lyn using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	122.0	CHEMBL3905	Homo sapiens	IC50	uM	0.122
	23120560	CHEMBL4804410	Inhibition of LYN in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-41400.0	CHEMBL3905	Homo sapiens	IC50	uM	-41.4
	23120561	CHEMBL4804410	Inhibition of LYN in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-10300.0	CHEMBL3905	Homo sapiens	IC50	uM	-10.3
	23120562	CHEMBL4804410	Inhibition of LYN in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-42200.0	CHEMBL3905	Homo sapiens	IC50	uM	-42.2
	23120563	CHEMBL4804410	Inhibition of LYN in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-21900.0	CHEMBL3905	Homo sapiens	IC50	uM	-21.9
	23120564	CHEMBL4804410	Inhibition of LYN in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-1300.0	CHEMBL3905	Homo sapiens	IC50	uM	-1.3
	23120565	CHEMBL4804410	Inhibition of LYN in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-12400.0	CHEMBL3905	Homo sapiens	IC50	uM	-12.4
	23121599	CHEMBL4804592	Inhibition of LYN in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	23121600	CHEMBL4804592	Inhibition of LYN in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	23121601	CHEMBL4804592	Inhibition of LYN in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	23121602	CHEMBL4804592	Inhibition of LYN in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	23121603	CHEMBL4804592	Inhibition of LYN in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	23121604	CHEMBL4804592	Inhibition of LYN in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL3905	Homo sapiens	INH	%	0.0
	23122646	CHEMBL4804997	Inhibition of human LYN assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	88.0	CHEMBL3905	Homo sapiens	Activity	%	88.0
	23123341	CHEMBL4805585	Inhibition of human LYN assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	77.0	CHEMBL3905	Homo sapiens	Activity	%	77.0
	23123800	CHEMBL4806044	Inhibition of DNA-tagged human LYN assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3905	Homo sapiens	Activity	%	100.0
	23124772	CHEMBL4806602	Inhibition of human LYN assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3905	Homo sapiens	Activity	%	100.0
	23124773	CHEMBL4806602	Inhibition of human LYN assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL3905	Homo sapiens	Activity	%	98.0
	23128236	CHEMBL4807887	Inhibition of LYN (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL3905	Homo sapiens	Activity	%	25.0
	23128237	CHEMBL4807887	Inhibition of LYN (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL3905	Homo sapiens	Activity	%	25.0
	23128238	CHEMBL4807887	Inhibition of LYN (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL3905	Homo sapiens	Activity	%	25.0
	23128782	CHEMBL4808060	Inhibition of LYNB (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	93.0	CHEMBL3905	Homo sapiens	INH	%	93.0
	23180264	CHEMBL4816267	Inhibition of human LYN at 0.1 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	B	Cc1ccc(NC(=O)c2ccc(C(F)(F)F)nc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL4846916	=	Inhibition	%	93.0	CHEMBL3905	Homo sapiens	INH	%	93.0
	23265644	CHEMBL4834279	Inhibition of LYN (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	130.0	CHEMBL3905	Homo sapiens	IC50	uM	0.13
	23265645	CHEMBL4834279	Inhibition of LYN (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	170.0	CHEMBL3905	Homo sapiens	IC50	uM	0.17
	23265646	CHEMBL4834279	Inhibition of LYN (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	=	IC50	nM	5000.0	CHEMBL3905	Homo sapiens	IC50	uM	5.0
Not Active	23270425	CHEMBL4835219	Inhibition of Lyn A kinase (unknown origin) at 10 uM	B	C[C@H]1CN(C(=O)CC[C@@]2(C3CC3)NC(=O)NC2=O)CCN1c1cc(F)cc(F)c1		CHEMBL4650334		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
	23284727	CHEMBL4838037	Inhibition of recombinant full length human Lyn at 10 uM using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	>	Inhibition	%	90.0	CHEMBL3905	Homo sapiens	INH	%	90.0
	23291270	CHEMBL4839539	Inhibition of human full length recombinant LYN at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	19.0	CHEMBL3905	Homo sapiens	INH	%	19.0
	23291271	CHEMBL4839539	Inhibition of human full length recombinant LYN at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	96.0	CHEMBL3905	Homo sapiens	INH	%	96.0
	23291272	CHEMBL4839539	Inhibition of human full length recombinant LYN at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	41.0	CHEMBL3905	Homo sapiens	INH	%	41.0
	23291342	CHEMBL4839563	Inhibition of human full length recombinant LYN at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	93.0	CHEMBL3905	Homo sapiens	INH	%	93.0
	23291343	CHEMBL4839563	Inhibition of human full length recombinant LYN at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	99.0	CHEMBL3905	Homo sapiens	INH	%	99.0
	23291344	CHEMBL4839563	Inhibition of human full length recombinant LYN at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	105.0	CHEMBL3905	Homo sapiens	INH	%	105.0
	23291414	CHEMBL4839587	Inhibition of human full length recombinant LYN at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	105.0	CHEMBL3905	Homo sapiens	INH	%	105.0
	23291415	CHEMBL4839587	Inhibition of human full length recombinant LYN at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	99.0	CHEMBL3905	Homo sapiens	INH	%	99.0
	23291416	CHEMBL4839587	Inhibition of human full length recombinant LYN at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	96.0	CHEMBL3905	Homo sapiens	INH	%	96.0
	23291448	CHEMBL4839599	Inhibition of human full length recombinant LYN by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	IC50	nM	7.0	CHEMBL3905	Homo sapiens	IC50	nM	7.0
	23291449	CHEMBL4839599	Inhibition of human full length recombinant LYN by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	IC50	nM	9.0	CHEMBL3905	Homo sapiens	IC50	nM	9.0
Not Active	23299138	CHEMBL4841682	Inhibition of LYN (unknown origin)	A	C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N		CHEMBL4864983		Inhibition	%		CHEMBL3905	Homo sapiens	INH		
Not Active	23317481	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	87.0	CHEMBL3905	Homo sapiens	% Control	%	87.0
Not Active	23317949	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23318616	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	90.0	CHEMBL3905	Homo sapiens	% Control	%	90.0
Not Active	23319099	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23319736	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23320211	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	75.1	CHEMBL3905	Homo sapiens	% Control	%	75.1
Not Active	23320889	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23321357	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	95.0	CHEMBL3905	Homo sapiens	% Control	%	95.0
Not Active	23321987	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	90.0	CHEMBL3905	Homo sapiens	% Control	%	90.0
Not Active	23322455	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL3905	Homo sapiens	% Control	%	96.0
Not Active	23323144	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23323612	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	88.0	CHEMBL3905	Homo sapiens	% Control	%	88.0
Not Active	23324048	CHEMBL4880667	Lyn (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-1.0	CHEMBL3905	Homo sapiens	% inhibition	%	-1.0
Not Active	23324466	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	96.8	CHEMBL3905	Homo sapiens	% Control	%	96.8
Not Active	23325101	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	92.0	CHEMBL3905	Homo sapiens	% Control	%	92.0
Not Active	23325569	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	97.0	CHEMBL3905	Homo sapiens	% Control	%	97.0
Not Active	23326216	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	99.0	CHEMBL3905	Homo sapiens	% Control	%	99.0
Not Active	23326684	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	83.0	CHEMBL3905	Homo sapiens	% Control	%	83.0
Not Active	23327384	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23327852	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23328439	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23328907	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	99.0	CHEMBL3905	Homo sapiens	% Control	%	99.0
Not Active	23329398	CHEMBL4881105	Lyn(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	100.0	CHEMBL3905	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23329853	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	75.0	CHEMBL3905	Homo sapiens	% Control	%	75.0
Not Active	23330321	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23331077	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	85.0	CHEMBL3905	Homo sapiens	% Control	%	85.0
Not Active	23331545	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23331891	CHEMBL4881431	NanoBRET assay (SGC) with LYN	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1	Non standard unit for type	CHEMBL3907057		IC50	M	8.2	CHEMBL3905	Homo sapiens	IC50	M	8.2
Not Active	23331899	CHEMBL4881439	NanoBRET assay (SGC) with LYN	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1	Non standard unit for type	CHEMBL4526351		IC50	M	7.0	CHEMBL3905	Homo sapiens	IC50	M	7.0
Slightly Active	23332132	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	46.0	CHEMBL3905	Homo sapiens	% Control	%	46.0
Not Active	23332598	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23333316	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23333666	CHEMBL4881469	Lyn(h) Eurofins Kinase panel	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% residual kinase activity	%	88.0	CHEMBL3905	Homo sapiens	% residual kinase activity	%	88.0
Not Active	23333955	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23334423	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23334911	CHEMBL4881534	Lyn (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	31.0	CHEMBL3905	Homo sapiens	% inhibition	%	31.0
Not Active	23335402	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	81.0	CHEMBL3905	Homo sapiens	% Control	%	81.0
Not Active	23335870	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	99.0	CHEMBL3905	Homo sapiens	% Control	%	99.0
Not Active	23336497	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23336965	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23337384	CHEMBL4881755	LYNAKINASE(H) Cerep selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	87.0	CHEMBL3905	Homo sapiens	% Ctrl	%	87.0
Not Active	23337642	CHEMBL4882013	LYN A Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	93.0	CHEMBL3905	Homo sapiens	% Ctrl	%	93.0
Not Active	23337643	CHEMBL4882014	LYN B Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	89.0	CHEMBL3905	Homo sapiens	% Ctrl	%	89.0
Not Active	23338046	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	87.0	CHEMBL3905	Homo sapiens	% Control	%	87.0
Not Active	23338514	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	79.0	CHEMBL3905	Homo sapiens	% Control	%	79.0
Not Active	23339126	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23339594	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23340231	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23340699	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23341356	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23341824	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	94.0	CHEMBL3905	Homo sapiens	% Control	%	94.0
Not Active	23342440	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23342908	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	92.0	CHEMBL3905	Homo sapiens	% Control	%	92.0
Not Active	23343538	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23344006	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23344644	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	81.0	CHEMBL3905	Homo sapiens	% Control	%	81.0
Not Active	23345217	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	94.0	CHEMBL3905	Homo sapiens	% Control	%	94.0
Not Active	23345685	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	87.0	CHEMBL3905	Homo sapiens	% Control	%	87.0
Not Active	23346262	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23346730	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23347332	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	84.5	CHEMBL3905	Homo sapiens	% Control	%	84.5
Not Active	23347822	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23348401	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23348869	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23349456	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	91.0	CHEMBL3905	Homo sapiens	% Control	%	91.0
Not Active	23350074	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23350542	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23351147	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23351615	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23352092	CHEMBL4882783	LYN A Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	1.053	CHEMBL3905	Homo sapiens	% Inhibition	%	1.053
Not Active	23352093	CHEMBL4882784	LYN B Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.942	CHEMBL3905	Homo sapiens	% Inhibition	%	3.9425
Not Active	23352639	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	98.0	CHEMBL3905	Homo sapiens	% Control	%	98.0
Not Active	23353107	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	82.0	CHEMBL3905	Homo sapiens	% Control	%	82.0
Not Active	23353989	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23354457	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	90.0	CHEMBL3905	Homo sapiens	% Control	%	90.0
Not Active	23355189	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	73.0	CHEMBL3905	Homo sapiens	% Control	%	73.0
Not Active	23355657	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	88.0	CHEMBL3905	Homo sapiens	% Control	%	88.0
Not Active	23356293	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23356761	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	82.0	CHEMBL3905	Homo sapiens	% Control	%	82.0
Not Active	23357370	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23358017	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23358485	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	97.0	CHEMBL3905	Homo sapiens	% Control	%	97.0
Not Active	23359071	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	93.7	CHEMBL3905	Homo sapiens	% Control	%	93.7
Not Active	23359669	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	81.0	CHEMBL3905	Homo sapiens	% Control	%	81.0
Not Active	23360137	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	80.0	CHEMBL3905	Homo sapiens	% Control	%	80.0
Not Active	23360722	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23361190	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	88.0	CHEMBL3905	Homo sapiens	% Control	%	88.0
Not Active	23361763	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23362299	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23362767	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	95.0	CHEMBL3905	Homo sapiens	% Control	%	95.0
Not Active	23364409	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	74.0	CHEMBL3905	Homo sapiens	% Control	%	74.0
Not Active	23364877	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	99.0	CHEMBL3905	Homo sapiens	% Control	%	99.0
Not Active	23365616	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23366159	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23366749	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23367217	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23367622	CHEMBL4883975	LYN ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	98.0	CHEMBL3905	Homo sapiens	% Residual activity with Skepinone-L	%	98.0
Not Active	23368095	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	82.0	CHEMBL3905	Homo sapiens	% Control	%	82.0
Not Active	23368563	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL3905	Homo sapiens	% Control	%	95.0
Not Active	23369162	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	97.0	CHEMBL3905	Homo sapiens	% Control	%	97.0
Not Active	23369630	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	94.0	CHEMBL3905	Homo sapiens	% Control	%	94.0
Not Active	23370119	CHEMBL4884363	Lyn(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	110.0	CHEMBL3905	Homo sapiens	% residual kinase activity	%	110.0
Not Active	23370598	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	86.0	CHEMBL3905	Homo sapiens	% Control	%	86.0
Not Active	23371066	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	89.0	CHEMBL3905	Homo sapiens	% Control	%	89.0
Not Active	23371875	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23372343	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	96.0	CHEMBL3905	Homo sapiens	% Control	%	96.0
	23373726	CHEMBL4885503	Lyn(LYN1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3905	Homo sapiens	pIC50		6.0
Not Active	23375023	CHEMBL4886013	Lyn Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	55.3	CHEMBL3905	Homo sapiens	% Inhibition	%	55.3
Not Active	23375413	CHEMBL4886395	v-yes-1 Yamaguchi sarcoma viral related oncogene homolog  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-1.0	CHEMBL3905	Homo sapiens	% inhibition	%	-1.0
Not Active	23375770	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	93.0	CHEMBL3905	Homo sapiens	% Control	%	93.0
Not Active	23376238	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	78.0	CHEMBL3905	Homo sapiens	% Control	%	78.0
Not Active	23376815	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23377283	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	80.0	CHEMBL3905	Homo sapiens	% Control	%	80.0
Not Active	23378143	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	89.0	CHEMBL3905	Homo sapiens	% Control	%	89.0
Not Active	23378611	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23379778	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23380246	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	99.0	CHEMBL3905	Homo sapiens	% Control	%	99.0
Not Active	23380652	CHEMBL4887005	Lyn kinase (h) CEREP ligand profiling	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		Inhibition	%	2.0	CHEMBL3905	Homo sapiens	% inhibition	%	2.0
Not Active	23380940	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	85.0	CHEMBL3905	Homo sapiens	% Control	%	85.0
Not Active	23381588	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3905	Homo sapiens	% Control	%	100.0
Not Active	23382056	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	95.0	CHEMBL3905	Homo sapiens	% Control	%	95.0
Not Active	23382445	CHEMBL4887106	Cerep profiling assay (LYN)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		IC50	nM	1100.0	CHEMBL3905	Homo sapiens	IC50	nM	1100.0
Not Active	23382680	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	85.0	CHEMBL3905	Homo sapiens	% Control	%	85.0
Not Active	23383148	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	80.0	CHEMBL3905	Homo sapiens	% Control	%	80.0
Not Active	23383845	CHEMBL4887470	LYN A Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	82.0	CHEMBL3905	Homo sapiens	% Ctrl	%	82.0
Not Active	23383846	CHEMBL4887471	LYN B Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	78.0	CHEMBL3905	Homo sapiens	% Ctrl	%	78.0
Not Active	23384332	CHEMBL4887927	Lyn(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	12.49	CHEMBL3905	Homo sapiens	% inhibition	%	12.49
Not Active	23385063	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	77.0	CHEMBL3905	Homo sapiens	% Control	%	77.0
Not Active	23385530	CHEMBL4879787	KinomeScan assay: inhibition of LYN	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	97.0	CHEMBL3905	Homo sapiens	% Control	%	97.0
